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ABSTRACT
Feeding of modified diets to Wistar rats modulated various drug - 
metabolising enzymes including the cytochrome P450 monooxygenases, the 
Phase II conjugation enzymes and the enzymes providing protection from 
oxidative damage.
Replacement of dietary carbohydrate derived from starch with glucose 
or fructose were largely without effect towards the cytochromes P450 
monooxygenases or the Phase II conjugation enzymes. However, diets high in 
sucrose decreased lauric acid hydroxylase activity and modestly decreased 
cytosolic catalase.
Administration of vitamin E - deficient diets for seven weeks decreased 
hepatic pentoxyresorufin - O - dealkylase and increased erythromycin N - 
demethylase, however, CYP3A apoprotein levels were not influenced by this 
treatment.
Intermittent dietary restriction was observed to retard the growth of 
rats. In addition, periods of calorie restriction were found to decrease serum 
concentrations of triglycerides and cholesterol. Changes to hepatic microsomal 
suspensions were also recorded, including increases in the activities of 
methoxy- and pentoxy - resoruhn - O - dealkylase and in total cytochrome 
P450 concentrations. Upon subsequent refeeding, these changes returned to 
control levels within 24 hours. Repeated cycles of food restriction and 
refeeding had no effect on hepatic cytochromes P450. Food restriction also 
decreased hepatic glutathione concentrations and induced a compensatory 
increase in hepatic glutathione reductase activity.
Oral intubation of increasing concentrations of sodium/copper 
chlorophyllin had no effect on cytochrome P450 monooxygenases and 
produced only modest increases in the activity of glutathione - S - transferase, 
at the lowest dose of chlorophyllin administered. The potent antimutagenic
properties of chlorophyllin in the Ames test were confirmed during these 
studies.
Modification of dietary methionine levels, whether deficiency or 
supplementation, could modulate the activities of hepatic cytochromes P450. 
Dietary supplementation with methionine induced CYP2E1 activity, as 
exemplified by p - nitrophenol hydroxylase. Dietary methionine deficiency 
decreased the liver* weight and, in 'the presence of the procarcinogen 
benzo[a]pyrene, caused a profound hypertrophy of the liver. In addition, 
induction of CYP1A2 by benzo[a]pyrene was potentiated by methionine 
deficiency. Moreover, methionine deficiency decreased hepatic glutathione 
concentrations by ~80% and caused a compensatory increase in hepatic 
glutathione reductase activity. Dietary methionine deficiency enhanced the 
expression of hepatic c - myc oncogene products as recorded by immunoblot 
analysis.
Investigation of dietary methionine deficiency upon renal and 
pulmonary tissue revealed that deficiency decreased lauric acid hydroxylase 
activity in the kidney. When methionine deficient animals were treated with 
benzo[a]pyrene, a profound induction of renal microsomal lauric acid 
hydroxylase activity was recorded. In addition, the combined treatments of 
methionine deficiency and benzo[a]pyrene administration also decreased 
pulmonary glutathione reductase activity compared to benzo[a]pyrene - 
pretreated rats receiving a control diet. These observations suggest that 
methionine deficiency may have limited effects upon pulmonary and renal 
tissues, the greatest impact being observed in the liver.
Critical appraisal of the efficacy of dietary antimutagens and 
anticarcinogens has revealed that many classes of such anutrients, whilst 
demonstrating potent anti - cancer properties in rodent bioassays, may be of 
limited efficacy for human subjects as insufficient quantities of these anutrient 
species are consumed in the diet or absorbed from the GI tract.
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Chapter 1
INTRODUCTION
1.1 Introduction
The recent publicity, verging upon obsession, with the importance of 
eating a balanced diet has overshadowed the scientific approach that has been 
taken to investigating the role dietary factors play in the regulation of drug 
metabolism. Even at the beginning of the century narrators of the time were 
making judgements upon where changes to the diet may lead -
'The doctor o f the future will give no medicine hut will 
interest his patients in the care o f the human frame, in diet, and 
in the cause and prevention o f disease.'
Thomas Edison ( 1847-1931)
Recent reviews (Parke and loannides 1994; Anderson and Kappas 
1991; Statland 1992; Rogers et al. 1993) have highlighted the impact of dietary 
components on the metabolism of xenobiotics and ultimately the cytochrome 
P450 mixed - function oxidase system which is largely responsible for phase I 
reactions leading to the elimination of chemicals. The cytochrome P450 system 
is involved in the functionalisation of xenobiotics leading to their elimination as 
conjugates following subsequent Phase II metabolism. Several authors have 
also documented the potential beneficial or preventive effects of altering dietary 
regimes (Wattenberg 1991; Hayatsu et al. 1993; Collins et al. 1994).
This introduction seeks to outline the importance of the xenobiotic 
metabolising enzymes, and particularly the cytochrome P450 monooxygenase 
system, and how altering components within the diet or dietary regimes can 
influence the profile of enzymes and the metabolism of carcinogens.
1.2 Carcinogenesis
Carcinogenesis is a multistage process that involves the transformation 
of a normal cell to a cell possessing a malignant phenotype. Despite extensive 
investigation the process is not clearly understood, although several 
mechanisms have been proposed. Widely accepted as a multistage process it is 
divided into initiation, promotion and progression phases (Figure 1.1); this 
model for carcinogenesis requires modification of the DNA - a genotoxic event 
- in order to trigger the transformation process. Further investigations have 
revealed that certain classes of chemicals can initiate chemical carcinogenesis 
without the need for a genotoxic event, resulting in non - genotoxic 
carcinogenesis.
1.2.1 Initiation
Described as a persistent and heritable alteration to a cell, initiation 
creates the potential for a cell, or those derived from it, to undergo malignant 
transformation if promotion occurs.
The process of initiation results from the chemical interaction of a 
reactive species with the DNA to yield a modification to the genetic code. The 
change may be persistent and heritable, in the form of a covalent modification 
resulting fi’om direct reaction, or may result fi"om an indirect reaction with 
DNA material that may hinder the duplication of the genetic code. This process 
of modification of the DNA can result fi’om the direct interaction with 
carcinogens, the direct - acting carcinogens, or may result only after 
metabolism of the chemical agent to yield an active species. This process of 
metabolic activation is an enzyme - mediated conversion of inactive 
procarcinogen to yield the ultimate carcinogenic species (Figure 1.2). One class 
of enzymes principally involved in this functionalisation of the procarcinogens 
to yield the ultimate carcinogenic species is the cytochrome P450 
monooxygenases.
Figure 1.1: Schematic Representation of Chemical Carcinogenesis
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1.2.2 Cytochromes P450
The cytochromes P450 are a large class of membrane bound, haem - 
containing proteins that are involved in the direct oxygenation of endogenous 
and xenobiotic compounds (Bast 1986). They are a series of related proteins 
divided into subfamilies by structural similarity. Given the vast number of genes 
coding for the cytochromes P450 (221 characterised by December 1994) 
(Nelson et al. 1993) a nomenclature was devised to subdivide these genes into 
families and subfamilies. Briefly, the prefix 'CYP' (derived from Cytochrome 
P450) is followed by a number, denoting the family from which the enzyme is 
derived, a letter, designating the subfamily, and finally a number regarding the 
individual gene within a subfamily (Nelson et al. 1993). The cytochromes P450 
exhibit the property of substrate specificity (Guengerich 1988), certain isoforms 
of the enzyme only metabolising particular compounds. However Hall et al.
(1989) have demonstrated that the same compound may be metabolised by 
several cytochromes P450. This was exemplified by cytochromes P450 
isoforms CYPlAl, CYP1A2, CYP2A1 and CYP2B1, all described to 
metabolise benzo[a]pyrene in vitro. In addition, potential substrates for the 
cytochrome P450 monooxygenases can be metabolised at different positions on 
the parent molecule, by different isoforms of P450, to yield different 
metabolites. Examples include lauric acid which can undergo 11 - 
hydroxylation by CYP2E1 (Fukuda et al. 1994; Amet et al. 1994) and by 
CYP2C2 (Fukuda et al. 1994); or 12 - hydroxylation by CYP4A1 (Parker and 
Orton 1980). Such differences in metabolism can have profound effects upon 
the fate of chemical species, exemplified in figure 1.3 for the Procarcinogen IQ. 
Other examples include indole - 3 - carbinol. Stresser et al. (1994a; 1994b) 
document that supplementation of rat diets with indole - 3 - carbinol (13 C) 
elevated the expression of CYPlAl, CYP1A2 and CYP3A1/2. In addition, in 
vitro metabolism studies using hepatic microsomal suspensions from 13 C - 
treated rats showed an increase in the conversion of the mycotoxin aflatoxin B%
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Figure 1.3 Representation of the Possible Routes of Metabolism 
For 2-Amino-3-Methylimidazo[4,5-f]Quinoline (IQ) Catalysed by 
Cytochromes P450
to metabolites AFQ| and AFM%. Both these metabolites were believed to 
represent a detoxication process and were attributed to increased CYP3A1/2 
and CYP1A2 expression respectively. In addition, treatment of rats with an 
inducer, P - naphthoflavone (BNF), resulted in the induction of CYPlAl 
predominantly and increased production of AFB] - 8,9 - epoxide, the ultimate 
carcinogenic metabolite of AFBj; thus illustrating that the metabolic fate of a 
chemical species may be dependent upon the route of metabolism, and by 
inference the isoform of cytochrome P450 present.
The cytochromes P450 also show many sex - specific (Kobliakov et al. 
1991) and species - specific differences (Degawa et al. 1987).
Of particular interest with regard to the cytochromes P450 was the 
demonstration of inducibility, the ability of certain compounds selectively to 
increase one or more enzyme proteins, usually involved in the degradation of 
that compound. A clear example of such a compound would be TCDD, 
responsible for the induction of a variety of proteins including CYPlAl and 
CYP1A2 isoforms of cytochromes P450 as well as glucuronosyl transferases 
(Kohn et al. 1993). This is achieved by complex formation between the Ah 
receptor protein and TCDD to yield an active receptor - ligand complex which 
binds to DNA - responsive elements increasing the transcription of TCDD 
responsive genes (Whitlock 1989; Nebert and Gonzalez 1985). This receptor - 
specific mechanism is not universal for all of the isoforms of cytochromes 
P450. Indeed, experiments using two different strains of mice, C57 noted to be 
Ah receptor positive, and DBA, lacking a functional Ah receptor in the cytosol, 
have shown that both strains of mice have the ability to increase the expression 
of CYPlAl and CYP1A2, in the presence of aroclor 1254, independently of a 
functional Ah receptor protein (Chou et al. 1993b). Also, the drug 
phénobarbital has been found to be responsible for the induction of CYP2B 
isoform of cytochrome P450 due to increases in mRNA synthesis (Adesnik et 
al 1981) but no receptor could be detected. Furthermore, the induction of
CYP2E1 associated with both ethanol and isoniazid treatment of rats was 
described to result from the translational activation of the mRNA coding for 
CYP2E1. This involved a process of mRNA stabilisation to hinder the 
degradation of the mRNA message. Increasing the translation of the message 
increased the levels of apoprotein detected by both immunoblotting and in vitro 
enzyme activity (Park et al. 1993).
The expression of cytochromes P450 is not confined to hepatic tissue, 
Hellmold et al. (1993) documenting the involvement of pulmonary P450 
isoforms in the metabolic activation of the heterocyclic aromatic amines IQ, 
MelQ and PhIP studied using the Ames mutagenicity assay. These included the 
cytochrome P450 isoforms CYPlAl and CYP2A3; this was subsequently 
confirmed by antibody inhibition studies using lung microsomal suspensions 
isolated from untreated rats. However the liver may be the predominant site of 
conversion of procarcinogens to the ultimate carcinogenic species that possess 
the potential to form DNA - adducts in hepatic as well as pulmonary and renal 
tissue (Wall et al. 1991).
Metabolic activation of potential procarcinogens need not necessarily 
lead to an alteration of the genome. Cytochromes P450 are believed to be 
responsible for the functionalisation, and consequently detoxication, of 
xenobiotics rendering them suitable substrates for the conjugation enzymes to 
enhance elimination of the compounds as water soluble metabolites (figure 
1.2). For example, functionalisation of xenobiotics by cytochromes P450 to 
yield electrophilic intermediates provides the ideal substrate for the glutathione 
- S - transferases (Ketterer 1988) Indeed deficiencies in glutathione - S - 
transferase activity may be linked to increased smoking - related lung cancers 
amongst Japanese cancer patients (Kihara et al. 1994). Interestingly skin 
fibroblast cells deficient in UDP glucuronosyl transferase enzymes were more 
susceptible to micronucleus formation resulting from B[a]P treatment.
underlining the protective effect for conjugation reactions (Vienneau et al. 
1995).
The phase II conjugation enzymes, including glutathione - S - 
transferase (Aniya et al. 1993) and glucuronosyl transferases (Bock and White 
1974) also show the property of inducibility, indicating that xenobiotics may 
not only influence the expression of cytochromes P450 to enhance 
functionalisation but may also increase the elimination of compounds as a result 
of conjugation. This may indeed make a major contribution to the 
anticarcinogenic potential of indole - 3 - carbinol (Nugon - Baudon and Rabot 
1994), a dietary anutrient component found in many green vegetables 
(M^Danell et al. 1989). Shertzer and Sainsbuiy (1991a) showed that inclusion 
of I3C in diets fed to both rats and mice increased the expression of glutathione 
- S - transferases in hepatic tissue and decreased the formation of AFB% - DNA 
adducts formed in hepatic DNA isolated from Fischer 344 rats.
1.2.3 Post - Initiation Events
Alterations to the genome only become permanent after cell division has 
occurred. The damage to the cellular DNA can be repaired by DNA 
polymerase I resulting in the excision and repair of the altered bases from the 
DNA. Estimation of the enormous number of DNA - altering events that occur 
daily, purportedly as high as 10^ mutations each day (Ames and Gold 1991), 
and the low incidence of detectable cancers in humans, may offer evidence for 
the fidelity of DNA polymerase I repair processes (Ames and Gold 1991). If 
cell division occurs before repair of the genetic code the modifications become 
fixed into the genome yielding permanent mutations. Interestingly, cell 
proliferation appears to be a requirement for initiation of chemical 
carcinogenesis (Cayama et al. 1978) and many carcinogens are necrogenic in 
nature, causing cell death and compensatory cellular proliferation (Soit and 
Farber 1976).
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1.2.4 Non - Genotoxic Carcinogenesis
Recent events have established a putative mechanism for carcinogenesis
that does not require the presence of a chemical carcinogen to modify the
genome. (Shaw and Jones 1994). Increasing the rate of cell turnover increases
the probability that replication of the DNA will not maintain the fidelity of the
genome (Cohen and Ellwein 1990). Indeed, Riley (1990) has proposed,
» %
through mathematical investigation of epidemiological data regarding the age - 
related tumour incidence in human adults, that the initial event in 
carcinogenesis may simply be an enhancement of the mutation rate. This 
mechanism potentially explains the ability of chemicals, growth factors and 
hormones to cause tumours without actual modifications to the genome 
(Purchase 1994; Shaw and Jones 1994). Increasing the rate of cell turnover 
may enhance the mutation rate by including deficiencies in the rate of DNA 
repair, by a decrease in the fidelity of the mechanism to copy the genome or 
through a process involving defective or decreased detoxication mechanisms. 
This may aid the interpretations of Ames and Gold (1990) and Ames et al. 
(1990) whom documented that 50% of all compounds tested in long term 
carcinogenicity studies at the Maximum Tolerated Dose (MTD) appeared to be 
rodent carcinogens. At MTD many compounds were proposed to cause 
mitogenesis; this increase in cell division was postulated to enhance the rates of 
mutagenesis by allowing insufficient time for repair of the genetic code, or 
through decreasing the fidelity with which the genome was duplicated. Indeed 
this mitogenesis induced by chemicals was proposed as a mechanism for the 
carcinogenicity of BHA, cafifeic acid and sesamol towards rat forestomach (Ito 
et al. 1993). Moreover, proliferation of the gastric mucosa was evident as 
elevations in the rates of DNA synthesis accompanied by increased expression 
of c - fos and c - myc protooncogenes (Ito et al. 1993). These proposals are 
further substantiated by the demonstration that diets high in phénobarbital.
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uracil and sodium saccharin, all of which are reported to promote bladder 
tumours in rats, resulted in increased DNA synthesis in urinary bladder (Debeic 
- Rychter and Wang 1990).
1.2.5 Promotion Phase
Promotion of an initiated cell is characterised by the selection and clonal 
proliferation of an initiated cell (Schulte - Hermann 1985). These cells express 
phenotypic differences from the parent cell stock and although not necessarily 
malignant in nature, are incompletely restricted by the restraints of the host 
environment. Tumour promotors are essentially non - mutagenic.
Promotion can result from treatment with numerous chemicals. 
However several classes of chemical, the so - called complete carcinogens, 
cause both initiation and promotion of cells, whereas the tumour promotors 
result only in the selection of altered cells to yield preneoplastic lesions.
Although poorly understood promotion may be the result of a wide 
variety of stimuli, including chemical, hormonal and growth factors. Free 
radicals and free radical generators remain amongst the most widely studied of 
the tumour promotors and numerous reviews document the effects of oxidative 
damage with regard to tumour promotion (Troll and Wiesner 1985; Sun 1990; 
Trush and Kensler 1991). The salient points derived form these observations 
include;
i) Free radical generating compounds (hydrogen peroxide, 
cumene hydroperoxide) and free radical generating systems 
(xanthine/xanthine oxidase) behave as tumour promotors in vitro.
ii) Tumour promotors such as TPA stimulate the production of 
free radicals.
iii) Tumour promotion can be effectively inhibited by 
antioxidants.
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iiii) Tumour promotors can modulate the activities of individual 
antioxidant enzymes.
Early investigations observed that tumour promotors, principally 1 2 - 0  
- tetradecanoylphorbol - 13 - acetate (TPA), caused a prolonged decrease in 
the ratio of reduced glutathione (GSH) to glutathione disulphide (GSSG) 
coupled with a marked decrease in glutathione peroxidase activity (Perchellet 
et al. 1986). Studies using an initiation - promotion model for chemical 
carcinogenesis revealed that profound biochemical differences exist between 
normal and nodular tissue isolated from the livers of rats receiving carcinogen 
treatment (Vo et al. 1988). These included decreased activity of catalase and 
glutathione peroxidases and increases in glutathione reductase activity present 
in nodular tissue. Similar observations were noted for the tumour promotor 
TPA when applied to mouse skin (Reiners et al. 1991a; Reiners et al. 1991b). 
Application of TPA decreased epidermal catalase, glutathione peroxidase and 
superoxide dismutase activities, whilst increasing xanthine oxidase activity 
substantially (Reiners et al. 1991a). Contrary to the findings of Perchellet et al. 
(1986) Reiners et al. (1991b) observed no changes to the levels of cellular 
reduced glutathione or GSSG for the epidermis following TPA application.
The promoting effects of both phénobarbital and diets high in fat have 
also mimicked the ability to modulate antioxidant enzymes - however, these 
changes appeared to be predominantly strain - specific amongst mice (Ahotupa 
et al. 1993). C3H mice appeared to be the most susceptible to the modifying 
effects of both high dietary fat and phénobarbital on the antioxidant enzymes. 
The C57 strain of mouse was largely unaffected by either of the manipulations 
used.
The tumour promotors, phénobarbital, lindane and paraquat decreased 
intercellular gap junctional communication (Klaunig 1992; Guppy et al. 1994) - 
in view of the observation that these effects were attenuated by phenolic 
antioxidants (Klaunig 1992) and potentiated by depletion of cellular glutathione
13
levels. Guppy et al. (1994) suggested that the inhibition of intercellular 
communication may be mediated by oxidative stress.
1.2.6 Oxidative Stress May Be An Initiator of Carcinogenesis
The putative initiating effects of free radicals upon carcinogenesis have 
been discussed in many reviews (Parke and loannides 1994; Feig et al. 1994). 
Increased expression of antioxidant enzymes, catalase and glutathione 
peroxidase, protected cultured cells from oxidant - induced cellular damage 
(Martins et al. 1991). Further analysis indicated that certain residues of the 
DNA were more sensitive to oxidative damage, using a detection system based 
upon measuring oxidative mutations to E. coli genome, namely cytosine dimer 
formation (Feig et al. 1994) and that prophylactic antioxidant therapy may slow 
tumorigenesis substantially by decreasing the mutations to the genome.
In addition, peroxisome proliferators - potent rodent carcinogens 
(Moody et al. 1991) - are believed to instigate carcinogenesis through an 
imbalance in the expression of peroxisomal enzymes leading to an increase in 
the intracellular concentrations of hydrogen peroxide (Reddy and Rao 1986). 
This excess hydrogen peroxide has been proposed as the cause for the 
increased oxidative damage to the DNA, measured as 8 - hydroxy - 
deoxyguanosine in hepatic DNA isolated from rats receiving perfluoroalkane 
peroxisome proliferators (Tagaki et al. 1991).
Interestingly, regenerating hepatic tissue showed increased 
susceptibility to oxidative damage, measured as 8 - hydroxy - deoxyguanosine 
(Adachi et al. 1994), thus indicating that hepatotoxic compounds, which result 
in the death of cells, may not themselves result in initiation of 
hepatocarcinogenesis but may trigger compensatory proliferation. This 
proliferation may act as a stimulus to fix mutations into the genome or may 
result in the clonal selection of initiated cells leading to promotion. However
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the process of regeneration may itself result in oxidative damage to the DNA 
(Adachi et al. 1994).
Therefore, it remains unclear whether the hepatomegaly documented 
for peroxisome proliferators (Lock et al. 1989) or the imbalance in catalase 
expression (Reddy and Rao 1986) may be the principal cause of the oxidative 
damage to the genome reported (Tagaki et al. 1991). The possibility remains 
that this may result as a combination of both mechanisms.
The advent of molecular biology techniques has helped to reveal that 
genetic changes and cellular oncogenes may also function as regulating factors 
in the progression of carcinogenesis (Locker 1991; Stanley 1995), however 
these fields of study are, as yet, in their infancy. However, this more 
fundamental, genetic component of carcinogenesis cannot be overlooked.
1.3 Sources of Dietary Carcinogens
Many authors state that diet may provide the greatest single route of 
exposure to xenobiotics and carcinogens for humans (Sugimura 1982; Overvik 
and Gustafsson 1990) and Doll and Peto (1981) have speculated that as many 
as 30% of all human cancers may be attributed to dietary factors. Ames et al.
(1990) document that plant materials contain many thousands of chemicals 
involved in the protection and defence of plant species, and of only a minute 
number of those thus far tested approximately half have demonstrated 
carcinogenicity at MTD in rodent carcinogenicity assays. These individual 
compounds may indeed contribute to the 10^ new DNA - adducts estimated to 
be formed daily (Ames and Gold 1991). It would appear from these 
investigations alone that 'living' or 'eating' are occupations to which a high 
degree of risk must be attached.
Due to the wide variety of food products consumed it seems 
implausible that any one food component would contribute significantly to the 
incidence of cancers within the body. However, a variety of structurally related
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carcinogens have come to light as a result of food preparation and are 
generated during cooking at high temperatures. These compounds, the amino - 
imidazoazaarenes (AIA) are derived from the interaction of amino acids and 
creatinine in the presence of sugars and a low water content. Typical food 
sources from which they are derived include the muscle meats (Sugimura
1982). These heterocyclic aromatic amines exhibit potent mutagenicity in the 
Ames Salmonella mutagenicity test (Overvik and Gustafsson 1990) and are 
carcinogenic in rats and mice. Of potential interest was the observation that 
formation of these heterocyclic aromatic amines is highly dependent upon 
temperature (Felton and Knise 1991; Skog et al. 1995) and that creatinine may 
be the limiting factor in their synthesis (Overvik and Gustafsson 1990).
Investigation of the effects of switching to a lacto - vegetarian diet from 
a mixed diet does not initially appear to corroborate these findings with regard 
to dietary mutagen intake. Urinary and faecal mutagenic activity was reported 
to decrease in the presence of a vegetarian diet but this was attributed to a 
diluting effect of increased fibre and water contents of the faeces (Johansson et 
aL 1992) rather than to a reduction in mutagen intake.
Estimation of human dietary intake of such dietary carcinogens is 
difficult. Felton and Knise (1991) speculate an intake of between l-70ng of 
individual AIA for every gram of meat consumed, confirmed by Wakabayashi 
et al. (1992) who reported a potential intake of some 69ng/g for PhIP alone 
from fried cod fish. Skog et al. (1995) reported that a variety of meat products 
produce a range of different compounds resulting from high temperature 
cooking but suggest that a major portion of these compounds may be retained 
in 'pan residues' rather than in the cooked foods. Clearly estimation of human 
intake of these dietary carcinogens remains difficult, however, current estimates 
of total AIA intake for humans appeared to be -12.5pg/day based upon high 
meat consumption (Felton et al. 1992).
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Without question the predominance of data would suggest that these 
compounds are frameshift mutagens when assessed by the Ames Salmonella 
mutagenicity assay (Snyderwine et al. 1988) and are capable of producing 
DNA - adducts in vivo in a number of organs, including liver, kidney and heart.
These heterocyclic aromatic amines require metabolic activation by 
CYPIA subfamily of cytochromes P450 monooxygenases (Overvik and 
Gustafsson 1990), predominantly CYÇ1A2 (Ayrton et al. 1989) and the 
putative carcinogenic species is believed to be the nitrenium ion.
The gut microflora may play an important role in the formation of 
DNA- and haemoglobin - adducts resulting from exposure to arylamine and 
other carcinogenic species. Scheepers et al. (1994) noted that germ - free 
animals presented fewer hepatic DNA and haemoglobin adducts for both 2 - 
nitrofluorene and 2 - aminoanthracene than rats possessing a conventional gut 
flora. Clearly enterohepatic circulation of the conjugates may be the cause for 
such increase in adduct formation, the gut flora cleaving the conjugates to yield 
further N - hydroxy compounds with the ability to increase adduct formation.
Carcinogenicity studies carried out using AIAs have established these 
compounds as potent rodent carcinogens (Wakabayashi et al. 1992), the most 
abundant mutagenic species present in grilled meat products, PhIP, producing 
mammary tumours in both Sprague Dawley and Fischer 344 rats.
In addition, many plant materials contain both mutagenic and 
carcinogenic species, including safrole, hydrazines, furocoumarins and 
glucoalkaloids (Ames 1983). Moreover, even simple modifications to the 
balance of nutrients within a diet may instigate proliferative changes to tissues. 
For example, a western - style diet high in fats and phosphate and low in both 
calcium and vitamin D induced hyperproliferation and hyperplasia of mammary 
gland ductal epithelial cells in female, virgin C57 mice (Kahn et al. 1994).
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In light of these cited discoveries changes to the diet which may aid the 
elimination of such dietary carcinogens may yield some benefit in decreasing 
the overall probability for chemical carcinogenesis.
1.4 Carbohydrates
Carbohydrates provide a readily available source of energy within the 
diet that may require little or no digestion to ensure its release. Divided into 
two classes, the complex carbohydrates (e.g. starches) and the simple 
carbohydrates (e.g. mono- and disaccharide) the carbohydrates may be present 
as a major component within the diet and affords the primary source of energy 
to the body.
Carbohydrates have also recorded the potential to modulate the 
xenobiotic metabolising enzymes and the process of chemical carcinogenesis. 
Before assessing the impact of carbohydrates or other macronutrients on drug 
metabolism it appears prudent to discuss the composition of diets fed to 
rodents and humans for experimental purposes. In order to retain parity with 
regard to the calorie intake within a diet, macronutrient components are added 
or withdrawn from the diet in order to vary the carbohydrate consumption. 
Therefore interpretation of the experimental findings in an absolute sense may 
prove flawed as, for example, changes observed due to a low carbohydrate diet 
may in fact be due to the decrease in availability of carbohydrate calories, or to 
an increase in the overall consumption of proteins or fats. Interpretation of the 
effects of a single macronutrient component of the diet therefore cannot be 
determined in isolation and must be reviewed with regard to the remainder of 
the diet, namely the protein and triglyceride content.
Epidemiological evidence has revealed a strong negative association 
between the consumption of starch and the incidence of bowel cancer in 
humans (Cassidy et al. 1994). Similarly animal studies showed that diets high in 
carbohydrate reduced the incidence of dimethylbenzanthracene - induced
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(DMBA) skin tumours in SENCAR mice when compared to an isocaloric, high 
fat diet (Birt et al. 1993). Moreover, restriction of carbohydrate calories during 
the promotion phase of DMBA - induced chemical carcinogenesis was effective 
at decreasing the incidence of tumours in SENCAR mice, but this was only 
evident when carbohydrate restriction occurred during the promotion phase 
(Birt et al. 1991).
A comparison of the effects of different carbohydrates using isocaloric 
diets containing either starch or sucrose revealed that diets high in sucrose 
increased the [^H] - thymidine labelling index - indicative of cell division - and 
increased the number of dysplastic crypt foci in the colon following treatment 
with 1,2 dimethylhydrazine (DMH) (Cademi et al. 1991). Subsequent 
investigations have confirmed these observations, adding that sucrose elevated 
faecal bile acid concentrations (Cademi et al. 1993) and also possessed the 
potential to increase the incidence of azoxymethane(AOM) - induced intestinal 
tumours in rats (Caderni et al. 1994). Increasing the faecal concentration of bile 
acids has been associated with the promotion of chemically - induced digestive 
tract tumours (Cohen and Raicht 1981; Vahouny et al. 1981), therefore 
establishing a possible promotional effect for diets high in sucrose, towards the 
AOM - initiated tumours documented by Cademi et al. (1994).
Dietary intervention studies in humans have shown that diets high in 
carbohydrate decreased the 2 - hydroxylation of oestradiol in male volunteers 
(Anderson et al. 1984) and also resulted in an increase in glucuronide conjugate 
recovery for acetaminophen and oxazepam (Pantuck et al. 1991). Whether 
these modulations were as a result of changes to protein or carbohydrate 
consumption remains open to speculation.
The effects of dietary carbohydrates upon the xenobiotic metabolising 
enzymes has received limited attention. Strother et al. (1971) noted that high 
intake of various sugars increased the barbiturate - induced sleeping time in 
rodents and was accompanied by decreases in the in vitro hepatic metabolism
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of barbiturates by postmitochondrial supernatants. These observations were 
subsequently confirmed using glucose (Peters and Strother 1972) adding that 
glucose pretreatment of rats increased hepatic glucose - 6 - phosphate 
dehydrogenase activity and decreased NADPH oxidase activity for microsomal 
suspensions.
Nakajima et al. (1982) observed that increasing the carbohydrate 
contents of diets fed to rats generally decreased the degree of metabolism of a 
wide variety of hydrocarbons including benzene, toluene, chloroform and 
styrene. The effect was less pronounced when the animals were maintained on 
the test diets for three weeks inferring that the modulatory effects observed 
were transient in nature. However interpretation of these findings was again 
difficult as it was unclear whether the effects were a direct result of alterations 
to the carbohydrate consumption or the indirect modification of protein intake 
(Nakajima et al. 1982).
The effects of chronic administration of diets containing varying 
amounts of carbohydrates further revealed that diets containing both high and 
low levels of dietary starch or sucrose possessed the ability to modulate the in 
vitro activities of cytochromes P450 (Sonawane et al. 1983). Diets high in 
sucrose or starch decreased the levels of hepatic cytochrome P450, however 
the onset was delayed and extent of this decrease was diminished in starch - fed 
rats. Similar patterns were observed for the levels of cytochrome b$. High 
carbohydrate diets could also instigate changes in the hepatic phase II 
conjugation enzymes, dependent upon the source of carbohydrate used: starch 
significantly decreased the activity of p-nitrophenol - UDP - glucuronosyl 
transferase when compared to a high sucrose diet. In more recent studies 
glucose administration in the drinking water decreased the mutagenicity 
associated with B[a]P, after metabolic activation using an activation system 
derived from Sprague Dawley rats treated with Aroclor 1254. A significant 
inhibition of the mutagenicity of B[a]P by glucose was recorded in Salmonella
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typhimimum strain TAIOO, and a significant decrease in the DNA - adduct 
formation with B[a]P in vitro was also noted in the presence of a microsomal 
activation system (Vance et al. 1990). Subsequent investigations revealed that 
glucose administration produced similar changes in the mutagenicity of B[a]P, 
the activation being catalysed by Aroclor 1254 - treated hamster hepatic 
preparations (Rubano et al. 1990). However, the same S9 derived activation 
system caused an increase in the mutagenicity of AFB% towards Salmonella 
typhimurium TAIOO. The DNA binding of AFBj to calf thymus DNA was also 
increased in the presence of microsomes isolated from glucose - treated 
hamsters (Rubano et al. 1990). The discrepancy between the observations for 
B[a]P and AFB% were tentatively attributed to changes to xenobiotic 
metabolising enzymes.
The data presented implies that dietary carbohydrates may influence 
both the initiation and promotion events of chemical carcinogenesis, 
particularly for cancers of the intestine where diets high in sucrose may 
contribute to proliferative changes. Of greater toxicological significance may be 
the changes to plasma cholesterol and triglycerides brought about by 
carbohydrate administration (Swanson et al. 1992; Halfnsch 1990), both 
implicated in the progression of coronary heart disease.
1.5 Fats
Fat is a macronutrient component of the diet and provides a very 
concentrated source of calories. This high caloric density affords some two - 
fold greater number of calories than an equal weight of carbohydrate. Fats may 
make up as much as 40% of the total calories (Carroll et al. 1986) consumed in 
the human diet (Burkitt 1971).
Fats are classified into categories, dependent upon their degree of 
saturation. Saturated fats contain fatty acids with no unsaturated bonds, 
whereas unsaturated fats comprise fatty acids containing one or more double
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bonds. Dietary fats have been implicated in the progression of chemical 
carcinogenesis and the subject has been widely reviewed by many authors 
(Hopkins and West 1976; Nigro 1981; Reddy 1981) reporting a direct 
relationship between fat content and tumour incidence.
Interestingly, 'over nutrition' has been implicated as a more likely 
candidate for the increased incidence of cancer. Experimental evidence has 
indicated that tumour incidence may not be dependent upon fat intake, but 
upon the total energy intake (Boissoneault et al. 1986; Albanes 1987; Birt 
1987) and that restricting the intake of either fat calories or carbohydrate 
calories could produce a similar decrease in the number of DMBA - induced 
carcinomas in mice (Birt et al. 1992).
1.5.1 Effects of Dietary Fat on Chemical Carcinogenesis
For the purposes of this discussion dietary fats will provide the basis 
for much of the experimental findings. Beems and Van Beek (1984) 
demonstrated that increasing the intake of fat in diets could increase the 
incidence of B[a]P - induced respiratory tract tumours in rodents. Further 
studies revealed that unsaturated fats produced an enhancing effect compared 
with diets containing high levels of saturated fats (from beef tallow).
Maintaining rats on isocaloric, high and low fat diets produced a 
markedly different response to a diethylnitrosamine (DEN) challenge (Hietmen 
et al. 1991). Animals maintained on a high fat diet (30%w/w) showed a high 
incidence of hepatic tumours, whereas animals maintained on a low fat diet 
displayed a greater overall incidence of tumours, which was, however, confined 
to extrahepatic tissues only. The high fat diets also increased alkane exhalation 
by the rats, believed to be indicative of whole body pro - oxidant state.
In a separate study, 20% com oil in the diet suppressed the incidence of 
DMBA - induced tumours in SENCAR mice, relative to 5% com oil diets, if 
the diets were fed during the TPA - mediated promotion phase (Locniskar et al.
22
1991). However, the differences in tumour incidence induced by the two diets 
diminished greatly with prolonged feeding. Both diets were found to reflect the 
effect on tumour incidence - increasing fat intake caused a decrease in 
hyperplasia.
Increasing the lard fat content of the diet correlated well with an 
increase in MNNG - induced colon tumours; however this was apparent only 
when the level of dietary fibre was kept low (Sinkeldam et al. 1990). Of interest 
was the assertion by Sinkeldam et al. (1990) that increasing the fibre content of 
the diet did not necessarily decrease the incidence of tumours for a given diet. 
In fact, the highest tumour incidence was recorded for a medium fat, medium 
fibre diet, suggesting that the association between dietary fat, fibre and the 
progression of colonic tumours may be complex.
More recently, principal fatty acids have been described to influence the 
incidence of chemically - induced tumours in rodents. Studies with linoleic acid 
have demonstrated that increasing the proportion of linoleic acid within a semi 
- synthetic diet produced a positive dose - response relationship for DMBA - 
induced tumour incidence in SENCAR mice following promotion with TPA. 
Low levels of dietary linoleic acid produced a low tumour incidence, whereas 
increasing levels produced substantial increases in the number of tumours 
(Fischer et al. 1992). An inverse correlation was described for linoleic acid 
content of the diet and papilloma yield. The authors proposed that this may 
relate to changes to the levels of free arachadonic acid in mouse skin resulting 
from this dietary modulation. This was substantiated by decreases in the 
epidermal concentrations of prostaglandin E2 following increases in the linoleic 
acid content of the diets (Fischer et al. 1992). It was postulated that these 
decreases in PGE2 production may be indicative of inhibition of the skin 
lipooxygenase, targets for the activity of TPA, and therefore decrease the 
apparent promotion caused by TPA. Similar effects for linoleic acid were 
reported by Belury et al. (1993), who added that high levels of linoleic acid in
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the diet decreased TPA - associated hyperplasia of the skin and decreased 
epidermal protein kinase C activity, associated with the plasma membrane.
The mechanistic basis for such observations may indeed be complex, 
involving many factors. Carcinogen uptake from the gut has been found to be 
independent of fat content within the diet (Laher et al. 1984) and may be one 
limiting factor in the incidence of tumours following carcinogen treatment. Of 
interest has been the observation that contents of the GI tract may modulate the 
uptake of B[a]P from the gut, com oil providing the greatest medium for 
assimilation of the B[a]P, whereas water and mixtures of oil and charcoal or 
water, and charcoal progressively hinder the uptake from the gut (Stavric and 
Klasson 1994).
1.5.2 Effects of Dietary Fats on Drug - Metabolising Enzymes
Dietary lipids also modulate the expression of xenobiotic - metabolising 
enzymes. Assessment of the mutagenicity of dietary procarcinogens, the 
heterocyclic aromatic amines, following metabolic activation by hepatic post - 
mitochondrial fractions (S9) isolated from rats maintained on diets high in 
triglycerides revealed an increase in the number of mutations in the Ames test - 
due to an increase in the level of metabolic activation caused by the diet 
(Alldrick et al. 1987). Diets high in olive oil increased the mutagenicity of IQ 
and MelQ to levels comparable to Aroclor 1254 - induced hepatic activation 
systems.
Feeding a diet high in lard to male Sprague Dawley rats caused 
pretranslational activation of CYP2E1, measured by Northern blot analysis of 
RNA isolated from rat hepatic tissue (Yun et al. 1992) This was subsequently 
observed to increase apoprotein concentrations leading to an increase in the 
hydroxylation of aniline by hepatic microsomal suspensions and was confirmed 
following Western blot analysis (Yun et al. 1992). No changes were observed
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in the activities or apoprotein levels of the CYPIA and CYP2C isoforms of 
cytochromes P450.
High fat diets have also been implicated in the induction of P450 
isoform CYP4A, as measured by lauric acid hydroxylase, and also in the 
increase in the number of peroxisomes in hepatic tissue, as characterised by the 
cyanide - insensitive p - oxidation of palmitoyl CoA (Gibson 1993).
Altering the lipid profile within the diet by changing the ratio of 
saturated to polyunsaturated fats has also been noted to alter the cytochrome 
P450 activités of hepatic tissue in male Sprague Dawley rats. Increasing the 
amounts of polyunsaturated fat tended to increase the basal activités of hepatic 
mixed function oxidases. However, increasing the ratio of polyunsaturated to 
saturated fats in the diet significantly potentiated the phénobarbital - induced 
elevation of total cytochrome P450 for hepatic microsomes in a dose - 
dependent manner (Saito and Yamaguchi 1994).
Further studies by the same authors revealed that manipulating the 
types of polyunsaturated fats incorporated into a diet could also modulate P450 
activities. Increasing the ratio of n-6 to n-3 polyunsaturated fatty acids brought 
about a dose - dependent decrease in phénobarbital - induced hepatic 
microsomal P450 content (Saito and Yamaguchi 1994).
Unsaturated fatty acids have also demonstrated differential effects on 
tumour growth and metastasis, n-3 fatty acids having an inhibitory effect on 
tumour growth whilst n-6 fatty acids were associated with a tumour promoting 
potential (De Vries and Van Noorden 1992).
1.5.3 Dietary Fats and Oxidative Stress
Different dietary fats may also exhibit the ability to modulate the 
activity of enzymes responsible for the defence against oxidative damage to 
cells. Diets containing high levels of triglycerides decreased colonic glutathione 
peroxidase activity, whereas menhaden oil - based diets elevated catalase and
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glutathione reductase activities in colonic mucosa when compared to rodents 
maintained on diets high in corn oil or beef tallow (Kuratko and Pence 1991). 
Interestingly Ahotupa et al. (1993) noted similar results, but observed only one 
strain of mouse (C3H) out of three, was sensitive to the effects of a diet high in 
triglycerides and there was a degree of strain susceptibility to the effects of 
high fat diets.
Of further interest were the observations that sources of dietary 
triglycerides could influence the longevity of rats. A low fat basal diet (5%w/w 
com oil) actually decreased the lifespan of female BAV mice compared to a 
high fat diet (20%w/w com oil) (Femandes 1995). Replacement of a high corn 
oil diet with a diet high in fish oils further increased the life expectancy of the 
mice. In addition to these findings, com oil was found to increase significantly 
the expression of c- myc and c - ras oncogenes in the spleen isolated from BAV 
mice, compared to mice kept on a diet high in fish oils. The same high fish oil 
diet was reported to increase the activities of catalase, glutathione peroxidase 
and superoxide dismutase in the liver (Fernandes 1995).
Taken together, the above observations may suggest that fats have the 
ability to promote chemical carcinogenesis. Diets high in com oil decreased 
glutathione peroxidase activity as well as increased the expression of cellular 
oncogenes. Given that both free radicals and oncogenes have demonstrated 
tumour promoting properties, these effects may contribute significantly to the 
promotion associated with increasing dietary intake of fats. The apparent 
absence of effects upon the activity of hepatic CYPIA (Yun et al. 1992) may 
conceivably imply that the initiation step of chemical carcinogenesis, resulting 
from the metabolic activation of chemical carcinogens, is largely unaffected by 
dietary lipids.
Increasing dietary intake of triglycerides was also associated with 
elevated levels of DNA damage, both low fat diets and calorie restriction 
offering protection against hepatic DNA damage (Djuric and Kritschevsky
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1993). This was subsequently confirmed for oxidative damage to lung tissue 
DNA, measured as 8 - hydroxydeoxyguanosine, in mice fed high fat diets 
(Nagashima et al. 1995). The DNA damaging properties of high fat diets may 
derive from the induction of CYP2E1 (Yun et al. 1992). CYP2E has 
established ability to produce superoxide anions in the presence of NADPH 
(Ekstrom and Ingelman - Sundberg 1989) and may contribute to the initiation 
of carcinogenesis by a non - genotoxic mechanism.
1.5.4 Fat Free Diets
Fat free diets led to a 30% decrease in the activity of hepatic UDP - 
glucuronosyl transferase enzymes and an accompanying decrease in apoprotein 
levels of some 200%, relative to a 5% com oil diet, implying functional 
changes to the enzyme protein molecules (Dannenberg and Zakim 1992). 
Analysis of the microsomal membranes revealed a change in the fatty acid 
profiles, characterised by lower levels of arachidonic and linoleic acids, and 
increases in palmitic and oleic acids. Fat - free diets could also depress
cytochrome P450 monooxygenase activities (Yoo et ^  1992). Both
dimethylnitrosamine N - demethylase activity, a probe for CYP2E, and CYP2E 
apoprotein levels were decreased, as were the 6p hydroxylation of 
testosterone, a probe for CYP3A, and levels of CYP3A apoprotein. No 
changes were noted in CYP2C11 apoprotein or in the associated activities of 
benzphetamine N - demethylase or testosterone 2a hydroxylase. Interestingly 
the levels of CYP1A2 were lower amongst animals kept on a fat - free diet.
In conclusion, these data would appear to suggest that diets high in 
triglycerides may promote the assimilation of hydrophobic dietary carcinogens 
and increase the potential for oxidative damage in hepatic tissues following 
induction of CYP2E (Ekstrom and Ingelman - Sundberg 1989). In addition the 
modulation of free radical metabolism caused by high fat diets may have the 
potential both to initiate cancer, by damaging cellular DNA or, by providing a
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promotional pressure, to select initiated cells. Certainly in rodents, the 
peroxisome proliferation associated with high fat diets may also be of 
significance with regard to hepatic carcinogenesis; however there is no 
evidence to support similar interpretations in humans (Moody et al. 1991). The 
modulating effects upon oncogene expression and enzyme activity of diets high 
in triglycerides may also be of concern with regard to chemical carcinogenesis. 
Diets high in triglycerides have correlated highly with the incidence of coronary 
heart disease, and this may be of greater significance than potential changes to 
chemical carcinogenesis.
1.6 Proteins
Proteins form an essential component of the diet, the building blocks of 
which, the amino acids, are required for the synthesis of proteins. Although 
efficient systems exist for recycling of amino acids, protein is required daily as 
part of a balanced diet.
1.6.1 Dietary Protein and Chemical Carcinogenesis
Altering the protein content in the diet can lead to a variety of effects, 
including the modulation of chemical carcinogenesis. Varying the levels of 
protein in diets fed to aflatoxin B j - treated rats influenced both the initiation 
and promotion phases (Appleton and Campbell 1983a). Animals receiving a 
low protein diet during the initiation phase of chemical carcinogenesis displayed 
symptoms consistent with the acute toxicity of AFBj, whereas those receiving 
a diet high in protein showed only mild toxicity.
Twelve weeks following the administration of AFBj, diets high in 
casein caused a marked increase in the number of y - glutamyl transpeptidase 
(GGT) - positive foci in the liver compared to animals fed a low protein diet 
during the same period. The inference from these findings was that protein 
content of the diet correlated well with the promotion of tumours in rats.
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Interestingly, the effects of diets high in protein on the initiation phase of 
carcinogenesis also appear to have been stimulatory in nature, potentially due 
to a decrease in the cytotoxicity of the carcinogen. Subsequent studies further 
confirmed these findings, Appleton and Campbell (1983b) adding that 
modulation of protein intakes during the promotional phase produced broadly 
similar effects; increased protein intake correlated well with increased incidence 
of hepatic tumours. Clearly, low protein diets fed during the initiation phase of 
chemical carcinogenesis decreased the incidence of AFBj - induced liver 
tumours due to the increased lethality of the carcinogen. During the promotion 
phase diets high in protein had a promoting effect upon chemical 
carcinogenesis.
Reappraisal of this experiment has extended the above findings by 
indicating that administration of low protein diets at the post - initiation stage 
caused a regression of hepatic GGT - positive foci following treatment with 
AFB% (Youngman and Campbell 1991). The presence of GGT - positive foci 
was restored when rodents were switched back to high protein diets. This 
demonstrated the potential promotional effects of high protein diets towards 
extensively remodelled hepatic foci. Later observations confirmed that feeding 
rodents diets low in protein (5% w/w) correlated well with a lower incidence of 
GGT - positive foci, preneoplastic lesions and ultimately a lower incidence of 
both hepatic and extrahepatic tumours following initiation with the carcinogen 
AFB| (Youngman and Campbell 1992).
1.6.2 Dietary Protein and Cytochrome P450 Monooxygenases
The activities of hepatic cytochromes P450 were also effected by the 
levels of dietary protein (Birt et al. 1983). The activities of aryl hydrocarbon 
hydroxylase and aniline 4 - hydroxylase were elevated with increasing protein 
content of the diet. Similar increases were also noted for total hepatic 
cytochromes P450. In addition, diets high in protein enhanced the
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hydroxylation of androstenedione at both the 16a and 5a positions, in vitro 
(Blanck et al. 1992). The same study also demonstrated that increasing the 
dietary content of protein did not effect the expression of c - myc, c - fos or c - 
ras proto - oncogenes at the level of mRNA (Blanck et al. 1992).
Low intake of dietary protein (5% w/w) decreased total cytochrome 
P450 contents and also the concentration of protein present in both microsomal 
and cytosolic fractions isolated from the liver of weanling rats (Mandel et al. 
1992). The same dietary regime also suppressed the in vitro production of 
AFBj dihydrodiol, believed to be indicative of the formation of the epoxide, 
the ultimate carcinogen. These in vitro effects of diets low in protein did not 
correlate well with the in vivo investigations in which a rapid increase in the 
binding of AFB% to hepatic DNA, as a result of maintaining rats on a low 
protein diet was observed (Mandel et al. 1992).
Pharmacokinetic investigations have revealed that a low protein diet 
(isocaloric with a high protein diet) decreased the elimination of doxorubicin 
from rabbits. The data also recorded an increase in the terminal elimination half 
life for both doxorubicin and the alcohol metabolite doxorubicinol (Cusack et 
al. 1992). Anderson et al. (1991) detailed a similar delayed clearance of 
theophylline from human subjects consuming diets low in protein.
Pelissier et al. (1993) described the potential of protein deficiencies to 
decrease hepatic and intestinal glutathione levels and increase the concentration 
of lipid peroxides in the intestinal mucosa of rats. Furthermore, protein 
deficiency decreased the activities of both intestinal and hepatic catalase as well 
as reduced the hepatic selenium - dependent glutathione peroxidase activity.
1.6.3 Dietary Protein and Phase II Conjugation Enzymes
Protein - free diets fed to male Wistar rats increased the activities of 
hepatic UDP - glucuronosyl transferase enzymes towards the substrates p - 
nitrophenol and o - aminophenol (Woodcock and Wood 1971). In addition, the
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activities of hepatic sulphotransferase enzymes were unaffected by this severe 
protein deficiency.
By contrast, low protein diets have also been associated with low 
glutathione - S - transferase and UDP - glucuronosyl transferase activities in 
the liver of weanling rats (Catania and Carrillo 1990). Similar decreases were 
also noted in the intestinal mucosa enzymes.
Therefore, these observations may suggest that diets high in protein 
may enhance both the initiation and promotion of chemical carcinogenesis, 
potentially by preventing the toxic effects of many carcinogen species, thereby 
allowing mutations to persist. Together with the promoting effects of increased 
orotate production (Visek 1992) following increased intake of protein, high 
protein diets may significantly contribute to the process of chemical 
carcinogenesis.
Low protein diets appeared to decrease the conjugation of potential 
carcinogens (Catania and Carrillo 1990) but may be responsible for an increase 
in the carcinogen - DNA adduct formation documented for rats (Mandel et al.
1992). Therefore whether diets low in protein may be of benefit with regard to 
the progression of chemical carcinogenesis remains unresolved at present.
1.7 Vitamins and Minerals
The vitamins and minerals provide essential micronutrient components 
of the diet and in many cases deficiency results in a well characterised series of 
effects. For experimental purposes overt signs of deficiency may prove difficult 
to achieve, often requiring many months of deprivation to achieve detrimental 
responses. Of interest is the assertion that many such micronutrients may 
provide a positive beneficial effect with respect to cancer prevention 
(Weisberger 1991).
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1.7.1 Vitamins
1.7.1.1 Vitamin C
The vast majority of organisms possess the necessary hepatic enzymes 
to synthesise ascorbate but humans, guinea pigs, bats and fish are deficient in L 
- gulonolactone oxidase, an important enzyme involved in the biosynthesis of 
ascorbate (Sauberlich 1994) and are thus unable to synthesise the vitamin and 
require exogenous supply.
Studies conducted a decade ago utilising mutant rat strains deficient in 
ascorbate synthesis pathways illustrated the effects of ascorbate deficiency 
upon hepatic drug - metabolising enzymes (Horio et al. 1986). Ascorbate 
deficiency decreased the maximal induction of cytochromes P450 induced by 
dietary PCB and associated microsomal enzyme activities including aniline 
hydroxylase and aminopyrine - N - demethylase. Overt ascorbate 
supplementation, using doses in excess of ascorbate levels necessary to prevent 
signs of scurvy, increased cytochrome P450 - mediated activities beyond those 
recorded for control animals (Horio et al. 1986).
Dietary ascorbate deficiency also diminished hepatic microsomal 
glucuronosyl transferase activities in guinea pigs (Newmann and Zannoni 
1990).
Subsequent studies in guinea pigs corroborated the findings of both 
Horio et al. (1986) and Neumann and Zannoni (1990) reporting that overt 
ascorbate deficiency decreased the hepatic microsomal activities of aniline 4 - 
hydroxylase, aminopyrine -N  - demethylase and p-nitroanisole - O - dealkylase 
as well as hepatic cytochrome P450 content (Kanazawa et al. 1991). 
Immunoblot analysis of these microsomal fractions revealed a decrease in 
apoprotein levels for CYP1A2 and CYP2E, whilst showing no change in the 
levels of hepatic CYP2B1 and CYP3A, indicating that the effects were isoform 
specific. Mori et al. (1992) confirmed the changes in enzyme activities and 
apoprotein levels for microsomes isolated from ascorbate - deficient guinea
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pigs and postulated that whilst ascorbate deficiency did indeed increase the 
levels of lipid peroxidation products present in the liver homogenates, lipid 
peroxidation was unlikely to be responsible for the selective decrease in 
cytochrome P450 isoforms observed. Mutagenesis studies using the ’umu' test 
showed that a deficiency in dietary ascorbate decreased the metabolic 
activation of the promutagens IQ and AFBj, by microsomes derived from 
guinea pigs.
Vitamin C supplementation has been described to decrease the level of 
AFB\ - DNA adduct formation in cultured woodchuck hepatocytes, but the 
effect was minor and showed poor dose dependency (Yu et al. 1994).
1.7.1.2 Vitamin E
Vitamin E comprises one of the fat soluble vitamins involved in the 
protection of lipid membranes from oxidant damage and has been described as 
a chain breaking antioxidant (Van Acker et al. 1993) with therapeutic potential 
in the prevention of atherosclerotic lesions (Godfried et al. 1989).
The potential of dietary deficiency of vitamin E to decrease the N - 
déméthylation of aminopyrine without modulation of total hepatic cytochrome 
P450 levels was described in the early 1970s (Carpenter 1972).
Vitamin E deficiency decreased trout hepatic microsomal levels of 
vitamin E which increased tissue susceptibility to lipid peroxidation. There 
were no changes to total hepatic cytochrome P450 levels nor to NADPH 
cytochrome P450 reductase activity. However hepatic glutathione peroxidase 
activity was suppressed (Williams et al. 1992). Interestingly vitamin E 
deficiency did increase the level of DNA - B[a]P adduct formation recorded for 
trout microsomes in vitro (Williams et al. 1992). Similar investigations in male 
rats demonstrated the potential of vitamin E deficiency to decrease total hepatic 
cytochrome P450 levels and to increase the hepatic stores of glutathione.
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Vitamin E deficiency gave rise to sex - specific changes in hepatic drug 
- metabolising enzymes; male rats were more sensitive to vitamin E deficiency, 
showing decreases in total hepatic cytochrome P450, whereas female rats were 
unaffected (Iwasaki et al. 1993). The activities of hepatic glucuronosyl- or 
phenol sulphate transferases were unaffected by vitamin E deficiency in both 
male and female rats (Iwasaki et al. 1993).
Suprisingly supplementation of diets with vitamin E only afforded mild 
protection against oxidative damage to tissue slices induced by ferrous salts and 
spontaneous lipid peroxidation (Chen et al. 1993). The in vivo effects of 
supplementation of rodent diets with vitamin E included an increase in the 
microsomal stores of vitamin E and an increase in total cytochrome P450 and 
NADPH cytochrome P450 reductase activity (Murray 1991). The same author 
also described an increase in the 16a hydroxylation of androstenedione and a 
complementary rise in the levels of an apoprotein recognised by anti - 
CYP2C11 antibodies. No changes were observed in the in vitro 6P-, 7a- and 
16p - hydroxylations of androstenedione.
Colin et al. (1991) have also described an increase in the activity of aryl 
hydrocarbon hydroxylase after supplementation of diet with vitamin E; this was 
accompanied by a decrease in lipid peroxidation products present in 
postmitochondrial supernatants and a decrease in the metabolism of B[a]P and 
mutagenicity towards Salmonella typhimurium strain TA98. Taken together, 
these findings imply that supplementation of nutritionally complete diets with 
vitamin E could modulate individual isoforms of cytochromes P450 and 
decrease the in vitro mutagenicity of B[a]P potentially by preventing its 
activation.
1.7.1.3 Vitamin A
Reports concerned with the effects of vitamin A on hepatic xenobiotic - 
metabolising enzymes are limited in number. Deficiency in vitamin A increased
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the pulmonary levels of cytochromes P450, following administration of a 
tobacco extract, when compared to corresponding control animals receiving 
the tobacco (Bhide et al. 1991). Similar manipulations were also noted to 
increase hepatic B[a]P hydroxylase activity (Bhide et al. 1991). Metabolism 
studies revealed that vitamin A deficiency increased the in vitro metabolism of 
B[a]P by hepatic postmitochondrial supernatants and increased the mutagenesis 
of B[a]P towards Salmonella typhimurium strain TA98 in the Ames test.
Overt vitamin A deficiency modified a wide range of hepatic xenobiotic
- metabolising enzymes (Colin et al. 1991). These effects included decreasing 
total hepatic cytochrome P450 and the activities of both epoxide hydrolase and 
UDP glucuronosyl transferase. A decrease was also noted in the concentration 
of hepatic glutathione and an increase in the activities of hepatic glutathione - S
- transferase enzymes (Colin et al. 1991).
Reduction in the dietary intake of vitamin A resulted in decreased levels 
of vitamin A, in both serum and hepatic tissue, accompanied by decreases in 
hepatic 16a- and 6P - androstenedione hydroxylase activities (Martini and 
Murray 1994). Immunoblot analysis recorded a decrease in CYP2C11 
apoprotein levels, the isoform principally responsible for steroid 16a 
hydroxylation, confirming the changes to steroid metabolism.
Supplementation of nutritionally complete diets with excess vitamin A 
was found to increase hepatic stores of vitamin A without altering the activity 
of CYP2C11, suggesting that cytochrome P450 levels were not directly related 
to levels of dietary vitamin A (Martini and Murray 1994). These findings, in 
part, contradict a previous study, by the same authors, documenting that excess 
dietary vitamin A gave rise to increased total hepatic cytochrome P450 as well 
as in the 6P- and 7a - steroid hydroxylases - associated with increases in 
apoprotein levels for CYP3A and CYP2A1/2 respectively (Murray et al. 
1991b).
35
Finally, supplementary vitamin A caused a dose - dependent decrease in 
the formation of hepatocyte DNA - AFBi adducts in woodchuck hepatocytes 
in culture (Yu et al. 1994).
1.7.1.4 Thiamine
The first reports documented an accelerated disappearance of 
dimethylnitrosamine from the serum of thiamine - deficient rats (Ruchirawat et 
^  1978) which did not correlate well with the hepatic conversion of 
dimethylnitrosamine to formaldehyde.
Further investigations indicated that thiamine deficiency increased the in 
vivo metabolism of paracetamol to water soluble products, including increased 
glucuronide and sulphate conjugates detectable in the liver and plasma 
(Ruchirawat et al. 1981).
More recent investigations revealed that dietary deficiency of thiamine 
led to increases in hepatic CYP2E1 activity as exemplified by the in vitro 
metabolism of dimethylnitrosamine and immunoblot analysis of CYP2E1 
apoprotein levels. The increase in activity was attributed directly to the 
deficiency in thiamine itself rather than through ketone body production (Yoo 
et al. 1990). No change was observed for the activity of hepatic CYP2C11 
measured as microsomal benzphetamine -N  - demethylase activity.
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1.7.2 Minerals
1.7.2.1 Selenium
Selenium forms an essential micronutrient component of the diet and is 
of principal use in the defence of cells against oxidative stresses. Selenium 
principally forms a component of glutathione peroxidase, a cytosolic enzyme 
involved in the breakdown of hydrogen peroxide and organic peroxides to less 
reactive water or alcohols respectively:
ROOM + 2G SH -----------> ROM + GSSG + H2O
Several classes of xenobiotic - metabolising enzymes are perturbed by 
dietary deficiency in selenium and these are clearly described by Reiter and 
Wendel (1983 and 1984). Dietary deficiency of selenium decreased the hepatic 
activity of NADPH cytochrome P450 reductase, selenium - dependent 
glutathione peroxidase and hepatic phenol sulphate transferases activities. 
Ethoxyresorufin - O - dealkylase, cytochrome P450 hydroperoxidase, UDP 
glucuronosyl transferase, glutathione - S - transferase and haem oxygenase 
were all enhanced as a result of dietary selenium deficiency (Reiter and Wendel
1983). These changes were subsequently confirmed in a follow - up 
investigation (Reiter and Wendel 1984).
Masukawa et al. (1984) outlined that selenium deficiency elevated the 
activities of glutathione - S - transferase in the liver, kidney and duodenal 
mucosa and, whilst decreasing selenium - dependent glutathione peroxidase 
activity, increased the total residual glutathione peroxidase activity in these 
tissues (Masukawa et al. 1984).
More recent investigations established that decreasing dietary selenium 
intake is associated with decreased colonic glutathione peroxidase and
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superoxide dismutase activities, and therefore may contribute to the toxicity of 
dimethylhydrazine in the colon (Pence 1991).
1.7.2.2 Copper
The biochemical events resulting from a dietary deficiency in copper 
have recently been reviewed by Prohaska (1990) and include decrease in 
hepatic catalase and superoxide dismutase activités (Taylor et al. 1988). 
Hepatic levels of glutathione peroxidase have also been shown to decrease as a 
result of a copper deficiency (Prohaska 1991) and the underlying molecular 
mechanism involved a decrease in the level of mRNA coding for glutathione 
peroxidase and did not occur as a result of perturbation of tissue selenium 
levels (Prohaska 1992). Lai et al. (1995) reported further that decreasing the 
dietary intake of copper, not only decreased the protein enzyme activities and 
mRNA levels for selenium - dependent glutathione peroxidase, but also for 
catalase in both hepatic and cardiac tissues. These results imply that regulation 
may occur primarily at the transcriptional level.
1.7.2.3 Iron
The effects of dietary iron deficiency upon xenobiotic - metabolising 
enzymes have received little attention but changes in both phase I and phase II 
drug metabolising enzymes have been reported. Rao and Jagadeesan (1995) 
demonstrated that reats fed iron - deficient diets showed decreased hepatic aryl 
hydrocarbon hydroxylase and epoxide hydrolase activities, whereas 
aminopyrine - N - demethylase, aniline - 4 - hydroxylase activities and the levels 
of microsomal P450 were unaffected. Decreases were also observed for hepatic 
UDP glucuronosyl transferases whereas no change was recorded for hepatic 
glutathione - S - transferases. Extrahepatic tissues were also effected by 
deficiencies in dietary iron, leading to decreased aniline hydroxylase and UDP
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glucuronosyl transferase activities in the lung, whereas renal tissue showed an 
increase in glutathione - S - transferase activity (Rao and Jagadeesan 1995).
1.8 Anutrients
Recent reviews have described that many minor anutrient components 
of the diet may have ^nticarcinogenic properties towards a variety of chemical 
carcinogens tested in rodent carcinogenicity assays (Wattenberg 1985; 
Weisberger 1991; Wattenberg 1990). The majority of these potential 
anticarcinogens are derived from the secondary metabolites produced by plants 
(Ames 1983).
Indeed many of these anticarcinogens are established as modifiers of 
both phase I and phase II xenobiotic - metabolising enzymes, particularly the 
cytochrome P450 monooxygenases. Some of the most widely studies classes of 
compounds include dietary indoles, carotenoids and polyphenols. Some of the 
responses to the cytochromes P450 brought about by dietary inclusion of this 
variety of chemicals is summarised in table 1.1, however in view of the massive 
number of investigations carried out, the readers are directed to comprehensive 
reviews by Johnson et al. (1994), Ferguson (1994) and further reviews by 
Sporn and Newton (1979), Gerster (1992) and Ito and Hirose (1989).
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Table 1.1: Examples of the Effects of Dietary Anutrient Compounds on the 
Expression of Hepatic Cytochrome P450 Monooxygenases:
ANUTRIENT:
Green Tea 
Polyphenols
Black Tea Polyphenols
Canthaxanthin
Camphor, Menthol, 
Pinene
Limonene
Diallyl Sulphide
Indole - 3 - Caibinol 
Indole - 3 - Carbinol
Indole - 3 - Carbinol
Caffeine
EFFECTS:
t  CYPIAI, T  CYP1A2, T  CYP4A
t  CYPIAI, t  CYPIA2, t  CYP2B
T T  Ethoxy-, Methoxy-, Pentoxy-, 
Benzoxyresoufin - O - dealkylase 
t  Total Cytochrome P450
T CYP2B Apoprotein and t  CYP2B 
mRNA levels
t  CYP2B Apoprotein levels
t  CYP2BI/2 Apoprotein and 
T  CYP2B mRNA Expression
T EthoxjTesorufin - O - dealkylase
T  Ethoxy- and Pentoxyresorufin - O 
- dealkylase Activity
t  CYPIAI, t  CYP1A2, 
t  CYP3AI/2
t t  Methoxyresorufin - O - 
dealkylase and CYPIA2 Apoprotein 
t  Ethoxyresorufin - O - dealkylase 
and t  CYPIAI Apoprotein
SPECIES: SOURCE:
RAT Bu Abbas etal.
(In Press)
RAT Sohn et al. 1994
RAT Astorg et al. 1994
RAT Austin et al. 1988
RAT Maltzman et al. 1991
RAT Pan et al. 1993
MOUSE Shertzer 1982
RAT Wortelboer et al. 1992
RAT Stresser etal. 1994a
RAT Ayaloguetal. (InPress)
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1.9 Summary
Whilst accepting that Thomas Edison may have been a little ambitious 
with regard to his interpretation of future medical research, this may highlight 
some very basic concepts which seem relevant to the modern lifestyle. 
Coronary heart disease and cancer are the major diseases responsible for 
mortality in the Western world. Both conditions are believed to be preventable 
and the best approach for reducing their incidence is potentially through the 
diet.
Much of the literature cited above, at least for rodents, documents that 
alterations to the diet can afford some genuine benefits in the prevention of 
cancers and may offer an insight into the treatment of human disease.
Metabolic activation of chemical carcinogens consumed through the 
diet leads to the proposed first step towards chemical carcinogenesis, initiation. 
Therefore the discovery of mechanisms by which this metabolism of unreactive 
precarcinogens can be decreased or attenuated could impart some form of 
protection from the initiation phase of chemical carcinogenesis.
The purpose of the research undertaken in this thesis is to investigate 
whether or not modifications to the diet, or dietary regimes may show promise 
towards modifying initiation of chemical carcinogenesis. As this principal step 
is largely governed by the metabolic activation and subsequent conjugation of 
putative carcinogenic species, these studies will focus primarily upon the 
influence diet may have over expression and the activity of xenobiotic - 
metabolising enzymes and the enzymes involved in the defence against oxidant 
stress. The rationale of these studies is that a potential decrease in metabolic 
activation, or increased elimination, of a toxicant species may reduce the 
potential for initiation of chemical carcinogenesis, thereby decreasing the 
cancer incidence.
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Chapter 2
MATERIALS AND METHODS
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2.1 Materials and Methods
2.1.1 Materials
The following chemicals, reagents and equipment were obtained from a 
variety of suppliers listed below:
2-Aminoanthracene, Ammonium persulphate, Benzo[a]pyrene, Bovine 
Serum Albumin, Na/Cu Chlorophyllin, Cumene hydroperoxide. Cytochrome C, 
Dithiothrietol, Erythromycin, Ethoxyresorufin, EDTA, Folin Ciocalteau phenol 
reagent. Fructose, Glucose-6-phosphate, Glucose-6-phosphate dehydrogenase, 
Histidine, Hydrogen peroxide, Lactalbumin, Leupeptin, 4-Methyl 
Umbelliferone, 1-Naphthol, 2-Naphthol, Nicotinamide Adenine Dinucleotide 
phosphate. Nicotinamide Adenine Dinucleotide (reduced), Resorufin, Palmitoyl 
Coenzyme A, Pentoxyresorufin, Phenylmethyl Sulphonyl fluoride, 
Phosphoadenosine phosphosulphate. Superoxide dismutase. Tris base, Trizma 
base and Uridine diphosphate glucuronic acid were obtained from Sigma 
Biochemicals, Poole Dorset, U.K.
Glucose, Imidazole, DL-Methionine, Sodium dithionite, Titanyl 
sulphate and Triton X-100 were obtained from BDH Biochemicals Ltd. 
Leicester, U.K.
Methoxyresorufin was obtained from Molecular Probes, Eugene, 
Oregon U.S.A.
Sucrose for Rodent Diets was obtained from a local supermarket and 
was the Silver Spoon Brand. The com oil used for the animal diets was the 
Mazola brand, and was obtained from the same source.
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Aroclor 1254 was obtained from the Robens Institute, University of 
Surrey, Guildford, Surrey, U.K.
Anti - Mouse c-myc monoclonal antibodies used were obtained from 
Biogenesis Ltd. Bournemouth, UK.
Rodent diet LAD-1, com starch, casein, mineral mix (AIN-76a) and 
vitamin mix (AIN-76a) were obtained from Special Diet Services U.K.
Lab M No.l Agar, ^^C-Lauric Acid (50mCi/mmol) and a-^^P 
Adenosine triphosphate were obtained from Amersham Intemational U.K.
Vogel Bonner minimal Agar plates were supplied by Becton Dickinson, 
Oxford, U.K.
Sterile polyethyene Universal bottles and sterile tubes(lOml) were 
supplied by Bibby Sterilin Ltd. Staffordshire, U.K.
Glass - backed Silica Gel 60 TLC plates were obtained from E.Merck, 
Darmstadt, Germany
Vertical Slab Gel Electrophoresis Unit - Hoeffer Scientific Instmments, 
San Fransisco, California, U.S.A
Gel Transfer (wet) System was purchased from Bio-Rad Laboratories, 
Hemel Hempstead, Herts U.K.
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All Animals used during these studies were purchased from University 
of Surrey, Animal Breeding Unit, Manor Farm, Guildford, Surrey, U.K.
All the solvents and acids used were the best available grade and were 
purchased from Fisons Ltd, U K; all other chemicals used were general purpose 
grade and purchased from various suppliers.
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2.2 Methods
2.2.1 Preparation of Activation System for Mutagenicity Studies
Male, Wistar, albino rats ( «200gm body weight) were treated with a 
single intraperitoneal (ip) dose of Aroclor 1254 (500mg/Kg) in com oil. 
Control animals received vehicle only. Animals were labelled by tail marking 
with indelible pen following administration.
The animals were housed in polyethylene cages, in groups of five, with 
woodchip bedding and were permitted food (LAD - 1, Special Diet Services) 
and water ad libitum. The animals were maintained at a temperature of 20°C 
with a relative humidity of 50% and a twelve hour light/dark cycle. Five days 
after dosing, the animals were sacrificed by cervical dislocation and the livers 
immediately excised, using sterile instmments. All manipulations were carried 
out aseptically. The livers were then washed in 1.15% (w/v) KCl. After 
recording the weights of the livers, they were scissor minced in 1.15%(w/v) 
KCl and homogenised in a precooled glass homogeniser with a teflon pestle. 
The homogenates were diluted to 25%(w/v) with 1.15%(w/v) KCl such that 
l.Ogm liver = 4.0ml homogenate. The homogenate was transferred into sterile 
centrifuge tubes and centrifuged at 9000g and 4°C for twenty minutes in a 
Beckman J2-21 centrifuge. The supematant fraction (S9) ws decanted and 
aliquoted into polyethylene tubes, and stored at -20°C until use.
2.2.2 Preparation of Microsomes
Aliquots of S9 were thawed over ice and decanted into 10ml 
polycarbonate centrifuge tubes, and centrifuged at 105,000g and 4°C for one 
hour in a Beckman L7 ultracentrifiige. The supematant fractions were decanted 
into polyethylene tubes and stored at -20°C. The microsomal pellets were 
washed with 1.15%(w/v) KCl. Further 1.15%(w/v) KCl was added to attain 
the original S9 volume. The pellet was gently dislodged from the tube and
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decanted into a homogeniser, where the microsomes were resuspended thus 
producing a 25%(w/v) microsomal suspension.
2.3 Characterisation of Microsomal Suspensions
2.3.1 Protein Determination
Protein concentrations were ascetained using the method of Lowry, 
(Lowry etal. 1951)
Reagents:
Copper Solution:
0.01%(w/v) CUSO4.5H2O
0.02%(w/v) (K.02C(CH0 H)2C02 -Na) 4H2O
0.02%(w/v) Na2C0 ]
This solution was freshly prepared 
Folin - Ciocalteau Phenol Reagent:
Commercial reagent was diluted 1:1 with distilled water immediately 
before use.
Assay Procedure:
The microsomal suspension (25%(w/v)) was diluted 1:25 with 0.5M 
NaOH and an aliquot (0.5ml) was added to 0.5M NaOH to give a total volume 
of 1.0ml. To this was added the copper solution (5ml). The mixture was 
allowed to stand for 10 minutes and the Folin Ciocalteau phenol reagent 
(0.5ml) was added and the tubes immediately vortex mixed. The absorbance of 
the solutions was measured at 720nm after 30 minutes. The protein 
concentrations were calculated with reference to a standard curve using Bovine 
Serum Albumin in the range 50 - 300pg.
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2.3.2 Cytochrome P450 Activities
2.3.2 Total Cytochrome P450
Total Cytochrome P450 was assayed according to the method of 
Omura and Sato (1964).
25%(w/v) microsomal suspension (0.5ml) was diluted 1:6 with 
potassium phosphate buffer (O.IM; pH=7.4). A few milligrams of sodium 
dithionite were added; mixed and the resulting solution divided between two 
cuvettes. Carbon monoxide was bubbled through one cuvette for about thirty 
seconds. A difference spectrum was obtained between 400 - 500nm using a 
Kontron Instruments Uvikon 860 spectrophotometer. The total cytochrome 
P450 was calculated using the extinction coefficient E=91mM"l.cm“ .^
2.3.3 The O - dééthylation of Ethoxyresorufin
Ethoxyresorufin - O - deethylase (EROD) activity is considered to be 
the marker enzyme activity associated with CYPIAI and was used throughout 
this study for that purpose. The activity was measured as outlined in the 
methos of Burk and Mayer (1974).
Reagents:
Tris.HCl buffer (0.IM; pH=7.8 at 37°C)
NADPH (50mM in l%(w/v) NaHCOg)
Ethoxyresorufin (0. ImM in 70%(v/v) Ethanol)
Resorufin (O.OlmM in 70% (v/v) Ethanol)
Assav Procedure:
Tris.HCl buffer (2.0ml) was placed in a fluorimeter cuvette with 
25%(w/v) microsomal suspension (50pl) and ethoxyresorufin (lOpl). The 
contents of the cuvette were thoroughly mixed and a baseline was recorded
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using a Perkin Elmer LS-5 luminescence spectrophotometer (Excitation X 
=510nm; Emission X=586nm; Excitation slit width=10cm; Emission slit 
width=2.5cm). The temperature of the reaction mixture was maintained at 37° 
C using a thermostatically controlled cell carrier. The reaction was initiated by 
addition of NADPH (lOpl). The linear, initial rate of reaction was recorded; 
calibration was carried out using aliquots of resorufin (5 pi) in the presence of 
buffer and microsomes.
An identical procedure was used to determine methoxyresorufin - O - 
déméthylation (MROD) activity of microsomal samples, which is believed to be 
the marker enzyme activity for CYP1A2 and was therefore used throughout 
this study for that purpose.
2.3.4 The O - depentylation of Pentoxyresorufin
Pentoxyresorufin - O - depentylase (PROD) is believed to be the 
marker activity for the CYP2B subfamily and was used to ascertain the levels 
of activity in microsomal samples. PROD activity was measured using the 
method of Lubet et al. (1985)
Reagents:
Tris.HCl buffer (0. IM; pH=7.8 at 37°C)
NADPH (50mM in l%(w/v) NaHCOg)
Pentoxyresorufin (ImM in 70%(v/v) Ethanol)
Resorufin (O.OlmM in 70%(v/v) Ethanol)
The following components were mixed in a fluorimeter cuvette:
Tris.HCl buffer (2.0ml)
25%(w/v) microsomal suspension (50pl)
Pentoxyresorufin (5 pi)
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The contents of the cuvette were mixed thoroughly and a baseline was 
recorded in a Perkin Elmer LS-5 luminescence spectrophotometer (Excitation 
X=510nm; Emission ^=586nm; Excitation slit width=10cm; Emission slit 
width=2.5cm). The reaction was initiated by addition of NADPH (lOpl). The 
linear, initial rate of reaction was recorded. Calibration was carried out using 
aliquots of resorufin (5 pi) in the presence of buffer and microsomes.
2.3.5 p-Nitrophenol Hydroxylase Activity
The oxidation of p-Nitrophenol to p-Nitrocatechol is considered to be 
the probe for the CYP2E subfamily of cytochrome P450. Therefore, it was 
used to determine the activity of CYP2E in this work. The method employed 
was that of Reinke and Moyer (1985).
Reagents:
Potassium phosphate bufer (0.2M; pH=6.8) 
p-Nitrophenol (ImM in buffer)
NADPH (lOmM in l%(w/v) NaHCOg)
Perchloric Acid (0.6N) 
p-Nitrocatechol (0.5mM in buffer)
Ascorbic acid (ImM in distilled water)
Assav Procedure:
Potassium phsphate buffer (0.7ml), p-nitrophenol (0.1ml), ascorbic acid 
(0.1ml) and 25%(w/v) microsomal suspension (0.2ml) were placed in 
polyethylene tubes and incubated in a shaking water bath at 37°C for two 
minutes. The reaction was initiated by the addition of NADPH (0.1ml) and the 
incubation was continued for a further 10 minutes. Termination of the reaction 
was achieved by addition of ice cold perchloric acid (0.5ml). The precipitated
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proteins were sedimented by centrifugation at 2000g for 10 minutes in a 
Beckman J-6B centrifuge. Aliquots of the resulting supernatants (1.0ml) were 
transferred to clean tubes, to which lOM NaOH (0.1ml) was added. The 
solutions were thoroughly mixed and their absorbances were measured at 
536nm using a Kontron Instruments Uvikon 860 spectrophotometer. The 
activity of the microsomal suspensions was ascertained by reference to a 
standard curve using p-nitrocatechol in the range of 10 - SOnmoles per tube.
2.3.6 Erythromycin - N - Demethylase Activity
The N - déméthylation of erythromycin is believed to be a characeristic 
probe activity for the CYP3A subfamily of cytochrome P450. It was therefore 
used to investigate the CYP3A activity in the present studies. This method is 
based upon that of Wrighton et al. (1985) and involved the measurement of the 
formaldehyde product (Nash 1953) formed from the methyl group.
Reagents:
Potassium phosphate buffer (50mM; pH=7.25)
Magnesium chloride (0.15M in water)
Erythromycin (0.0 IM in buffer)
NADPH (16mM in 1% (w/v) NaHCOg)
Nash Reagent (4M Ammonium acetate containing 4ml/L acetylacetone) 
Trichloroacetic Acid (12.5% (w/v))
Assav Procedure:
Potassium phosphate buffer (0.6ml), MgCl2 (0.1ml), erythromycin 
(0.1ml) and 25%(w/v) microsomal suspension (0.2ml) were added to tubes and 
incubated at 37°C for two minutes in a shaking water bath. The reaction was 
initiated by addition of NADPH (0.1ml) and the incubation continued for a 
fiirther 10 minutes. The reaction was terminated by addition of ice cold
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trichloroacetic acid (0.5ml) . The protein precipitate was removed by 
centrifugation of the samples at 2000g for 10 minutes using a Beckman J-6B 
centrifuge. Freshly prepared Nash reagent (1.0ml) was added to aliquots of the 
resultant supematant (1.0ml). The solutions were mixed well and incubated at 
37°C for 40 minutes in a shaking water bath. The absorbance of the solutions 
was then read at 412nm in a Kontron Instruments Uvikon 860 
spectrophotometer. The activity of the microsomal suspensions was calculated 
with reference to a standard curve using formaldehyde in the range 0 - 
300nmoles per tube.
2.3.7 Laurie Acid Hydroxylase Activity
The hydroxylation of lauric acid at the 12- position is known to be an 
activity of the CYP4A isoform of cytochrome P450 and was therefore used as 
a measure of CYP4A activity in this work. The method used is as described by 
Parker and Orton (1980) which measures the combined products of 11- and 
12- hydroxylation.
Reagents:
Lauric Acid (200mM in methanol) [A]
- Lauric Acid (lOpCi/ml in methanol)
Tris.HCl buffer (0.5M; pH=7.4)
NADPH (40mM in l%(w/v) NaHCOg)
HCl (3M)
Assav Procedure:
Lauric acid solution [A] was diluted 1:200 with assay buffer to produce 
a ImM lauric acid solution. For each millilitre of this ImM solution - 
lauric acid (50pl) was added to produce lauric acid solution [B]. The following 
were added to polypropylene tubes:
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Lauric acid solution [B] 210pl
25%(w/v) microsomal suspension 200pl
Tris.HCl buffer 1.5ml
The tubes were mixed thoroughly and incubated at 37°C for 4 minutes 
in a shaking water bath. The reaction was initiated by addition of NADPH (5 Op 
1) and the incubation continued for a further 10 minutes. The reaction was 
terminated by addition of 3M HCl (200pl). The contents of the tubes were 
extracted with diethylether (10ml) on a rotating shaker for 60 minutes; the 
tubes were allowed to stand for 5 minutes before withdrawal of aliquots 
(8.5ml) of the organic phase. These aliquots were placed in clean, dry tubes and 
the ether evaporated to dryness at 30°C under a stream of nitrogen. The 
residues were reconstituted by addition of methanol (60pl) and an aliquot of 
this solution was spotted onto glass - backed silica TLC plates.
The plates were run in a hexane:ether;acetic acid (70:28:1) solvent 
system. Following evaporation of the solvent from the plates, these were 
scanned using a Berthold LB2842 linear TLC analyser. Computational 
integration of the radioactivity peak afforded measurement of the lauric acid 
hydroxylase activity of the microsomal suspensions.
The disadvantage of this method is clear when trying to resolve both 
11- and 12- hydroxy- metabolites of lauric acid; using this system the two 
metabolites co - elute, however only the 12 - hydroxylation of lauric acid is 
associated with CYP4A1. Consequently, changes in lauric acid hydroxylase 
activity were confirmed immunologically.
2.4 Determination of Hepatic Microsomal Glucuronidation Reactions
2.4.1 Glucuronidation of Planar Substrates:
The glucuronidation of planar substrates utilises a particular form of 
UDP - glucuronosyl transferase enzyme. 1-Naphthol is believed to be a suitable 
probe to investigate this activity. The method employed is that of Bock and
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White (1974), with modifications by Mackenzie and Hannien (1980) and 
Sneganoff and Jamet (1985).
Reagents:
Potassium phosphate buffer (50mM; pH=7.25) containing EDTA (5mM) 
Magnesium chloride (lOOmM in distilled water)
1-Naphthol (0.5mM in assay buffer)
UDP - Glucuronic acid (20mM in assay buffer)
Reaction Termination - Trichloroacetic acid (0.4M) containing glycine (0.6M) 
pH=2.2
Assav Procedure:
Potassium phosphate buffer (0.75ml), MgCl2 (50pl) , 1 - Naphthol 
(lOOpl) and 25%(w/v) microsomal suspension (50pl) were added to sovirel 
tubes and incubated at 37°C in a shaking water bath for 5 minutes. The 
reaction was initiated by the addition of UDP - glucuronic acid (50pl) and the 
mixture was incubated for a further 4 minutes. The reaction was terminated by 
adding the Termination Reagent (1.0ml) and placing the tubes on ice for 5 
minutes. Incubation mixtures were extracted using chloroform (10ml) for 
15minutes on a rotating shaker. An aliquot of the aqueous fraction (1.0ml) was 
added to 0.45M NaOH (2.0ml) in a quartz fluorimeter cuvette. The 
luminescence of the samples was recorded using a Perkin Elmer luminescence 
spectrophotometer ( Excitation X=293nm; Emission A,=335nm; Excitation slit 
width=10cm; Emission slit width=2.5cm). A standard curve using 1-Naphthol 
glucuronide was employed to determine the degree of glucuronidation in the 
range of 0.4 - 20nmoles per tube.
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2.4.2 Glucuronidation of Non Planar Substrates
This method was used to investigate the activity of UDP - glucuronyl 
transferase enzymes towards a non - planar substrate 4-methyl umbelliferone. 
The method employed for this procedure was that described by Arias (1962).
Reagents:
Tris.HCl buffer (0.5M; pH=7.8)
Magnesium chloride (12.5mM in water)
4-methyl umbelliferone (3mM in buffer)
UDP - glucuronic acid (2mM in buffer)
Assav Procedure:
Tris.HCl buffer (2.15ml), MgCl% (lOOpl), 4-methyl umbelliferone (100 
pi), and 25%(w/v) microsomal suspension (200pl) were added to sovirel tubes 
and incubated at 37°C in a shaking water bath for 5 minutes. The reaction was 
initiated by the addition of UDP - glucuronic acid (lOOpl) and incubation was 
continued for a further 30 minutes. The reaction was terminated by the addition 
of ice cold chloroform (10ml) and mixed thoroughly. The tubes were 
centrifuged at 2000g for 5 minutes in a Beckman J-6B centrifuge and the 
aqueous fraction was recovered. The aqueous fraction was extracted with 
chloroform twice more.
Aliquots of the aqueous phase (1.0ml) were added to Tris.HCl buffer 
(1.5ml) containing p - glucuronidase (75U/ml) and incubated at 37°C in a 
shaking water bath for 90 minutes.
Following incubation, 0.5M glycine buffer (5.0ml) was added and the 
luminescence recorded using a Perkin Elmer LS-5 luminescence 
spectrophotometer (Excitation ^=375nm, emission X=460nm; Excitation slit 
width=10cm; Emission slit width=2.5cm)
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A series of standards (2 - lOnmoles per tube), each carried through the P - 
glucuronidase digestion, were used to ascertain the degree of glucuronidation.
2.5 Characterisation of 25%(w/v) Cytosolic Fractions
2.5.1 Protein Determination
Protein concentrations were ascertained using the method of Lowry 
(Lowry et al. 1951). The reagents and assay procedure are as outlined 
previously (Section 2.3.1). The only difference was that the 25%(w/v) cytosolic 
fraction was diluted 1:100 with 0.5M NaOH and an aliquot (0.5ml) was added 
to 0.5M NaOH to give a final volume of 1.0ml.
2.5.2 Determination of the Total Tissue Glutathione Concentration
This was carried out essentially by the method of Akerboom and Sies 
(1981). All oxidised glutathione (GSSG) is reduced, in the presence of 
NADPH, by glutathione reductase to yield reduced glutathione (GSH). This 
reacts with 5',5 dithiobis(2-nitrobenzoic acid) (DTNB) to yield a coloured 
product.
Reagents:
Potassium phosphate buffer (0. IM; pH=7.0; 37°C) containing EDTA (2.5mM) 
Perchloric acid (2M) containing EDTA (4mM)
3 [N-morpholino] propane-sulphonic acid (0.3M) containing potassium 
hydroxide (3M)
NADPH (5pM in l%(w/v) NaHCOg)
Glutathione Reductase (6U/ml in assay buffer)
5',5 dithiobis[2-nitrobenzoic acid] (3.8mM in 1% (w/v) NaHCOg)
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Assav Procedure:
Samples of the 25%(w/v) cytosolic fraction were diluted 1:8 with 
potassium phosphate buffer (O.IM; pH=7.0). To aliquots of the diluted 
cytosolic fraction (1 0ml) was added perchloric acid/EDTA reagent (1.0ml) and 
MOPS/KOH reagent (1.0ml). Glutathione standards (0 - 0.5mM) were carried 
through the same procedure. The resultant heavy precipitate was removed by 
centrifugation of the samples at 2000g for 10 minutes using a Beckman J-6B 
centrifuge. The supematant fractions were decanted into clean tubes.
Potassium phosphate/EDTA buffer (1.0ml), NADPH (50pl), 
glutathione reductase (20pl) and supematant fraction (lOOpl) were added to 
spectrophotometer cuvettes, the reaction was initiated following the addition of 
DTNB (lOOpl) and the linear, initial rate of reaction was ascertained using a 
Kontron Instmments Uvikon 860 spectrophotometer equipped with a thermal 
jacketed cell (37°C) recording at 412nm. A standard curve was employed to 
ascertain glutathione concentration in the range 0-0.5mM glutathione per tube.
2.5.3 Determination of Cytosolic Glutathione Reductase
This activity was determined by the method of Carlberg and Mannervik
(1975)
Reagents:
Potassium phosphate buffer (O.IM; pH=7.5) containing 0. l%(w/v) EDTA 
Oxidised glutathione (17.5mM in buffer)
Flavin adenine dinucleotide (0.3mM in buffer)
NADPH (2mM in l%(w/v) NaHCOg)
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Assav Procedure:
Samples of the 25%(w/v) cytosolic fraction were diluted 1:50 with 
potassium phosphate buffer. To a quartz spectrophotometer cuvette was added 
an aliquot of diluted cytosol (3.0ml), oxidised glutathione (200pl) and flavin 
adenine dinucleotide (lOOpl). The reaction was initiated by addition of NADPH 
(200pl) and followed at 334nm for about three minutes using a Kontron 
Instruments Uvikon 860 spectrophotometer with a thermal heated cell (37°C). 
The glutathione reductase activity was calculated using the extinction 
coefficient E=4.3mM“^.cm'^.
2.5.4 Determination of Cytosolic Glutathione - S - Transferase Activities
This method employed two substrates, 3,4 dichloronitrobenzene 
(DCNB) and 1-chloro, 2,4 dinitrobenzene (CDNB) to ascertain substrate 
specificities of the glutathione - S - transferases found in the cytosolic fraction. 
The method employed was that of Habig et al. (1974)
2.5.4.1 Using DCNB as a Substrate
Reagents:
Potassium phosphate buffer (0. IM; pH=7.5)
3,4 dichloronitrobenzene (25mM in ethanol)
Reduced glutathione (25mM in buffer)
Assav Procedure:
The 25%(w/v) cytosolic fraction was diluted 1:4 with assay buffer. 
Potassium phosphate buffer (1.8ml), DCNB (lOOpl) and reduced glutathione 
(0.5ml) were mixed in a spectrophotometer cuvette. The reaction was initiated 
by addition of an aliquot of diluted cytosol (lOOpl). The linear, initial rate of 
reaction was ascertained at 345nm using a Kontron Instruments Uvikon 860
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spectrophotometer. Glutathione - S - transferase activity was calculated using 
the extinction coefficient E=8.5mM"^.cm"l.
2.S.4.2 Using CDNB as a substrate
Reagents:
Potassium phosphate buffer (0. IM; pH=7.5)
1-chloro 2,4 dinitrobenzene (25mM in ethanol)
Reduced glutathione (5mM in assay buffer)
Assav Procedure:
The 25%(w/v) cytosolic fraction was diluted 1:100 with assay buffer. 
Potassium phosphate buffer (1.8ml), CDNB (lOOpl) and reduced glutathione 
(200pl) were mixed in a spectrophotometer cuvette. The reaction was initiated 
by the addition of the diluted cytosolic fraction (lOOpl). The linear, initial rate 
of reaction was ascertained at 340nm using a Kontron Instruments Uvikon 860 
spectrophotometer. Glutathione - S - transferase activity was calculated using 
the extinction coefficient E=9.6mM"l.cm"l.
2.5.5 Measurement of Cytosolic Glutathione Peroxidase Activity
This method involved the indirect spectrophotometric determination of 
glutathione peroxidase activity (GPx) employing the measurement of NADPH 
oxidation by glutathione reductase. The method used is that of Wendel (1981). 
This method, which employed two substrates, hydrogen peroxide and cumene 
hydroperoxide to measure selenium - dependent and selenium - independent 
glutathione peroxidase respectively.
Reagents:
Potassium phosphate buffer (O.IM; pH=7.0)
Reduced glutathione (40mM in buffer)
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Hydrogen peroxide (0.2mM in distilled water)
Sodium azide (ImM in distilled water)
Glutathione reductase (40U/ml in buffer)
NADPH (2.4mM in buffer)
Assav Procedure:
The 25%(w/v) cytosolic fractions were diluted 1:10 with assay buffer. 
Potassium phosphate buffer (0.5ml), reduced glutathione (50pl), NADPH (50p 
1), hydrogen peroxide (lOOpl), sodium azide (50pl), NADPH (50|xl) and 
distilled water (lOOpl) were added to a spectrophotometer cuvette and mixed 
thoroughly. The reaction was initiated by addition of an aliquot of the diluted 
cytosolic fraction (lOOpl). The linear, initial rate of reaction was recorded and 
the activity of glutathione peroxidase was ascertained by calculation using the 
extinction coefficient E=6.3mM"^ .cm"^.
To determine the activity of selenium - independent glutathione 
peroxidase the substrate cumene hydroperoxide (40mM in 20%(v/v) methanol) 
was substituted for the hydogen peroxide.
2.5.6 Measurement of Hepatic Sulphotransferase Activity
This method of Sekura et al. (1981) was employed to determine the 
activity of hepatic phenol sulphotransferase enzymes.
Reagents:
Sodium phosphate buffer (1 .OM; pH=7.4)
2-Naphthol (ImM in 5%(v/v) acetone)
Phospho - adenosine phosphosulphate (PAPS) (2mM in buffer)
2-mercaptoethanol (O.IM in distilled water)
60
Methylene Blue Reagent (Methylene Blue (250mg), anhydrous sodium sulphate 
(50g), and concentrated sulphuric acid (10ml) made up to a volume of 1 litre 
with distilled water.)
Assay Procedure:
Sodium phosphate buffer (150pl), 2-naphthol (lOOpl), 25%(w/v) 
cytosolic fraction (50pl) and mercaptoethanol (20pl) were added to sovirel 
tubes and incubated at 37°C in a shaking water bath for 5 minutes. The 
reaction was initiated by addition of PAPS (40pl) and the incubation continued 
for a further 30 minutes. The reaction was terminated by addition of Methylene 
blue reagent (0.5ml) and followed by extraction with chloroform (2.0ml). The 
two phases of the mixture were mixed using a vortex mixer and separated by 
centrifugation at 2,000g for 5 minutes using a Beckman J-6B centrifuge. The 
chloroform layer was transferred to a glass tube containing anhydrous sodium 
sulphate («lOOmg) and the absorbance determined at 651nm using a Kontron 
Instruments Uvikon 860 spectrophotometer. The activity of hepatic phenol 
sulphotransferase was ascertained from the relationship Ipmole naphthol 
sulphate yields A55 %=30.
2.5.7 Determination of Cytosolic Superoxide Dismutase
Based upon the methods of McCord and Fridovich (1969) and Salin 
and McCord (1974), superoxide dismutase activity was determined by the 
degree of inhibition of the reduction of cytochrome C, when compared to 
comercial preparations of superoxide dismutase. Superoxide anions were 
generated by the progessive oxidation of hypoxanthine and xanthine to yield 
uric acid.
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Reagents:
Potassium phosphate buffer (50mM; pH=7.8) containing EDTA (0. ImM) 
Hypoxanthine (1,5mM in buffer)
Xanthine Oxidase (56mU/ml in buffer)
Cytochrome C (0.3mM in buffer)
Assay Procedure:
Samples of 25%(w/v) cytosolic fraction were diluted 1:100 in assay 
buffer. Potassium phosphate buffer (2.6ml), hypoxanthine (lOOpl), xanthine 
oxidase (lOOpl), cytochrome C (lOOpl) and an aliquot of diluted cytosolic 
fraction were added to a spectrophotometer cuvette and mixed thoroughly. The 
linear, initial rate of reaction was ascertained by following the progress of the 
reaction at 550nm, for about two minutes, using a Kontron Instruments Uvikon 
860 spectrophotometer. The superoxide dismutase activity of individual 
samples was ascertained by comparison with a standard curve in the range of 0- 
lOU superoxide dismutase.
2.5.8 Measurement of Cytosolic Catalase Activity
Based upon the method of Baudhuin (1974) the assay measured the 
unmetabolised hydrogen peroxide by reaction with titanium ions under acid 
conditions to yield a coloured titanium - peroxide complex.
Reagents:
Imidazole buffer (20mM; pH=7.0) containing bovine serum albumin (Ig/L) 
Triton X-100 (2.0%(v/v) in buffer)
Imidazole buffer (20mM; pH=7.0) containing bovine serum albumin (Ig/L) and 
3.5mM hydrogen peroxide.
Titanyl sulphate (2.25g/L) in 2N sulphuric acid.
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Assay Procedure:
All the solutions used were precooled to 0°C prior to the experiment. 
Samples of 25%(w/v) cytosolic fraction were diluted 1:200 with imidazole 
buffer. Aliquots of the diluted cytosol fraction (lOOpl) were added to precooled 
glass test tubes. To each tube was added triton X-100 (lOOpl) and the reaction 
was initiated by the addition of imidazole buffer containing hydrogen peroxide 
(2.0ml). The reaction mixtures were incubated for 4 minutes in an ice/water 
bath (0°C). The reaction was terminated by addition of titanyl sulphate reagent 
(3.0ml) and the absorbance recorded at 405nm using a Kontron Instruments 
Uvikon 860 spectrophotometer. The activity of the cytosolic fractions was 
ascertained with reference to a standard curve, using hydrogen peroxide in the 
range of O-Tpmoles per tube.
2.6 Measurement of Hepatic Cytosol Metallothionein Content
The determination of metallothionein content of hepatic cytosol fractions is 
based upon the detection of Cd^^^ bound to partially purified cytosol. This 
method is essentially based upon those of Eaton and Toal (1982) and Dieter et 
aL(1987).
Reagents:
Haemoglobin (2%(w/v) in distilled water)
Cd^^^ Solution (stock)
Cadmium chloride (ImM in distilled water)
Assay Procedure:
The labelled Cd^^^ stock solution was diluted with unlabelled CdCl2 
(ImM) to give a resulting solution with an activity of approximately 5-10,000 
counts/min/ml. This provided the working solution. Aliquots of the 25%(w/v)
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cytosolic fraction (200pl) were dispensed into Eppendorf microcentrifrige tubes 
(1.0ml) and were placed in a boiling water bath for 2 minutes. The resulting 
suspension was sedimented by centrifugation of the samples at 10,000g for 2 
minutes using an Eppendorf microfuge centrifiige. To each of these samples 
was then added an aliquot of the working solution containing Cd^^^ (200pl). 
The samples were then incubated for 10 minutes at room temperature. After 
incubation, an aliquot of 2%(w/v) haemoglobin (200pl) was added to each tube 
and these were subsequently vortexed thoroughly. After mixing, the tubes were 
returned to a boiling water bath for 2 minutes. The resulting suspension was 
removed by centrifugation at 10,000g for 2 minutes. A further aliquot of the 
haemoglobin solution was added and the process of heating and centrifugation 
repeated. After this final centrifugation, aliquots of the resultant supernatant 
(500|il) were transferred to clean polystyrene tubes and the radioactivity was 
determined using an LKB Gamma counter. The concentration of 
metallothionein present in each sample was calculated with reference to a 
standard curve using purified human metallothionein in the range 0-1 pg per 
tube.
2.7 Measurement of Peroxisome dependent P - Oxidation of Palmitoyl CoA
Based upon the method of Lazarow and de Duve (1976) this assay 
relies upon the oxidation of palmityl CoA, yielding reduced NAD*  ^ and FAD. 
In the persence of cyanide ions the oxidation of NADH by the mitochondria is 
blocked, leading to a build up of NADH, which is monitored throughout the 
reaction. The FADH2 produced is oxidised in the presence of molecular 
oxygen, regenerating FAD.
Reagents:
Tris.HCl buffer (60mM; pH=8.3)
Triton X-100 ( l%(w/v) in buffer)
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Substrate solution - [coenzyme A (6.5mg); FAD (14.9mg); nicotinamide 
(1.27g); Dithiothreitol (64.8mg); KCN (19.5mg); fatty acid free BSA 
(22.5mg); NAD (37mg) all made up to a final volume of 100ml in assay buffer] 
prepared freshly and kept on ice.
Palmityl CoA (7.7mg/ml in buffer)
Assav Procedure: .
Samples of 25%(w/v) whole homogenate were diluted 1:1 in triton X- 
100 , mixed and incubated at 37°C for 2 minutes. The resulting solutions were 
centrifuged at lOOOg for 3 minutes in a Beckman J-6B centrifuge. The 
supernatant was decanted and kept on ice.
Substrate solution (2ml) and Tris.HCl buffer (960pl) were added to a 
spectrophotometer cuvette and incubated at 37°C for 10 minutes. An aliquot 
(40|il) of the supernatant fraction was added to the cuvette and a baseline 
recorded. The reaction was initiated by addition of palmitoyl CoA (20pl) and 
the cuvette contents were mixed throroughly. The reaction was followed at 
340nm using a Kontron Istruments Uvikon 860 spectrophotometer with a 
thermal heated cell carrier (37°C). Each reaction was incubated for at least 10 
minutes and the rate of reaction ascertained from the extinction coefficient E 
=6.22mM"^.cm” .^
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2.8 The Ames Mutagenicity Assay
The mutagenicity testing procedure used during this study was 
essentially that of Maron and Ames (1983).
2.8.1 The Bacteria
Three strains of Salmonella typhimurium were used in this study: TAIOO 
which is believed to be most sensitive to base - pair substitution mutagens such 
as the polyaromatic hydrocarbons; TA98 which is believed to be most sensitive 
to frame shift mutagens such as the aromatic amine (IQ) and TA1530 which is 
also believed to be most sensitive to frameshift mutations, particularly those 
caused by intercalating agents.
Solutions:
Nutrient Broth Supplemented with Ampicillin (NB+)
-Nutrient Broth No.2 (2.5%(w/v))
-Ampicillin (72pM)
For Bacteria strain TA1530 Nutrient Broth No.2 was used, without Ampicillin
Growth of the Bacteria:
Frozen permanent stock cultures were inoculated into 10ml of NB+ 
using a heat sterilized platinum wire. The broth was then incubated for 16 
hours at 37°C in a shaking water bath.
2.6.1.1 Testing of the Bacterial Genotype
Periodically, a set of standard tests were carried out on the bacterial 
tester strains to ensure that they retained their particular characteristics.
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Solutions:
Agar [ 0.6%(w/v) No.l agar; 0.5%(w/v) NaCl in distilled water]
Low L-histidine/biotin [0.5mM 1-histidine; 0.5mM biotin in distilled water]
High L-histidine/biotin [O.IM L-histidine; 0.5mM biotin in distilled water] 
Potassium phsphate buffer (0.2M; pH=7.4)
Histidine Requirement:
The bacterial strains possess a lesion in the histidine operon rendering 
the bacteria incapable of synthesising histidine and consequently possess an 
absolute requirement for histidine in the growth medium. This lesion forms the 
basis of the Ames test; the formation of colonies in the presence of low levels 
of histidine indicates that mutagenic events have occurred within the histidine 
gene locus facilitating the synthesis of histidine.
Test Procedure:
High histidine/biotin (lOOpl) was spread onto the surface of minimal 
agar plates and when the solution had dried the tester strain were streaked onto 
the plates. Plates which had not been supplemented with high histidine/biotin 
were also streaked with bacteria. The plates were incubated at 37°C for 24 
hours. Failure to grow in the absence of histidine demonstrated that the 
bacteria were still His"^ .
Crvstal Violet Test:
This test was used to detect the deep rough mutation on the bacterial 
genome. This mutation ensures that the lipopolysaccharide coat, normally 
surrounding the bacteria, would not be fully formed, remaining porous and 
therefore allowing the passage of large molecular weight compounds by 
diffusion.
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Reagent:
Crystal Violet (0.1% (w/v))
Test Procedure:
An aliquot of the bacterial culture (lOOpl) was added to nutrient agar 
(2ml) supplemented with low histidine/biotin (10% (v/v)). Potassium phosphate 
buffer (0.2M; pH=7.4) was added and the mixture poured onto minimal agar 
plates. When the agar had solidified, a sterile filter paper disk was placed into 
the centre of the plate and crystal violet solution (40pl) was pipetted onto the 
surface of the disk. The plates were incubated at 37°C for 24 hours. A zone of 
inhibition, in the bacterial lawn, around the disk indicated the presence of the 
mutation.
Presence of the R - Factor:
Two strains of bacteria used in the study, TA98 and TAIOO, contain the 
R - factor plasmid pKMlOl. This plasmid increases the susceptibility of the 
bacteria to mutagens. Part of the plasmid also confers antibiotic resistance to 
ampicillin to the bacteria and consequently each strain of bacteria were assessed 
for their resistance to ampicillin, as an indication for the presence of the 
plasmid.
Reagents:
Ampicillin (0.023M in 0.02M NaOH)
Test Procedure:
An aliquot of the bacterial culture (lOOpl) was added to nutrient agar 
(2ml) containing low histidine/biotin (10%(v/v)) mixed, and poured onto 
minimal agar plates. When the top agar had solidifed a sterile filter disk was
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placed onto the centre of the plate and ampicillin (40pl) pipetted onto the disk. 
The plates were incubated at 37°C for 24 hours. No zone of inhibition in the 
bacterial lawn, around the disk, indicated the presence of the R - factor.
Viability Test Procedure:
Overnight bacterial culture (lOOpl) was added to nutrient broth 
supplemented with ampicillin (NB+) (10ml) and mixed thoroughly. For 
Salmonella strain TA1530 nutrient broth without ampicillin was used. An 
aliquot of this suspension was transferred to fresh NB+ (10ml) and mixed; this 
serial dilution was repeated a third time. An aliquot of this final dilution (lOOpl) 
was added to nutrient agar (2ml), fortified with high histidine/biotin (15% v/v). 
The resulting mixture was poured onto minimal agar plates and incubated at 37 
°C for 24 hours. The colonies were then counted and the number of whole cells 
in the culture calculated.
2.8.2 Ames Test System
2.8.2.1 Preparation of the Activation System
Many compounds are only mutagenic following metabolic activation. Thus it 
was usually necessary to include an activation system in order to achieve the 
mutagenic activity. Activation systems utilised preparations from animal tissue, 
either post mitochondrial fraction (89) or microsomal suspension (isolated 
microsomes), both at 25%(w/v).
Reagents:
KCl (0.33M in distilled water)
MgCl2 (0.08M in distilled water)
Cofactor solution (20mM NADP; 25mM glucose - 6 - phosphate in assay 
buffer)
Potassium phosphate buffer (0.2M; pH=7.4)
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Activation Systems:
REAGENT:
KCl
MgCl2
Cofactor Solution
S9 or Microsomal 
Suspension
Potassium Phosphate 
Buffer
25%:
10%(v/v)
10%(v/v)
20%(v/v)
25%(v/v)
35%(v/v)
10%:
10%(v/v)
10%(v/v)
20%(v/v)
10%(v/v)
50%(v/v)
When a microsomal suspension was used, the activation system was 
supplemented with glucose - 6 - phosphate dehydrogenase (1 unit per plate.)
2.S.2.2 Test Procedure
The following were added to sterile, 10ml polyethylene tubes.
-2ml molten nutrient agar containing low histidine/biotin (10% v/v)
-0.1ml test solution (in distilled water or DMSO)
-0.1ml of fresh 16 hour bacterial culture
-0.5ml Potassium phosphate buffer or activation system
The contents of the tubes were then mixed and poured onto minimal 
agar plates. The plates were incubated at 37°C for 48 hours and the number of 
revertant colonies were then counted manually. Positive controls, listed in table 
2.1, were included in each test where appropriate, and similarly spontaneous 
reversion rates were also determined.
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Table 2.1: Positive Control and Spontaneous Reversion Regimes for 
Salmonella typhimurium strains used in the Ames Mutagenicity Assay.
Bacterial tester Strain 
Used:
TA1530
TA98
TAIOO
Positive Control with 
Activation System:
Nitrosopiperidine
(4mg/plate)
2 - Aminoanthracene 
(5pg/plate)
2 - Aminoanthracene 
(5pg/plate)
Positive Control without 
Activation System:
N - methyl - N - nitro - N
- nitrosoguanidine
(0.5pg/plate)
2 - Nitrofluorene 
(2pg/plate)
N - methyl - N - nitro - N
- nitrosoguanidine
(0.5 p/plate)
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A compound was deemed to show significant mutagenicity if it at least doubled 
the spontaneous reversion rate and showed a concentration dependent increase 
in mutagenic response.
2.9 Discontinuous Sodium Dodecyl Sulphate (SDS) Polyacrylamide Gel 
Electrophoresis (PAGE) and Western Blot Analysis of Microsomal 
Proteins and c - myc Oncogene Products
Reagents:
Upper Gel buffer - 0.5M Tris.HCl; 0.4%(w/v) SDS ; pH=6.8
Lower Gel buffer - 1.5M Tris.HCl; 0.4%(w/v) SDS ; pH=8.8
Electrode Buffer - 0.025M Tris.HCl; 0.192M glycine; 0.1%(w/v) SDS; pH=8.3
Transfer Buffer - 0.02M Tris.HCl; 0.15M glycine; 13.33%(v/v) methanol
Wash Buffer - 0.22%(v/v) Triton X-100; l%(v/v) PBS; l%(w/v) BSA
PBS - 0.8%(w/v) NaCl; 0.02%(w/v) KH2PO4; 0.29% K2HPO4; 0.02%(w/v)
KCl
Freshly prepared ammonium persulphate (lOOmg/ml)
2.9.1 Discontinuous SDS - PAGE
The method used to separate microsomal proteins was that of Laemmli (1970)
2.9.1.1 Sample Preparation for 25%(w/v) Microsomal Suspensions
Sample buffer was used as follows;
Trizma base (L51g) was dissolved in distilled water (15ml) and the pH 
adjusted to 6.8 with hydrochloric acid. The following were then added:
- 10%(w/v) SDS (40ml)
- 2-mercaptoethanol (10ml)
- Glycerol (20ml)
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- Bromophenol blue dye (0.004g)
The final volume was then adjusted to 100ml with distilled water. The 
25%(w/v) microsomal suspensions were diluted with sample buffer to give a 
final protein concentration of 2mg/ml.
2.9.1.2 Preparation of Samples for c - myc Protooncogene Product Analysis
Reagents:
Homogenisation buffer containing proteinase inhibitors was prepared as 
reported bv Knowles et al. 0990)
320mM sucrose (in 50mM Tris.HCl)
ImM EDTA (in 50mM Tris.HCl)
ImM DL - dithiothrietol (in 50mM Tris.HCl)
To the resulting solution were added phenyl methyl sulphonyl fluoride (lOOp 
g/ml), leupeptin (lOpg/ml), soybean trypsin inhibitor (lOpg/ml) and aprotinin 
(2pg/ml). The pH of the resultant solution was adjusted to 7.0 with 
hydrochloric acid.
Small pieces of frozen tissue («l.Ogm) were coarsely broken and placed 
in a precooled Teflon beaker containing a tungsten - carbide ball bearing. The 
samples were then disrupted using a Braun Mikro Dismembranator 2000 for 30 
seconds. The resulting powder was transferred to the homogenisation buffer 
and diluted to 50%(w/v) with the homogenisation buffer such that Ig liver = 
2ml of diluted homogenate.
The 50%(w/v) homogenate was then aliquoted (1.0ml) and centrifuged 
at 13,000g for 30 minutes at 4°C using an lEC Centra M2 microcentrfuge 
(International Equipment Company, USA.) The supernatants were collected 
and diluted with sample buffer to give a final protein concentration of 40mg/ml.
Positive controls consisting of 15 day old neonatal rat hepatic tissue 
were treated in a similar fashion.
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2.9.1.3 Preparation of the Gel
Two cleaned, dry glass plates were clamped together in a Hoefer 
Scientific Instruments vertical slab gel - setting unit. Lower gel was prepared as 
follows:
Lower Acrvlamide Gel Mixture:
Acrylagel (8.11ml)
Bis Acrylagel (3.38ml)
Lower gel buffer (6.25ml)
Distilled water (7.14ml)
Ammonium persulphate (125pl)
N,N,N',N' - tetramethyl ethylene diamine (TEMED) (20|il)
The above solution was poured between the two plates, followed by a few 
microlitres of water - saturated butanol and the lower gel was allowed to set. 
Once polymerised, the surface of the acrylamide gel was washed with water to 
remove the butanol. The upper gel was prepared as follows:
Upper Acrvlamide Gel Mixture: 
Acrylagel 
Bis Acrylagel 
Upper gel buffer 
Distilled water 
Ammonium persulphate 
TEMED
(1.0ml)
(400pl)
(2.5ml)
(6.0ml)
(lOOpl)
(20pl)
The upper gel was poured between the plates and a comb was inserted 
to form the sample well. When the upper gel had set, the comb was removed 
and the position of the wells marked. The plate cassette was placed in a
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Hoeffer vertical slab gel electrophoresis chamber, the wells were filled with 
electrophoresis buffer and the appropriate amount of sample protein loaded 
into each well. The top reservoir was clamped into position and filled with 
electrode buffer, as was the bottom reservoir. A current of 20mA was applied 
down the gel using a Pharmacia EPS 500/400 power supply. The current was 
maintained until the dye front was approximately 2cm form the base of the 
lower gel.
2.9.2 Western Blot Analysis
This technique involved the transfer of proteins from the gel onto the 
surface of nitrocellulose membrane and immunostraining as previously reported 
(Towbin et al. 1979). The electrophoresis plate cassette was dismantled and the 
top and bottom of the gel cut away. The gel was then marked to determine 
orientation. The prepared gel was then placed in transfer buffer overnight (4° 
C). The transfer itself was effected using a Bio-rad wet transfer cassette - the 
following arrangement was used for the transfer:
1 layer of Scotchbrite scouring pad
2 layers of Whatman No. 1 filter paper
The prepared gel
1 layer of Nitrocellulose membrane
2 layers of Whatman No. 1 filter paper
1 layer of Scotchbrite scouring pad
Air bubbles were carefully removed before addition of each subsequent layer of 
the 'sandwich’ by rolling in transfer buffer. The cassette was closed and placed 
in a Bio-rad transfer tank so that the nitrocellulose was closest to the positive 
electrode. The tank was filled with transfer buffer and a potential difference of 
60v applied across the gel for 80 minutes.
75
The cassette was dismantled and the nitrocellulose placed in wash 
buffer overnight under refrigeration. A variety of primary antibodies were used 
to detect protein products from gel electrophoresis. An example for the 
detection procedure is listed below:
i) Primary Antibody - 1:10,000 dilution of Anti - 
CYPIA polyclonal antibody in 50ml wash buffer. Incubation for 
1 hour.
ii) The nitrocellulose was then rinsed with 2 changes 
of wash buffer for 30 minutes
iii) Secondary Antibody - 1:2500 dilution of donkey 
anti - sheep IgG horseradish peroxidase conjugate in 50ml of 
wash buffer. Incubation for 1 hour.
iv) The nitrocellulose was then rinsed with 2 changes 
of wash buffer for 30 minutes.
v) The nitrocellulose was then transferred to a PBS 
solution for 10 minutes.
vi) Development of the nitrocellulose membrane was 
carried out in Tris.HCl (O.IM; pH=7.4) containing 3,3' 
diaminobenzidine (1 mg/ml) and 30%(w/v) hydrogen peroxide 
(40|xl). Once the bands had developed, the nitrocellulose was 
washed exhaustively in ice cold distilled water.
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Statistical Analysis was carried out to assess the data presented for 
statistically significant differences. Unless otherwise stated, a student T ' test 
was used for direct comparison of the data.
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Chapter 3
EFFECTS OF REFINED CARBOHYDRATES ON 
DRUG METABOLISM IN THE LIVER
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3.1 Introduction
The first reports on the effects of high carbohydrate diets on hepatic 
xenobiotic - metabolising enzymes focused on barbiturate - induced sleep 
duration after feeding a variety of sugars as part of the diet. Strother et al. 
(1971) reported that when sucrose replaced a standard laboratory diet for 
fifteen hours each day, the sleep induced by hexobarbital, pentobarbital and 
secobarbital was significantly increased in Swiss Webster mice. The same 
workers showed that administration of glucose in the drinking water and 
sucrose in a powdered diet also increased barbiturate - induced sleep duration. 
In vitro studies in these animals indicated a significant decrease in the 
metabolism of hexobarbital, but no change was noted in the 4 - hydroxylation 
of aniline and only glucose decreased the hepatic metabolism of p - 
nitroanisole. This data was corroborated by Peters and Strother (1972), also 
showing a decrease in in vitro benzphetamine metabolism as well as lower 
cytochrome P450 levels and lower cytochrome P450 reductase and cytochrome 
C reductase activities in hepatic microsomes.
Sonawane et al. (1983) established a relationship between duration of 
administration of an isocaloric high starch or high sucrose diet to male CD rats 
and effects upon hepatic drug metabolism. At three days and fourteen days the 
liver weight, as a percentage of the body weight, was elevated in those animals 
fed a high sucrose diet. An elevation in hepatic microsomal cytohrome P450 
concentration was also reported at day fourteen for high sucrose diets. No 
changes were noted in cytochrome b$ activity. Feeding a high sucrose diet also 
appeared to depress aminopyrine - N - demethylase activity on days three and 
seven, whereas hepatic p - nitrophenol glucuronosyl transferase activity was 
elevated with increasing duration of sucrose diet intake.
Mutagenesis studies by Rubano et al. (1990) indicated that pretreatment 
of hamsters receiving glucose in the drinking water with Aroclor 1254 elevated 
the number of revertants caused by afiatoxin Bj and depressed the number of
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revertants caused by benzo(a)pyrene in the Ames Test using an S9 mediated 
activation system when compared to animals receiving Aroclor 1254 alone. The 
degree of metabolism of both afiatoxin and B[a]P by Aroclor 1254 
pretreated hepatic microsomes showed a similar profile; glucose pretreatment 
elevating AFBj metabolism whilst suppressing the metabolism of B[a]P in 
vitro. This data was supported by Vance et al. (1990) whom observed a 
decrease in the mutagenicity of B[a]P mediated by hepatic microsomes isolated 
from rats pretreated with Aroclor 1254 and glucose compared to rats receiving 
Aroclor 1254 pretreatment alone. A decrease in the in vitro formation of 
B[a]P - DNA adducts was also observed using microsomes isolated from 
glucose pretreated animals.
Sucrose has also been implicated in the modulation of chemical 
carcinogenesis. Cademi et al. (1993) showed that sucrose increased the number 
and severity of azoxymethane - induced intestinal tumours in rats, compared to 
rats fed a diet high in cornstarch.
In view of these findings and nutritional studies on dietary habits 
indicating an increase in consumption of refined sugars (Anderson 1982; 
Hackett et al. 1984) suggesting that refined sugar made up approximately 21% 
of the total calorific intake, about 43% of the total carbohydrate intake, this 
study was undertaken to investigate the effects of high glucose, sucrose and 
fructose diets upon hepatic xenobiotic - metabolising enzymes of the rat. The 
objectives of the study are to investigate whether chronic administration of high 
sugar diets could effect the profile of hepatic cytochrome P450 and phase II 
conjugation enzymes and to assess their impact upon initiation of chemical 
carcinogenesis.
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3.2 Materials and Methods
3.2.1 Materials
Diets high in glucose, sucrose and fructose were prepared from 
individual components. Glucose was obtained from Fisons UK, Fructose was 
obtained from Sigma Biochemicals (Poole, Dorset, UK) and sucrose was 
obtained from a local supermarket and was the Silver Spoon brand of icing 
sugar. Rovimix A, a vitamin A preparation, was obtained form Roche UK.
3.2.2 Methods
Twenty male, Wistar albino rats (60gm) were obtained from the 
University of Surrey Experimental Biology Unit. The rats were randomly 
divided into four groups of five animals and housed in polyethylene cages as 
outlined in the "Methods" section (Chapter 2).
A semi - synthetic, powdered diet was prepared from individual 
components and mixed thoroughly. The diet was divided into four equal 
portions and starch was added to the basal diet (250g/kg). To each of the test 
diets was added glucose, sucrose or fructose (250gm/kg). The diets were 
stored in vacuum - sealed polyethylene bags at 4°C in darkness until used. A 
summary of the diet composition is given in table 3.1. The animals were 
allowed ad libitum access to the test diets and water throughout the test 
period. Fresh diet was placed in the cages daily.
At the end of the experimental period all animals were sacrificed by 
cervical dislocation and tissues prepared to give 25%(w/v) postmitochondrial 
supernatants as outlined previously (Chapter 2.2).
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Table 3.1: The Composition of the Semi - Synthetic Diets Fed to Rats.
COMPONENT: Glucose Diet: Sucrose Diet: Fructose Diet: Control D
(gm/kg) (gm/kg) (gm/kg) (gm/kg;
CASEIN 100 100 100 100
GLUCOSE 250 - - -
SUCROSE 50 300 50 50
FRUCTOSE - - 250 -
CORNSTARCH 452 452 452 702
CELLULOSE 50.0 50.0 50.0 50.0
CORN OIL 50.0 50.0 50.0 50.0
VITAMIN MIX 8.64 8.64 8.64 8.64
MINERAL MIX 35.0 35.0 35.0 35.0
CHOLINE 1.34 1.34 1.34 1.34
ROVIMIX A 0.024 0.024 0.024 0.024
METHIONINE 3.0 3.0 3.0 3.0
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3.3 Results
3.3.1 Animal Husbandry
Throughout the period of study all the animals remained alert and active 
and in good health. Measurement of body weight, food and water consumption 
was carried daily. Figure 3.1 shows the mean body weight gain of all the 
groups of animals throughout the study period. Rats maintained on the high 
sugar diets showed poor weight gain from commencement of the study when 
compared to control animals fed the high cornstarch diet; the sucrose treated 
rats recorded the lowest weight gain over the study period. For this reason the 
study was terminated after twenty one days rather than continuing for greater 
duration. The data also showed that food consumption for the sucrose and 
fructose treated groups was generally lower than for the control (Figure 3.2) as 
was the corresponding water consumption (Figure 3.3)
3.3.2 Observations at Autopsy
At autopsy no gross anatomical differences or abnormalities were 
observed in any of the rats fed a high glucose or fructose diet. However 
distention of one of the kidneys was observed in two of the animals fed the high 
sucrose diet. This distention appeared to focus on the renal pelvis, without 
affecting the renal cortex, and the kidney was found to be fluid filled in both 
animals. This hydronephrosis was absent from the groups maintained on 
glucose or fioictose diets.
Investigation of tissue weights revealed that all treatments with diets led 
to lower absolute liver weight. These decreases in liver weight of 30%, 25% 
and 15% respectively for glucose-, sucrose- and fructose- containing diets were 
statistically significant in the case of the high sucrose diet (P<0.02) (Table 3.2). 
Moreover, the sucrose diet produced a statistically significant (P<0.02) 
increase in brain weight (13%).
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Table 3.2: Organ Weights and Blood Analysis in Rats Maintained on Diets high in
Glucose, Sucrose or Fructose.
PARAMETER Control High Glucose High Sucrose High Fructose
(25% w/w) (25% w/w) (25% w/w)
BODY WEIGHT 
(gm)
LIVER WEIGHT 
(gm)
KIDNEY 
WEIGHT (gm)
BRAIN WEIGHT 
(gm)
LIVER/BODY 
WEIGHT(%)
KIDNEY/BODY 
WEIGHT (%)
BRAIN/BODY
WEIGHT(%).10-3
HAEMOGLOBIN
(gm/IOOml)
HAEMATOCRIT
184.9 ±24.5
10.2 ± 1.6
1.72 ±0.14
1.42 ±0.06
5.53 ±0.28
0.96 ± 0.22
7.76 ± 0.99
9.49 ±1.0
28.4 ±3.8
163.0±15.6 151.3 ±7.9
8.22 ± 1.55
1.39 ±0.19
1.46 ±0.08
5.01 ±0.47
0.85 ±0.03
9.69 ± 0.57
30.4 ±1.3
7.78 ± 0.69
1.85 ±0.74
1.61 ±0.11
5.15 ±0.52
1.24 ±0.54
9.85 ± 0.67
28.5 ± 1.9
162.4 ± 12.4
8.66 ± 1.09
1.47 ±0.14
1.55 ±0.12
5.34 ±0.61
0.91 ±0.05
9.02 ± 1.08 10.63 ±0.41*** 9.56 ±0.58*
9.87 ±0.28
29.3 ±0.6
* 0.05 > ? >  0.01, ** 0.01 > P >  0.001, *** 0.001 >P
Figures show Means ± Standard Deviation for Five Animals.
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When organ weights were expressed with respect to body weight to 
take into account the effects of large differences in body weight neither the 
liver nor kidneys showed statistically significant changes; however a statistically 
significant increase in brain weight was observed in animals fed the sucrose or 
fructose diets.
3.3.3 Effect of Refined Sugars upon Hepatic Monooxygenase Activities in the Rat
Without exception, maintenance of rats on diets high in glucose, 
sucrose or fructose produced no effect on the dealkylations of ethoxy-, 
methoxy- or pentoxyresorufin. Similarly, the activities of p-nitrophenol 
hydroxylase and erythromycin - N - demethylase were unaffected by the same 
diets. A modest decrease in lauric acid hydroxylase activity was noted in 
response to maintaining rats on high sucrose diets.
3.3.4 Effect of Diets High in Refined Sugars upon Hepatic Cytosolic Enzymes
A slight, but statistically significant decrease in catalase activity was 
observed for animals fed the high sucrose diet.
Glucose and Fructose treatments caused a decrease of 25% and 45% 
respectively in hepatic total glutathione concentrations, but neither of these 
decreases were statistically significant as a result of large statistical deviations. 
None of the other parameters studied were modulated by the high sugar diets.
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Table 3.3: Effects of Dietary Carbohydrates on Rat Hepatic Microsomal Enzyme
Activities.
PARAMETER Control
Cytochrome P450: 0.19 ± 0.03
(nmoles/mg protein)
Microsomal Protein 56.9 ±4.1
(mg/g Liver)
Ethoxyresorufin - O 1.79 ± 0.4
- dealkylase 
(pmoles/min/mg
protein)
Pentoxyresorufin - O 1.13 ± 0.30
- dealkylase 
(pmoles/min/mg
protein)
MethoxjTesorufin - 2.43 ± 0.54
O - dealkylase 
(pmoles/min/mg 
protein)
p - Nitrophenol 
hydroxylase 
(nmoles/min/mg 
protein)
Erythromycin - N - 0.56 ± 0.16
demethylase 
(nmoles/min/mg 
protein)
Lauric acid 1.87 ± 0.50
hydroxylase 
(nmoles/min/mg 
protein)
Naphthol 0.86 ± 0.41
glucuronide 
(nmoles/min/mg 
protein)
High Glucose High Sucrose High Fructose
25%(w/w) 25%(w/w) 25%(w/w)
0.19 ±0.03 0.15 ±0.03 0.16 ±0.04
57.4 ±6.5 56.7 ±6.5 63.8 ±10.9
2.13 ±0.27 1.84 ±0.23 1.90 ±0.18
1.26 ±0.30 1.31 ±0.23 1.32 ±0.12
3.02 ± 0.30 2.70 ± 0.50 2.96 ± 0.46
0.49 ±0.09 0.48 ±0.09 0.43 ±0.14 0.42 ±0.08
0.60 ±0.17 0.51 ±0.17 0.67 ±0.22
1.79 ±0.28 1.19 ±0.30 1.31 ±0.27
0.78 ± 0.24 0.73 ± 0.32 0.82 ± 0.29
* 0.05 > P >  0.01, ** 0.01 > P >  0.001, ***0.001 >P  
Results are Expressed as Mean ± Standard Deviation of five Animals.
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Table 3.4: Effects o f Carbohydrate Diets upon Rat Hepatic Cytosolic Enzymes.
PARAMETER Control Glucose Diet Sucrose Diet Fructose Diet
25%(w/w) 25%(w/w) 25%(w/w)
Cytosol protein 130.4 ±11.8 134.8 ±13.0 124.4 ± 9.8 136.0 ±6.2
(mg/g liver)
Gluthathione transferase 19.5 ± 2.2 18.1 ±3.1 20.0 ±1.4  19.9 ± 2.4
(DCNB substrate)
(nmoles/min/mg
protein)
Glutathione transferase 1975 ± 152 1950 ±331 1999 ±141 1881 ±283
(CDNB sustrate)
(nmoles/min/mg
protein)
Total glutathione (mM) 4.05 ±0.62 3.06 ±0.72 4.48 ±2.21 2.19 ±1.84
Gutathione reductase 21.4 ± 1.4 21.8 ±2.3 21.8 ± 1.2 23.2 ± 1.2
(nmoles/min/mg 
protein)
Selenium dependent 363 ±50  319 ± 56 340 ± 32 350 ± 37
glutathione peroxidase 
(nmoles/min/mg 
protein.)
Selenium dependent 203 ±19  184 ±28 198 ± 24 191 ±20
glutathione peroxidase 
(nmoles/min/mg 
protein)
Catalase 38.6 ±4.3 36.3 ±4.5 32.2 ±0.84* 32.2 ±4.8
(pmoles/min/mg 
protein)
Superoxide dismutase 27.6 ±4.0 23.1 ±4.9 28.0 ±3.0 28.5 ±5.5
(units/mg protein)
* 0.05 > P >  0.01, ** 0.01 > P >  0.001, ***0.001 >P
Data Expressed as Means ± Standard Deviation of Five Animals
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3.4 Discussion
3.4.1 Animal Husbandry
Rats maintained on diets high in refined carbohydrate, compared to 
control fed animals, gained weight poorly throughout the duration of the study. 
Assessment of food consumption over the same period revealed that although 
palatability of diets high in sucrose or fiuctose may in part be responsible for 
the poor weight gain, the comparison of glucose and control diets recorded 
similar food consumptions and may therefore have been expected to gain 
weight in a comparable fashion. Based upon the assertion that the diets used 
were essentially isocaloric in nature the recorded detriment in weight gain may 
imply poor calorie efficiency or poor utilisation of the calories for growth.
This effect appears difficult to interpret. A mineral or nutrient 
deficiency may be ruled out as the diets were synthesised from a basal diet that 
was divided into four equal portions to which were then added either starch, 
glucose, sucrose or fiuctose. A more plausible explanation is that calories were 
lost through the production of heat i.e. thermogenesis (personal communication 
Prof. M. Stock, St. Georges Medical School, University of London.). 
Maintenance of rats on ’cafeteria' style diets gave rise hyperphagia and 
increased energy consumption (Rothwell and Stock 1979) which was 
concurrent with an increase in oxygen consumption and calorie expediture over 
a twenty four hour period (Rothwell and Stock 1982). Interestingly, this was 
coupled with an increase in body fat content, brown adipose tissue (BAT) 
weight and protein content (Rothwell et al. 19821.
The data presented in this study does not corroborate these findings as 
no hyperphagia was recorded (Figure 3.2) and changes to body composition 
and BAT composition were not measured. Previous studies investigating the 
thermogenic effects of diets high in sucrose (Rothwell and Stock 1984) differed 
significantly from this present experiment regarding protocol in that sucrose 
was administered to rodents in the drinking water (10% w/v) rather than
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incorporated into the diets. This practice has previously been shown to cause a 
hypophagic effect, causing a decrease in food consumption yet this was not 
observed by Rothwell and Stock (1984). The data did however demonstrate 
that sucrose caused a modest reduction in body weight despite equivalent mean 
calorie intake between test and control animals. Calorie expenditure was found 
to be elevated following administration of sucrose and associated with a 
decrease in net calorie efficiency.
The available data did not allow firm concusions to be drawn as to the 
loss in weight gain noted in animals maintained on high sugar diets, but the 
possibility that thermogenesis may be responsible for the poor calorie efficiency 
merits additional investigation and cannot be ruled out. Interestingly the 
hyperphagia previously documented (Rothwell and Stock 1979) was absent and 
may relate, in part, to the palatability of diets high in refined sugars.
3.4.2 Renal Lesions Induced by Diets High in Sucrose
The presence of renal hydronephrosis in two of the five rats maintained 
on a diet high in sucrose is difficult to explain. Histological analysis of the renal 
cortex recorded no pathological changes present in the glomerulus or the renal 
tubules (data not shown) which contradicts previous experimental findings. 
Both Cohen and Rosenmann (1971) and Kang et al. (1977) observed that 
maintaining rats on diets high in sucrose produced elevations in urinary N - 
acetyl - P - glucosaminidase activity and intercapillary glomerulosclerosis, 
characterised by an enlargement of the glomerulus and a widening of the 
mesangal areas within the kidney. However these effects were only noted after 
treatment for substantial periods of time, up to eleven and sixteen months 
respectively.
Subcutaneous injection of sucrose to rats gave rise to vacuolation of 
proximal tubule cells resulting ftom the osmotic effects of sucrose (Maunsbach 
et al. 1962); however no such changes were noted when tissue sections were
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examined under the microscope. Unfortunately - kidney function was not 
investigated in this study.
Diets high in sucrose may have hypertensive potential in normotensive 
rats (Preuss et al. 1992) and a potential to increase systolic blood pressure in 
addition to decreasing urinary volume, urinary creatinine, sodium and 
potassium levels in spontaneously hypertensive rats (Preuss et al. 1994). These 
effects were recorded over long periods, up to five months, (Preuss et al.
1992), and therefore the short duration of this study is unlikely to contribute to 
the renal lesions observed in the present study (three weeks). As yet, the 
observed hydronephrosis remains unexplained.
3.4.3 Investigation of Organ Weights
High sucrose diets caused a significant decrease in liver weight 
compared to animals fed a high starch, control diet (table 3.2). However 
interpretation of these findings was difficult due to massive fluctuations in body 
weight recorded for all animals maintained on a refined sugar diet. In order to 
account for these changes liver weight was expressed as a percentage of body 
weight (table 3.2). This expression indicated that the alterations to body weight 
accounted for the significant decrease in liver weight recorded. This confirmed 
the findings of Sonawane et al. (1983) that rats maintained on a diet high in 
sucrose recorded no changes to liver weight after four weeks of dietary 
intervention.
Sucrose however, caused a statistically significant increase in brain 
weight (table 3 .2) and subsequent expression of the data as a proportion of 
body weight demonstrated that both sucrose and fructose produced a 
statistically significant increase in brain weight as a percentage of body weight .
Given the assertion that treatment - related changes to brain weight are 
unlikely in rats of a similar age (personal communication Dr. M. Dobrota, 
University of Surrey) the slight increase in brain weight recorded for the
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sucrose - treated animals may be artifactual in origin, potentially due to the 
small numbers of animals used in each treatment group.
3.4.4 Sucrose - Induced Decrease in Hepatic Lauric Acid Hydroxylase Activity
In the absence of immunological analysis of apoprotein levels for 
CYP4A, the major catalyst for hydroxylation of lauric acid, interpretation of 
the decrease in hepatic lauric acid hydroxylase activity is difficult. Note should 
be made that whilst the hydroxylation of lauric acid was used as the putative 
marker for the activity of CYP4A within these studies, both CYP2E (Amet et 
^  1994) and CYP2C2 (Fukuda et al. 1994) have also recorded the potential to 
contribute to the hydroxylation of lauric acid and other medium chain length 
fatty acids at a variety of positions along the chain length. These findings have 
been confirmed by the demonstration that ethanol pretreatment of rats resulted 
in increased © - oxidation of fatty acids and the induction of CYP2E1 (Ma et 
ah 1993).
Bearing this in mind, tentative interpretation of this data may suggest a 
decrease in the activity of CYP4A in hepatic microsomes. Observations that 
starvation of rats increased both P oxidation of fatty acids in the peroxisome 
and the © - hydroxylation of fatty acids in microsomes, contributing to the 
catabolism of fatty acids (Orellana et al. 1992) may infer that the decrease in 
fatty acid oxidation by hepatic microsomes could also be the result of 
anabolism with regard to fatty acids.
Based upon the implication that diets high in sucrose produce 
hypertriglyceridemia and hypercholesterolemia in rats and humans (Duerden et 
^  1990; Morikofer - Zwez et al. 1991; Pfeuffer and Barth 1992) without 
affecting cholesterol synthesis (Duerden et al. 1990) it is tantalising to 
speculate that the decrease in the oxidation of lauric acid recorded in this study 
may result from a switch to the synthesis of triglycerides rather than 
catabolism. Indeed triglycerides may provide little of the metabolic energy to
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the rats maintained on diets high in sucrose. However similar effects are 
documented for blood plasma chemistry following consumption of diets high in 
fructose (Hallfnsch 1990; Swanson et al. 1992). Fructose also decreased lauric 
acid hydroxylase activity (-30%) but this was not found to be statistically 
significant.Interestingly, consumption of high dietary levels of triglycerides has 
been established as a potent inducer of CYP4A (Gibson 1993) and the 
hypertriglyceridaemia associated with streptozotocin - induced diabetes has 
been proposed as the possible inducer of CY4A recorded for diabetic rats 
(Barnett et al. 1994; Shimojo et al. 1993). Therefore the hypothesis that the 
changes to CYP4A described for high sucrose diets may be caused by 
perturbations to triglyceride metabolism seems unfounded. Indeed previous 
observation appeared to suggest that the hypertriglyceridaemia associated with 
diets high in sucrose may be expected to elevate activities of CYP4A. This 
discrepancy remains unresolved. Further investigation is necessary to evaluate 
the correlation between the decrease in the oxidation of lauric acid and the 
perturbation of triglyceride metabolism caused by the adminitration of sucrose 
or fructose.
3.4.5 Sucrose Induced Decrease in Cytosolic Catalase Activity
The apparent significant decrease in cytosolic catalase activity observed 
for rats fed diets high in sucrose appeared without cause. A similar 10% 
decrease was noted for fructose - treated rats, however this was not found to 
be statistically significant due to the large variance within the group. The 
modest nature of this decrease, whilst representing a decrease in cellular 
capacity to metabolise potentially hazardous hydrogen peroxide, is most likely 
to be of limited significance due to the abundance of catalase present in hepatic 
tissue.
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3.5 Conclusions
Whether the decrease in lauric acid hydroxylase activity recorded in this 
study was a direct result of inclusion of sucrose within the diet or as a result of 
perturbation of cellular homeostasis remains unresolved. However, it cannot be 
overlooked that this may indeed have involved depressed expression in CYP4A. 
Based upon dietary studies investigating the eating habits of children in the United 
Kingdom, consumption of refined sugars may approach some 120gm/day, as much 
as 49% of the total carbohydrate calorie intake (Hackett et al. 1984). As sucrose 
may make up as 50% of the total sugar consumption (Anderson 1982) there may 
be a perceived cause for real concern with respect to any toxicological significance 
of such findings. The 35% decrease in the activity of lauric acid hydroxylase may 
be of limited biological effect. No changes were documented for the remaining 
parameters measured. However, the relatively short duration of this experiment (3 
weeks) may, in part, be responsible. Given human dietary preferences for 
consumption of increasing quantities of refined carbohydrates an extention of this 
experiment to assess the longer term effect of sugar consumption may be prudent.
Little information remains available as to the potential of sucrose to cause 
renal lesions, but in view of the massive consumption of sucrose within the 
population, without overt toxic effects, this may stand testament to the reserve 
capacity for filtration within the kidney or, more plausibly, the absence of any 
recorded lesion in human subjects.
The experimental data obtained in the present study present no evidence 
for a modulating effect upon chemical carcinogenesis within hepatic tissue, 
although previous investigators have noted that diets high in sucrose increased 
faecal bile acid concentrations and colonic mucosa proliferation (Cademi et al.
1993) and the incidence of azoxymethane - induced tumours in rat intestine 
(Cademi et al.l994y This facet of sucrose consumption, whilst of toxicological
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significance, was beyond the scope of this experiment. Yet in view of the findings 
presented and those previously published it may be prudent to assume that the 
effects of a diet high in refined carbohydrates are promotive in nature and have no 
influence upon the initiation of chemical carcinogenesis, by virtue of changes in the 
bioactivation of chemical species.
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Chapter 4
IMPACT OF INTERMITTENT CALORIE 
RESTRICTION ON DRUG METABOLISM
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4.1 Introduction
4.1.1 Impact of Chronic Calorie Restriction upon Cheimcal Carcinogenesis
Early assessment of the impact of dietary restriction upon 
carcinogenesis revealed that reducing the calorie intake could significantly 
decrease the incidence and growth of tumours in rodents (Tannenbaum 1942; 
Tannenbaum 1944). More recent investigations have added that calorie 
restriction can prolong the lifespan of autoimmune - prone mice (Kubo et al. 
1987) and rats (Salmon et al. 1990), and that mild calorie restriction can 
produce a significant decrease in the incidence, multiplicity and tumour burden 
of rodents treated with a variety of chemical carcinogens (Kritchevsky 1990).
Of interest was the observation that both total dietary restriction 
(simply providing less food to test animals) and calorie restriction (providing 
less calories in the form of fat or carbohydrate in a nutritionally complete diet) 
both reduced the incidence of DMBA induced skin tumours in mice; however 
calorie restriction was found to be the most effective (Birt et al. 1991). If 
calorie restriction occurred during or preceding initiation with chemical 
carcinogens little effect on tumour incidence was recorded, the most profound 
effects on tumour incidence being observed only when calorie restriction was 
carried out during the promotion phase of chemical carcinogenesis (Birt et al. 
1991).
Roebuck et al. (1993) recorded that both dietary restriction and meal 
feeding (removal of the diet for several hours each day) were effective at 
reducing the incidence of pancreatic tumours induced by azaserine 
administration. Again, both food restriction and meal feeding protocols were 
found to be effective at reducing tumour incidence during the post - initiation 
phase of carcinogenesis.
Calorie restriction has also proved effective at decreasing the incidence 
of 6 - nitrochrysene induced hepatic tumours several months after carcinogen 
administration (Fu et al. 1994) inferring that calorie restriction may be effective
99
at decreasing tumour incidence long after the initiation event or any DNA 
repair has occurred.
The molecular basis for such observations suggests a multitude of 
putative mechanisms. Wall et al. (1992) characterised a two - fold increase in 
the level of metabolites formed from B[a]P administered to food restricted rats. 
This was accompanied by corresponding increases in the levels of microsomal 
metabolism of p - nitroanisole and the glucuronidation of p - nitrophenol. 
Similar results have been reported in the metabolism of aflatoxin B% in calorie 
restricted rats (Pegram et al. 1989; Chou et al. 1993a) and an associated 
decrease in the level of AFBj - DNA adducts formed. However contradictory 
results were noted for B[a]P, including an increase in the in vitro and in vivo 
metabolic activation of B[a]P, coupled with an increase in the levels of B[a]P - 
DNA adducts formed in hepatic tissue (Chou et al. 1993a).
4.1.2 Effects of Chronic Calorie Restriction on Hepatic Cytochrome P450 
monooxygenases
Calorie restriction has also increased the inducibility of hepatic 
cytochrome P450 monooxygenases; calorie restriction increased the in vitro 
activities of PROD and benzphetamine - N - demethylase and increasing total 
cytochrome P450 levels in rat hepatic tissue following administration of 
phénobarbital (Alterman et al. 1995). Similar effects were observed for EROD 
activity following the administration of 3 - methylcholanthrene. Food restriction 
alone enhanced hepatic aryl hydrocarbon hydroxylase and 7 - ethoxycoumarin - 
O - dealkylase activities (Kwei et al. 1991). Moreover it prevented the age - 
related decrease in the hepatic activities of testosterone 6p hydroxylase, lauric 
acid 12 - hydroxylase and nitrophenol hydroxylase, suggesting the potential to 
modulate activities of the individual isoforms of cytochromes P450, CYP3A, 
CYP4A and CYP2E respectively (Leakey et al. 1989a). These findings were 
further supported by Manjgaladze et al. (1993) documenting increased levels of
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CYP2E1 dependent p - nitrophenol hydroxylase activity and a decrease in the 
expression of hepatic CYP2C1 lin the rat, following chronic calorie restriction.
Calorie restriction has also been documented to increase the expression 
of hepatic cytochrome P450 isoforms CYP2B (Fernandes et al. 1990) and 
CYPlAl (Manjgaladze et al. 1993), the latter being independent of any 
changes in Ah receptor binding in the liver and since such increases in CYPl Al 
activity were recorded in DBA/2J mice, a strain of mouse lacking normal Ah 
receptor binding characteristics (Chou et al. 1993b).
Calorie restriction has also been associated with a decrease in the 
concentration of lipid peroxidation products found in the liver (Koizumi et al. 
1987) and extrahepatic tissues (Xia et al. 1995) accompanied with increases in 
the activities of antioxidant enzymes. These included catalase, superoxide 
dismutase and glutathione peroxidase isolated from heart, brain and kidney 
tissue (Xia et al. 1995). In addition calorie restriction decreased the age - 
related reduction in hepatic glutathione concentrations (Laganiere and Yu 
1989; Manjgaladze et al. 1993).
Other influences of dietary restriction upon rodents have included 
decreases to the activity of hepatic Protein Kinase C - associated with tumour 
promotion (Kris et al. 1994; Birt et al. 1994) and reductions in the proliferation 
of epithelial and lymphoid tissue from autoimmune - prone mice (Ogura et al.
1989).
4.1.3 Effects of Chronic Calorie Restriction upon Oncogene Expression
Calorie restriction has also been demonstrated to increase the level of 
unscheduled DNA synthesis (Lipman et al. 1989) and modulate the expression 
of numerous genes at the level of mRNA in hepatic tissue. Decreases in the 
expression of c - myc (Nakamura et al. 1989) and c - fos and c - ki - ras 
oncogenes (Himeno et al. 1992) were noted in rodents maintained on a regime 
of chronic calorie restriction, speculating that calorie restriction may possess
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the potential to decrease tumour incidence by preventing proliferative changes 
associated with control of cellular growth.
More recently the antagonism of carcinogenesis associated with calorie 
restriction was proposed to arise from increases in the levels of DNA 
replication and apoptosis, both effects being abolished by subsequent ad 
libitum feeding of animals (Grasl - Kraupp et al. 1994).
4.1.4 Intermittent Calorie Restriction
Conversely, few investigations report effects of intermittent calorie 
restriction. As previously discussed, removal of food for several hours each day 
decreased tumour incidence in rats (Roebuck et al. 1993). Removal of food 
"every other day" as a protocol for calorie restricting mice was observed to 
increase the life expectancy of mice during a lifetime study (Goodrick et al.
1990). However this effect appeared highly dependent upon the time at which 
the dietary restriction was instigated - maximum effect being produced at 1.5 
months of age rather than 6 or 10 months of age. Certain strain - specific 
differences were also recorded, B6AF/J mice demonstrating the greatest 
increase to lifespan.
Further studies of intermittent calorie restriction, alternating between ad 
libitum and 40% calorie restriction every 48 hours, have outlined that such 
calorie restriction had no effect on the incidence of DMB A - induced mammary 
tumours in rats (Mehta et al. 1993). In addition this calorie cycling gave rise to 
modulation of plasma levels of endothelins, believed to play a role in 
carcinogenesis.
The current experiment aimed to establish whether or not periods of 
calorie cycling may modulate the activities of hepatic xenobiotic - metabolising 
enzymes and hence infiuence the initiation phase of chemical carcinogenesis. 
For this a protocol of severe calorie restriction followed by a period of 
repletion was chosen. Similar patterns of 'dieting' are utilised by humans in an
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attempt to reduce body weight; therefore possible effects of intermittent calorie 
restriction may have some bearing upon tumour incidence in human subjects.
4.2 Materials and Methods
4.2.1 Materials
The pelleted diet used was Rodent Diet LAD - 1 obtained from Special 
Diet Services (U.K»). Blood plasma> analysis for total triglycerides and 
cholesterol was carried out using a Cobas Mira Sample analyser.
4.2.2 Methods
32 male, Wistar albino rats (-200gm) were obtained from the 
University of Surrey Experimental Breeding Colony and were divided into pairs 
of equal weight and housed singly in polyethylene cages. These rats were 
placed on a fast/refeed dieting regime of food restriction followed by a period 
of ad libitum feeding. All rats were allowed ad libitum access to drinking 
water. Each cycle of food restriction was four days duration and the repletion 
phase lasted three days.During the fast/refeed protocol one animal from each 
pair received food ad libitum. The degree of food restriction used 
corresponded to 50% by weight of the food consumed by the pair - fed animal 
during the previous 24 hours. Food was weighed out and apportioned each 
morning over the fourteen day period. The diet cycling was repeated twice, the 
total study length being fourteen days.
Animals were sacrificed at day seven (at the end of the first repletion 
phase), at day eleven (after the end of the second dieting phase) and on each 
subsequent repletion day up to day fourteen. Controls were taken for direct 
comparison on days seven, eleven and fourteen .
Rats were killed by cervical dislocation and small quantities of blood 
withdrawn from the ventricles of the heart for blood plasma analysis of total 
triglyceride and total cholesterol concentrations. The liver was then excised.
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washed in ice cold KCl (1.15% w/v) and frozen in liquid nitrogen and stored at 
-80°C. All Postmitochondrial supernatants were prepared and stored as 
outlined in Chapter 2.
4.3 Results
4.3.1 Animal Husbandry
During the experimental phase the rats appeared active and alert. For 
the periods of food restriction subjective observation recorded that the rats 
were much more active and demonstrated anticipatory behaviour, awaiting 
food distribution. The predominant portion of the food was subsequently 
consumed within two hours. During the repletion phase the rats showed 
profound hyperphagia, as evidenced by figure 4.1, which lasted twenty four 
hours, before food consumption returned to control values.
At autopsy no anatomical abnormalities were noted for any of the 
animals. The animals maintained on a period of 50% calorie restriction showed 
significantly lower body weight compared to corresponding age - matched 
controls and, despite the hyperphagia described during the repletion phase, the 
body weight did not recover during the period of the study (Table 4.1).
Autopsy did reveal that following dietary restriction for four days, the 
liver weight, as a percentage of the body weight, was significantly decreased 
(P<0.001) when compared to control animals. During the repletion phase the 
relative liver weight recovered during the first twenty four hours, however 
surpriseingly, during day two of the second repletion phase the relative liver 
weight was found to decrease. The first period of diet cycling was not found to 
produce any effects upon organ weight that carried through to the second 
period of dietary cycling.
Measurement of total plasma triglycerides and total plasma cholesterol 
revealed that dietary restriction caused a statistically significant decrease 
(P<0.01) in plasma triglyceride concentration. Plasma triglycerides recovered
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Figure 4.1 Mean Food Consumption
Control and Fast/Refed Animals
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slightly during the first day of the repletion phase (P<0.05) before decreasing 
further during the second day of repletion. (P<0.01) and then rising again 
during the third and final day of refeeding (P<0.05).
Plasma cholesterol concentration also recorded a statistically significant 
decrease (P<0.05) during the dieting phase of the experiment. This decrease 
continued and deepened during the first twenty four hours of the repletion 
phase (P<0.01), however it recovered to control levels during the second day 
of ad libitum feeding. There was no effect on hepatic protein concentrations 
for either microsomal or cytosolic fractions at any time point during the 
experimental protocol.
4.3.2 Influence of Intermittent Calorie Restriction upon Microsomal Xenobiotic -
Metabolising Enzymes
The only changes to hepatic xenobiotic - metabolising enzymes were 
recorded during the diet restriction phase of the experimental protocol, all 
measured in vitro enzyme activities having returned to control values upon 
refeeding the diets ad libitum (Table 4.2 and Table 4.3). A 50% increase in the 
concentration of total cytochrome P450 was observed for hepatic microsomes.
Assessment of the dealkylation of methoxy- and pentoxyresorufin 
revealed increases in activity by 45% and 70% respectively (Table 4.2), 
whereas ethoxyresorufin - O - dealkylase activity was unaffected. The 
hydroxylation of p - nitrophenol was noted to increase by approximately 30% 
following a period of calorie restriction (table 4.3), but the effect was not found 
to be statistically significant by student T ' test (P>0.05).
4.3.3 Influence of Intermittent Dietary Restriction on Hepatic Cytosolic 
Glutathione Conjugations
Whilst intermittent calorie restriction did not influence the activities of 
glutathione - S - transferases (G-S-T) (table 4.4) and glutathione peroxidases
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(table 4.5), the period of calorie restriction was found to produce a 60% 
decrease in hepatic glutathione concentrations (Table 4.4). In addition, a 
modest increase of some 45% was observed for glutathione reductase activity 
over the same period of calorie restriction. Over the repletion phase of the 
experimental protocol, the hepatic concentration of glutathione and glutathione 
reductase activity were unchanged when compared to control animals, 
indicating recovery during the twenty four hours immediately after the 
instigation of refeeding. As discussed previously, intermittent food restriction 
produced no effect upon hepatic glutathione peroxidase activities.
4.4 Discussion
4.4.1 Animal Husbandry
Deprivation of food availability to just 50% of an ad libitum fed control 
was sufficient to arrest the growth of rats, in contrast, calorie restriction to the 
level of 60% or 70% of control intake values has been described as sufficient to 
allow growth of the rats of a comparable age to those used during this 
experiment (Cleary et al. 1987; Engelman et al. 1990). It has been 
demonstrated that retardation of growth was largely governed by calorie intake 
and not deprivation of essential nutrients. Chevalier et al. (1995) documented 
that dietary restriction to a level of some 40% less food than control, ad 
libitum fed animals, produced restriction dependent decreases in plasma retinol 
concentrations without influencing the concentration of retinoids present in the 
liver, lungs and intestinal tissue after some three months of deprivation. It 
appears unrealistic to assume that the short periods of food restriction utilised 
during this protocol would be sufficient to precipitate a deficiency - type 
syndrome.
The subjective observation attesting to the anticipatory behaviour of the 
rats during the food restriction phase has been recorded previously in similar 
experimental protocols (Duffey et al. 1990a; Duffey et al. 1990b). The
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inference of these investigations implied that the stimulus for rodent circadian 
behaviour switched from a normal light - dark pattern to a circadian cycle 
governed by the time at which food was presented (Duffey et al. 1990b). In 
addition, feeding behaviour changed from a 'nibbling pattern' to a meal feeding 
pattern similar to that observed during these experiments (Duffey et al. 1990a).
The decrease in liver weight noted during the food restriction phase of 
this protocol was marked but recovered quickly upon refeeding. It is 
conceivable that the apparent loss in liver weight may have resulted from 
depletion of hepatic stores of glycogen; however this assumption appeared 
unrealistic as glycogen makes up only some 2 - 8% of hepatic tissue weight 
(Muir1972) whereas in the present study a decreases of as much as 25% in hepatic 
weight was evident. Similar findings were noted by Chevalier et al. (1995) and 
Cleary et al. (1987) in response to calorie restriction for three months. Yet in 
contrast to these observations, Chevalier et al. (1995) also described decreases 
in organ weights for the kidneys and lung tissue after three months. From the 
present data it is unclear whether a reduction in the number of hepatocytes or 
through a shift in water balance and hence cell size are responsible for the 
lower liver weight.
The apparent gain in liver weight, followed by a modest decrease during 
the refeeding phase of the experimental protocol may appear more difficult to 
resolve; however the most plausible interpretation of this observation is that the 
recovery of hepatic weight during the first day of repletion is followed by a 
subsequent recovery of body weight at a lower liver/body weight ratio. This 
situation may be further compounded by the observed hyperphagia recorded 
during the first day of repletion, resulting in an artificial elevation of apparent 
body weight.
The reduction in plasma cholesterol and triglyceride concentrations 
appeared to confirm the findings of Cleary et al. (1987) whom reported 
substantial decreases after long term calorie restriction in rats.
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4.4.2 Effect of Intermittent Calorie Restriction on Rat Hepatic Cytochrome P450 
Activities
The increased dealkylation of methoxy- and pentoxyresorfin recorded 
during the food restriction phase of the experimental protocol appeared to have 
no origin - however certain possible mechanisms can be ruled out.
The dealkylation of methoxyresorufin offers a sensitive probe for the 
activity of CYP1A2 and it is tempting to postulate that inducers of this activity 
may be derived from the diet. Given that such increases in the activity of 
CYP1A2 correspond only with periods of calorie restriction it may be inferred 
that no such inducer is present in the diet. A fiirther source of potential 
inducing species may be derived from the utilisation of body stores of 
triglycerides (Huff et al. 1991) thereby releasing stored deposits of inducing 
agents (Kalina et al. 1991). Such inducing species may include the aromatic 
amines and environmental contaminants such as the polychlorinated biphenyls. 
This putative mechanism for the induction of CYP1A2 may however be of 
limited merit with regard to this protocol as the rodents used were obtained 
from an experimental breeding colony and hence had little opportunity to be 
exposed to such environmental contaminants. Moreover, polychlorinated 
aromatic hydrocarbon contaminants are potent inducers of CYPlAl, 
characterised by increased activity of ethoxyresorufin - O - dealkylase 
(Henneman et al. 1994); such increase in CYPlAl activity was not evident in 
the present experiments, furthermore, if such release of contaminants were 
responsible for the induction of CYP1A2, the effect would be expected to last 
longer than the duration of the diet restriction phase as seen in the present 
studies. These observations would suggest that induction through the release of 
stored contaminants with induction potential from adipose tissue deposits was 
highly unlikely.
114
The induction of hepatic CYP1A2 and CYP2B isoforms of cytochrome 
P450 displays some parallel with the pattern encountered for streptozotocin 
induced diabetes in rats. Moreover, the observations that feeding diets high in 
medium chain triacylglycerols also induce the same isoforms, may indicate a 
common mechanisim (Barnett et al. 1990). For both diabetes and high intake of 
triacylglycerol, hyperketonaemia was proposed as a possible causal agent for 
the induction of both CYP1A2 and 42YP2B (Barnett et al. 1990). It is 
reasonable to speculate that a similar pattern of hyperketonaemia may offer an 
explanation for the induction of CYP1A2 and CYP2B demonstrated in the 
present studies. However doubt may be cast upon such a hypothesis as marked 
induction of CYP2E1 has also been described as a result of both streptozotocin 
induced diabetes (Shimojo et al. 1993) and fasting of rats (Miller and Yang 
1984). In both cases the causal agent was believed to derive from high plasma 
levels of ketone bodies. Similar inducing potential has been documented for 
acetone (Miller and Yang 1984) and acetaldehyde (Terelius et al. 1991). The 
calorie restriction phase of the present dietary regime did not appear to result in 
the induction of CYP2E, denoted by the hydroxylation of p - nitrophenol, 
indicating that the rats were unlikely hyperketonaemic. In essence, without 
direct assessment of plasma ketone body concentrations conclusive clarification 
of such a proposal may be difficult. The relatively small increases in CYP1A2 
activity afforded by calorie restriction are of little toxicological significance in 
light of the potential for induction caused by xenobiotics (Park and Bjeldanes 
1992). It therefore remains difficult to evaluate whether dietary restriction may 
indeed have any effect upon the initiation process of chemical carcinogenesis, 
but it must be stressed that the present studies address only the short - term and 
not the lonf term impact of intermittent calorie restriction.
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4.4.3 Effects of Intermittent Calorie Restriction upon Hepatic Phase H 
Conjugation Enzymes
The observation that calorie restriction did not alter hepatic UDF - 
glucuronosyl transferase activity is in agreement with the findings of Kwei et al. 
(1991) and may corroborate the findings for gluthathione - S - transferase 
activity, describing no increase in enzyme activity (Koizumi et al. 1987; Kwei 
et al. 1991).
4.4.4 Changes to Glutathione Metabolism:
The depletion of hepatic glutathione followed by a compensatory 
increase in glutathione reductase activity established during this experimental 
protocol is in agreement with previous studies where calorie restriction was 
shown to diminish hepatic glutathione concentrations (Zhu et al. 1989). 
However the severity of glutathione depletion appeared far greater during this 
experiment and may ultimately be dependent upon the degree of calorie 
deprivation.
A further possible mechanism offering explanation for the glutathione 
depletion may result from the availability of the cofactor NADPH, responsible 
for the reduction of glutathione disulphide (GSSG) to glutathione (GSH). By 
restricting the available energy within the diet the cellular concentration of 
NADPH may fall (Parke 1991) leading to a decrease in the rate of chemical 
reduction of GSSG to GSH. As cellular levels of GSSG rise, the cell may 
actively excrete GSSG - at the expense of ATP - thereby decreasing the cellular 
concentrations of GSH (Boobis et al. 1989). Without direct measurements of 
cofactor concentrations within the cell and hence the chemical reduction of 
GSSG to GSH such a hypothesis remains untested. However given the pivotal 
role of NADPH within the cell for both biotransformation reactions and 
chemical reduction, this proposal is not inconceivable.
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Decreasing protein intake within the diet, by inference, caused a 
decrease in sulphur amino acid intake, both documented to decrease hepatic 
glutathione levels. Food restriction by some 50%, leading to concomitant 
decrease in protein intake was observed to decrease hepatic glutathione 
concentrations. Overt calorie restriction has also been described to induce 
apoptosis - programmed cell death - within hepatic tissue leading to a decrease 
in liver weight (Grasl - Kraupp et al. 1994; James and Muskhelishvili 1994). 
Similar findings have been observed during this study and it is possible to 
speculate a relationship between the two events, decreasing the hepatic 
glutathione concentration and the induction of apoptosis.
Decreases in total glutathione concentration have led to the induction of 
malic enzyme (Ayala et al. 1991) which in conjunction with malate 
dehydrogenase, is associated with the transfer of reducing equivalents from 
NADH to NADPH (Coleman and Kuzawa 1991). The increase in GSH 
reductase activity documented may utilise the increased availability of NADPH 
to increase the rate of turnover of hepatic glutathione. However under 
conditions of calorie restriction the synthesis of reduced NADH and NADPH 
may be compromised, the majority of the reducing equivalents derived form the 
mitochondrial oxidation of fatty acids. This decrease in cofactor availability 
may diminish the probability that GSSG will be reduced to GSH. As GSSG 
concentrations rise GSSG may be actively excreted fi-om the cell by ATP 
dependent mechanisms into the blood (Boobis et al. 1989). The net effect 
results in the depletion of total hepatic glutathione and an increase in blood 
plasma glutathione (Richie et al. 1994).
This decrease in reduced glutathione in the liver, coupled with the 
diminished concentrations of ATP, NADH and NADPH may be sufficient to 
trigger apoptosis (Cascales et al. 1994), if not sufficient as a trigger in 
themselves, these changes may be of detriment to the cell by increasing the 
susceptibility of hepatocytes to oxidative damage induced by free radicals or
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covalent binding of toxicants following metabolic activation (Comporti et al.
1991). Interestingly glutathione depletion alone have been observed to induce 
apoptosis in cultured neuronal cells (Ratan et al. 1994) and may therefore 
influence hepatocyte death.
Whilst the source of glutathione depletion remains largely speculative, 
the toxicological impact of such decreases in tissue glutathione are more clearly 
understood. Conjugation of xenobiotic species with glutathione provides a 
prinicipal mechanism for elimination of xenobiotics (Ketterer 1988). Therefore 
a decrease in tissue glutathione concentrations may conceivably lead to a 
decrease in the elimination of these electrophilic xenobiotic species. The 
increase in glutathione reductase observd in this study appearing to be an 
adaptive change to compensate for low tissue glutathione concentrations. 
Increasing the turnover of glutathione may help to maintain high concentrations 
of reduced glutathione within hepatic tissue.
Depletion of tissue glutathione compromises rate of xenobiotic 
detoxication through decreasing the activity of the glutathione - S - transferases 
(Ketterer 1988). Indeed the importance of glutathione as a cofactor for 
conjugation reactions (Parke 1991) and as a protective agent against oxidative 
damage (Parke 1982; Boobis et al. 1989) has been widely reported.
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4.5 Conclusions
The impact of intermittent dietary restriction or patterned dietary 
restriction upon rodents appears to be limited. The process of chemical 
carcinogenesis was largely unaffected (Mehta et al. 1993) and the minor 
increase in lifespan following intermittent feeding of rat is both strain specific 
and dependent upon the time at which initiation of the protocol occurred 
rGoodrick et al. 1990).
This study has described that intermittent calorie restriction can 
influence the expression of hepatic cytochromes P450 isoforms CYP1A2 and 
CYP2B as well as decrease hepatic glutathione concentrations. This is in 
complete contrast to the observations for chronic calorie restriction, including 
transcriptional activation of CYP2E1 (Johansson et al. 1990) and increases in 
the hydroxylation of ethoxycoumarin, aniline and diethylnitrosamine (Imaoka et 
ah 1990).
It has recently been reported that moderate calorie restriction elevated 
NADPH cytochrome P450 reductase and NADPH cytochrome b$ reductase 
activities as well as 6P, 16a and 16p hydroxylations of testosterone (Sohn et 
af 1994). The implications resulting from the induction of CYP1A2 and 
CYP2B noted during this study may be minor. The increases of 45% and 70% 
in CYP1A2 and CYP2B activities respectively is unlikely to be sufficient to 
contribute significantly to increase the metabolic activation of chemical 
carcinogens. The observation that intermittent food restriction resulted in 
increased CYP1A2 activity, a cytochrome P450 isoform pivotal in the 
metabolic activation of procarcinogen species derived from the diet e.g. the 
heterocyclic aromatic amines (Aryton et al. 1990), may be of concern with 
regard to the initiation of chemical carcinogenesis. This detrimental change may 
be viewed with further gravity in light of the depletion of hepatic glutathione 
concentrations - the principal route of detoxication for a number of cytochrome 
P450 - generated reactive intermediates (Ketterer 1988).
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In addition, this depletion of tissue glutathione concentration may in 
itself be of importance regarding the defence against oxidative damage. 
Glutathione provides a majority of the reducing species involved in the 
neutralising of free radical and active oxygen species, either through 
glutathione peroxidases or by direct reaction. Decreasing the degree of 
protection from oxidant species increases the potential for damage to the liver 
leading eventually cellular necrosis (Comporti et al. 1991). Any effect that 
calorie restriction may impose upon the local concentrations of cofactors within 
the tissue may only exacerbate the severity of the condition.
Whilst of little importance when confined to short duration, increasing 
the period over which such severe calorie restriction is sustained may severely 
compromise the integrity of hepatic tissue and increase the probability of tissue 
injury. Given that the effects documented during this investigation were of 
extremely limited duration the harmful implications proposed for the induction 
of CYPl A2 and the decrease in liver glutathione concentrations may also prove 
of short duration. Yet the apparent readiness of individuals to choose this 
method of calorie deprivation to instigate weight loss, coupled with the 
apparent continuation of such dietary regimes, does raise the probability for 
increasing the risk to humans; either by increasing initiation of chemical 
carcinogenesis or decreasing the available defence against reactive oxygen 
species.
Evidently serious thought should be given before undertaking such 
dietary regimes. It may appear appropriate to maintain an adequate level of 
protein intake in order to obviate the effects of food restriction upon hepatic 
glutathione concentrations.
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Chapter 5
EFFECTS OF METHIONINE DIETS ON DRUG 
METABOLISM
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5.1 Introduction
5.1.1 Methyl Donor Deficiencies and Chemical Carcinogenesis
The dietary lipotropes, choline, methionine and folic acid have long 
been established as modifiers of chemical carcinogenesis. As early as 1973 
lipotrope - deficient diets were noted to enhance intestinal carcinogenesis 
caused by dimethyl hydrazine (Rogers and Newbeme 1973), it was also 
recognised that a dietary deficiency in lipotropes alone was sufficient to induce 
hepatocarcinogenesis in rodents in the absence of any carcinogen (Copeland 
and Salmon 1946; Ghoshal and Farber 1984). Interestingly, synthetic choline - 
devoid diets have shown greater propensity to induce tumours than semi - 
synthetic choline - devoid diets (Nakae et al. 1992). The multitude of studies 
subsequently carried out over the following 1 5 - 2 0  years has led to the 
compilation of extensive review literature (Lombardi and Smith 1994; Poirier 
1994; Mason 1994; Ghoshal and Farber 1993; Newbeme and Schager 1993).
Yokoyama et al. (1985) have described that, in addition to the 
hepatocarcinogenic potential of choline deficiency, choline - devoid diets fed to 
rats treated with diethylnitrosamine (DEN) had a promoting effect upon 
chemical carcinogenesis. Similar responses were recorded following treatment 
with diets deficient in both choline and methionine (Sawada et al. 1990) as well 
as for folate deficient diets (Cravo et al. 1992). However, treatment of animals 
with a tumour promotor such as phénobarbital did not enhance the 
hepatocarcinogenic potency of a choline devoid diet (Saito et al. 1990).
Experimental evidence indicates that the hepatocarcinogenic effects of 
choline - devoid diets may be sex specific, female rats recording some resistant 
to the hepatonecrogenic and hepatocarcinogenic effects of choline - devoid 
diets (Saito et al. 1991). Furthermore, treatment of male castrated rats with 
ethynyloestradiol, previously described as a tumour promotor (Yager and 
Yager 1980), led to the féminisation of male rats, and to a decrease in the
122
incidence of liver tumours following treatment with lipotrope - deficient diets 
(Fullerton et al. 1993).
The biochemical effects of lipotrope deficiencies have been clearly 
characterised. Reduction in the intake of dietary methyl donors has been 
described to decrease tissue levels of S - adenosyl methionine (SAM) in the 
liver, kidney and lungs of rats (Shivapurkar and Poirier 1983). Lipotrope - 
deficient diets are also stimulated hepatocyte turnover (Chandar et al. 1987), 
characterised by necrosis and compensatory mitogenesis (Saito et al. 1994). 
Moreover, during the first 72 hours of choline deficiency the profile of fatty 
acids within the nuclear and microsomal membranes was altered, the changes 
including a decrease in phosphatidyl choline content and an increase in 
microsome phospholipase A2 activity (Kapoor et al. 1992). Increasing the 
duration of choline deficiency led to an accumulation of 1,2 - sn - 
diacylglycerol within cell membranes (de Costa et al. 1993); this was associated 
with increased cytosol and membrane bound protein kinase C activity which 
may impart yet another mechanism of carcinogenesis, the upregulation of cell 
growth by activation of protein kinase C ( Nishizuka 1984).
5.1.2 Dietary Methyl Donor Supplementation and Chemical Carcinogenesis
Supplementation of nutritionally complete diets with choline and 
methionine decreased the incidence of spontaneous leukaemia in AK mice 
(Wainfan et al. 1990). However, supplementation with choline and methionine 
was reported to have mixed effects towards chemically induced tumours. 
Shivapurkar et al. (1986) recorded that dietary supplementation did not prevent 
the promotion of DEN - initiated tumours by DDT or phénobarbital; in contrast 
both choline and methionine inhibited liver tumour formation after initiation 
with DEN (Fullerton et al. 1990), whereas choline was shown to enhance 
acetylaminofluorene promoted liver tumours, after initiation by 
methylnitrosourea, in female rats (Tessitore et al. 1992). Additional studies
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have also outlined the ability of S - adenosylmethionine, given by 
intraperitoneal injection, to arrest the growth of DEN induced tumours and 
resulted in the lost ability of preneoplastic cells to evolve to overt cancers 
(Pascale et al. 1992).
5.1.3 Influence of Methyl Donor Deficiencies on the Generation of Reactive
Oxygen Species
There is experimental evidence that many of the effects attributed to 
choline - devoid diets may result from free radical mediated damage. Radical 
trapping agents such as N - tert - butyl - a  - phenylnitrone prevented nuclear 
lipid peroxide formation caused by choline - devoid diets (Rushmore et al. 
1987) and dietary choline deficiency elevated the levels of 8 - hydroxy - 
deoxyguanosine associated with oxidative damage to DNA (Hinrichsen et al. 
1990). Additional studies outline that deprivation of dietary iron prevented the 
increase in lipid peroxidation and 8 - hydroxy - deoxyguanosine levels
associated with choline deficient diets (Yoshiji et ah 1992). Further
experiments have established that lipotrope deficiencies can increase the 
number of DNA strand breaks in rat lymphocytes. This was believed to be 
associated with alterations in folate - dependent thymidylate synthesis (James 
and Yin 1989).
5.1.4 Bioactivation of Chemical Carcinogens During Methyl Donor Deficiency
In the presence of aflatoxin Bj (AFBj) , methyl donor deficiencies in 
rodents suppressed the level of DNA - AFBj adducts formed in vivo (Mehta et 
al 1992), being attributed to diminished metabolic activation of carcinogen. 
The rate of DNA - adduct repair was identical in both control and methyl donor 
deficient rats.
The impact of methyl donor deficiency and associated cirrhosis on the 
activity of xenobiotic - metabolising enzymes has been extensively studied.
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Choline deficiency decreased total cytochrome P450 and levels (Murray et 
al 1986a), as well as 7 - ethoxycoumarin - O - dealkylase, aryl hydrocarbon 
hydroxylase and ethylmorphine N - demethylase activities (Murray et al. 1986a) 
and erythromycin - N - demethylase activity (Kolars et al. 1990).
Modulation of steroid metabolism by choline - deficienct diets has also 
been reported, characterised by decreases in the 16a and 6p hydroxylation of 
androstenedione (Murray et al. 1986b). The decrease in the 16a hydroxylation 
of steroids corresponded to a concomitant decrease in microsomal apoprotein 
levels recognised by anti - CYP2C11 antibodies (Murray et al. 1991b).
Recorded effects of methionine deficiency upon hepatic xenobiotic - 
metabolising enzymes appeared limited to decreasing mixed function oxidase 
activity in Broiler chicks (Takahashi and Horiguchi 1991). Induction of 
monooxygenase activity was also found to be more profound in methionine 
deficient animals after treatment with phénobarbital (Nurmagambetov et al. 
1991; Nurmagambetov et al. 1992).
5.1.5 Influence of Methyl Donor Deficiencies on Oncogene Expression
Assessment of the effects of a methyl donor deficient diet upon hepatic 
tissue has revealed that, at the molecular level, such deficiencies gave rise to 
alterations to the genome, characterised by hypomethylation of the DNA 
(Locker et al. 1986). This hypomethylation occurs rapidly - within one week - 
and may also effect the méthylation patterns of RNA molecules (Wainfan et al. 
1989), principally transfer RNA (Wainfan et al. 1986). This process of 
hypomethylation appeared to be random in origin, hypomethylation having 
been documented for P hydroxy - P - methyl - glutamyl Coenzyme A genes 
(Coni et al. 1992) and a variety of cell cycle control genes including c - fos, c - 
Ha - ras, c - Ki - ras and c - myc ( Zapisek et al. 1992; Wainfan and Poirier
1992). In addition these changes have been linked with increased levels of 
mRNA for these genes (Wainfan and Poirier 1992; Dizik et al. 1991).
125
Furthermore, choline - devoid diets may also contribute to mutations in 
oncogenes, including the tumour suppressor genes p53 (Smith et al. 1993), 
which may be reversible. Christman et al. (1993a) described that, after 
maintaining rats on a severe methyl donor - deficient diet followed by a 
balanced methyl donor replete diet, the levels of mRNA coding for the 
oncogenes c - myc, c - fos and c - Ha - ras decreased. However the 
hypomethylation of the genes coding for c - myc, c - fos and c- Ha - ras 
persisted long after feeding the rats on a replete diet. Clearly this persistence 
may influence the growth regulation of cells (Christman et al. 1993b).
Rats deficient in methionine displayed increased blood glutathione 
concentrations at the expense of the hepatic concentrations (Richie et al. 1994). 
Severe methionine deprivation led to a dramatic decrease in liver glutathione 
concentration and was accompanied by increased expression of liver 
metallothionein (Sendelbach et al. 19901.
The biochemical impact of excess dietary methionine has included 
decreasing mixed - function oxidase activity in Broiler chicks (Takahashi and 
Horiguchi 1991) and decreased copper superoxide dismutase activity and 
copper concentrations in heart, liver and lung tissue (Strain and Lynch 1990).
The aims of this investigation were to assess the impact of differing 
levels of dietary methionine on the activity of hepatic xenobiotic - metabolising 
enzymes. Divided into two parts, these experiments will deal firstly with the 
effect of dietary supplementation with methionine and secondly the influence of 
methionine deficiency. A further experiment was carried out to investigate 
whether methionine deficiency influences the expression of xenobiotic - 
metabolising enzymes in response to a chemical carcinogen challenge.
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PART A: Methionine Supplementation Studies
5.2 Materials and Methods
5.2.1 Materials
Both DL - methionine and carboxymethylcellulose were obtained from
Sigma Biochemicals Ltd. (Poole, Dorset, U.K.). Rodent diet LAD - 1 was
obtained from Special Diet Services.» %
5.2.2 Methods
Eight Wistar albino male rats (~200gm) were obtained from the 
University of Surrey Experimental Biology Unit (Guildford, Surrey) and were 
housed in two groups of four animals as outlined in the chapter 2.
Throughout the experimental period the animals were allowed ad 
libitum access to both food and water. During the test period the animals 
received daily for three days a suspension of methionine (l.Og/kg Body 
Weight) in carboxymethylcellulose (2% w/v, in water) by gastric intubation. 
Control animals received the vehicle only (Carboxymethylcellulose 2% w/v).
The rats were sacrificed by cervical dislocation and the livers excised, 
washed in ice m- cold KCl (1.15% w/v), blotted dry and weighed. Each tissue 
was then prepared to a postmitochondrial supernatant and stored at -20°C as 
outlined in the chapter 2.
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5.3 Results
5.3.1 Animal Husbandry
Throughout the experimental protocol the administration of methionine 
was well tolerated by all the animals who remained active and alert. The 
treatment caused no retardation of growth (Table 5.1). At autopsy no changes 
were recorded to gross anatomy of the animals and liver weight was 
unaffected. Protein levels, both microsomal and cytosolic, were not 
significantly modulated by the methionine treatment.
5.3.2 Effects of Methionine Supplementation upon Hepatic Microsomal 
Cytochrome P450 Activities
Supplementation of the diet with methionine doubled the in vitro 
conversion of p - nitrophenol to p - nitrocatechol (Table 5.2), the was found to 
be statistically significant.
Investigation of the rates of dealkylation for ethoxy-, methoxy- and 
pentoxyresorufin revealed that methionine supplementation did not modulate 
these activities. However, methionine did cause a 25% decrease in the 
déméthylation of erythromycin, but statistical significance was not attained.
5.3.3 Impact of Methionine Supplementation on Phase H Conjugation Reactions:
All the activities studied were not perturbed by methionine 
supplementation (table 5.2).
5.3.4 Effects of Excess Dietary Methionine on Free Radical Defence Mechanisms:
Supplementation of the diet with methionine failed to perturb any of the 
parameters studied (table 5.3)
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Table 5.1: Effect of Dietary Supplementation with Methionine on Body Weight and
Liver Parameters:
PARAMETER: CONTROL DIET: METHIONINE
SUPPLEMENTED
(l.Og/kg):
Body Weight
Liver Weight
LiVer/Body Weight (%
Microsomal Protein 
(mg/gm liver)
Cytosolic Protein 
(mg/gm liver)
238.5 ±13.5 
13.54 + 0.86 
5.7010.82 
15.7 ±0.82
78.812.49
228.51 11.7 
13.4411.29 
5.90 10.40 
14.810.99
78.214.0
* 0.05 > P >  0.01; ** 0.01 > P >  0.001; ***0.001 >P
Data presented as Mean 1 Standard Deviation for Four Animals
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Table 5.2: Effect of Methionine Supplementation on Hepatic Microsomal
Monooxygenase Enzymesin the Rat:
PARAMETER: CONTROL DIET: METHIONINE
SUPPLEMENTED (l.Og/kg):
Ethoxyresorufin-O - Dealkylase 9.15 + 1.19 11.05 +1.67
(pmole/min/mg protein)
Pentoxyresorufin - O - Dealkylase 0.51 +0.19 0.54 + 0.04
(pmoles/min/mg protein)
Methoxyresorufin - O - Dealkylase 12.87 ± 3.05 13.37 ± 2.74
(pmoles/min/mg protein)
p - Nitrophenol Hydroxylase 0.46 + 0.16 0.93 ± 0.28*
(nmoles/min/mg protein)
Erythromycin - N - demethylase 8.77 + 1.09 6.52 ± 1.17
(nmoles/min/mg protein)
Laurie Acid Hydroxylase 1.41 ±0.31 1.36 + 0.12
(nmoles/min/mg protein)
1 - Naphthol Glucuronide 5.57 + 1.46 7.16 ± 3.99
(nmoles/min/mg protein)
4 - Methylumbelliferone 3.31 + 1.11 3.04 + 1.14
Glucuronide 
(nmoles/min/mg protein)
0.05 > P > 0.01; ** 0.01 > P > 0.001; *** P < 0.001
Data Represents Mean ± Standard Deviation for Four Animals
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Table 5.3: Impact of Methionine Supplementation on the Activity o f Hepatic
Cytosolic Enzymes in the Rat;
PARAMETER: CONTROL DIET: METHIONINE
SUPPLEMENTED (l.Og/kg):
Total Glutathione Concentration 5.19 ± 1.56 7.27 ± 1.76
(mM)
Glutathione Reductase 17.6 ± 1.66 15.4 ± 1.29
(nmoles/min/mg protein)
Glutathione - S - Transferase 1655 ± 301 1305 ± 92
(Chlorodinitrobenzene)
[nmoles/min/mg protein]
Glutathione - S - Transferase 23.5 + 2.92 20.7 ± 1.42
(Dichloronitrobenzene)
[nmoles/min/mg protein]
Selenium Dependent Glutathione 362 + 61 378 + 31
Peroxidase 
(nmoles/min/mg protein)
Selenium Independent Glutathione 168 + 75 202 + 19
Peroxidase 
(nmoles/min/mg protein)
Catalase 0.18 + 0.01 0.17 + 0.008
(pmoles/min/mg protein)
Superoxide Dismutase 46.9 + 5.0 43.4 + 2.5
OJnits/mg protein)
Phenol Sulphate Transferase 0.44 + 0.05 0.45 + 0.05
(nmoles/min/mg protein)
* 0.05 > ? >  0.01; **0.01 > ? >  0.001; ***0.001 >P
Data Represents Mean ± Standard Deviation for Four Animals
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5.4 Discussion
5.4.1 Possible Implications for Induction of Hepatic CYP2E
The cytochrome P450 isoform CYP2E has been proposed as the 
principal catalyst for the metabolism of a variety of xenobiotics, characterised 
by small molecular weight such as halothane, paracetamol and chlorzoxazone 
(Gonzalez and Gelbion 1990). Therefore the induction of CYP2E, denoted by 
the increased hydroxylation of p-nitrophenol (Reinke and Mayer 1985), implied 
that induction resulted from the presence of high concentrations of methionine.
The implications resulting from this increase in activity may be 
widespread. The CYP2E isoform of cytochrome P450 has been implicated in 
the futile cycling of NADPH (Ekstrom et al. 1986; Ekstrom and Ingelman 
Sundberg 1989) and chronic ingestion of ethanol, a potent inducer of CYP2E, 
increased free radical formation (Ekstrom et al. 1986; Montoliu et al. 1994) 
and lipid peroxidation (Montoliu et al. 1994). Extrapolation of such 
observations to an in vivo situation may prove difficult. Indeed increasing the 
production of free radicals may yield an increase in oxidative damage but the 
presence of high cellular concentrations of glutathione and high levels of 
glutathione peroxidase and catalase activities may afford protection so that 
such increases in free radical production may be of little biological significance. 
Indeed no changes in the activities of glutathione peroxidases, catalase, 
glutathione reductase or to hepatic concentrations of glutathione were 
observed, indicating that in a healthy animal such induction of CYP2E may be 
of little toxicological significance. Further observations attest to the very short 
duration of this induction once a chemical challenge has been removed (Ronis 
et al. 1991). A single dose of acetone was described to increase p-nitrophenol 
hydroxylase activity without changing cellular levels of mRNA (Park et al.
1993). Upon cessation of the acetone treatment the activity of CYP2E 
diminished rapidly, firstly by inactivation of the enzyme and later by removal of 
apoprotein from microsomal membranes (Ronis et al. 1991).
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PART B: Methionine Deficiency Studies
5.5 Materials and Methods
5.5.1 Materials
The semi - synthetic powdered diet was formulated from individual 
components. Lactalbumin and benzo[a]pyrene were obtained from Sigma 
Biochemicals Ltd. (Poole, Dorset, U.K.). Rovimix A, a preparation of vitamin* X
A, was obtained from Roche (U.K.). Mouse anti c - myc oncoprotein IgGk - 1 
antibodies were obtained from Biogenesis Ltd. (Bournemouth, U.K.). A kit for 
the determination of protein kinase C activity (RPN 77) was obtained from 
Amersham Ltd. (U.K.).
5.5.2 Methods
Twenty male, Wistar albino rats (~60gm) were obtained from the 
University of Surrey Experimental Biology Unit (Guildford, Surrey). The 
animals were divided randomly into four groups of five animals and housed in 
polyethylene cages as outlined in Chapter 2.
The methionine - deficient and control diets were synthesised from the 
individual components and thoroughly mixed, as outlined in table 5.4. The diet 
mixture was then divided into two equal portions, to the control diet was added 
methionine (0.3% w/w) and the diet remixed thoroughly. The diets were 
vacuum sealed into polyethylene bags and stored at 4°C until needed.
Two groups of rats were fed a diet deficient in methionine (Table 5.1), 
the remainder of the rats were fed a control diet containing methionine (0.3% 
w/w). The rats were allowed ad libitum access to both food and water for the 
six weeks of the study period. Fresh diet was placed in the cages daily. Twenty 
four hours before sacrifice one group of rats from both control and methionine 
- deficient dietary regimes received a single intraperitoneal dose of 
benzo[a]pyrene in com oil (l.Omg/kg body weight).
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Table 5.4: Composition of Control and Methionine - Deficient Semi - Synthetic Diets
Used:
COMPONENT: CONTROL DIET: METHIONINE DEFICIENT
(g/kg) DIET:
(g/kg)
Lactalbumin 100 100
Sucrose 100 100
Com Starch 652 652
Cellulose 50 50
Com Oil 50 50
Mineral Mix 35 35
Vitamin Mix 8.64 8.64
Rovimix A500 0.024 0.024
Choline Chloride 1.34 1.34
Methionine 3.0
Both diets were synthesised in two batchs, the basal methionine deficient diet being 
divided into two equal portions before a methionine supplement was added back to 
give a control, methionine supplemented diet.
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The rats were sacrificed by cervical dislocation and the liver, kidneys 
and lungs were excised, washed in ice - cold KCl (1.15% w/v) and blotted dry. 
Small portions of hepatic tissues were frozen in liquid nitrogen and stored at - 
80°C for analysis of c - myc oncogene expression. The remainder of the tissues 
were prepared to postmitochondrial supernatants and stored at -20°C for 
further analysis.
For the purposes of statistical analysis, unless otherwise stated, animals 
kept under differing dietary regimes and the same carcinogen treatment 
protocols were assessed by student 't' test to investigate the effects of 
methionine deprivation upon the induction of hepatic enzymes following insult 
with benzo[a]pyrene.
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5.6 Results
5.6.1 Animal Husbandry
Throughout the experimental phase the animals remained active and 
alert and appeared in good health. All animals gained weight normally and 
recorded no statistically significant differences in body weight at death. No 
differences in food consumption were noted (data not shown).
No gross anatomical differences were seen with the test animals. Liver 
weights, expressed as a percentage of the body weight, showed that dietary 
deficiency in methionine caused a statistically significant decrease.
5.6.2 Effect of Methionine Deficiency on Induction of Hepatic Microsomal
Monooxygenases
Administration of B[a]P did not influence the hepatic concentrations of 
cytochrome P450 for rats maintained upon the same dietary regime (Table 5.6); 
however comparing the effects of methionine deficiency upon cytochrome 
P450 concentrations showed that B[a]P caused a statistically significant 
increase in the total cytochrome P450 concentrations compared to B[a]P 
treated control animals.
In addition, administration of B[a]P increased markedly ethoxy-, 
methoxy- and pentoxyresorufin - O - dealkylase activities (Table 5.6). The 
extent of induction of methoxyresorufin - O - dealkylase by benzo[a]pyrene 
was higher in the methionine deficient rats.
Both methionine deficiency and B[a]P treatment, or a combination of 
the two, were without effect towards the in vitro activities of p - nitrophenol 
hydroxylase, erythromycin - N - demethylase and lauric acid hydroxylase. The 
formation of naphthol glucuronide by hepatic microsomal suspensions was also 
unaffected by the presence of either dietary deficiency in methionine or B[a]P 
treatment.
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Figure 5.1: Western Blot analysis of CYPIA apoproteins in Hepatic 
Microsomes isolated from Rats Maintained on diets deficient in methionine and 
following treatment with Benzo[a]pyrene:
M A A B B P C C D D
Immimoreactive bands correspond to apoprotein Levels Reactive to Anti CYPIA Antibodies. 
Each track corresponded to 40pg of Solubilised Microsomal Protein. Legend: M - Marker 
correspond to molecular weights, ISOkd, 116kd, 84kd, 58kd, 48.5kd, 36.5kd and 26.6kd; A - 
Control Diet; B - Methionine Deficient Diet; P - Positive, Control Aroclor 1254 - treated Rat 
liver Microsomes; C - Control Diet + B[a]P (Img/kg); D - Methionine Deficient Diet + B[a]P 
(Img/kg).
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Western blot analysis using antibodies reactive towards CYPIA 
apoprotein detected no significant differences between the expression of 
apoprotein in both methionine deficient and control liver microsomes.
5.6.3 Impact of Dietary Methionine Deficiency upon Hepatic Glutathione 
Concentrations and Phase H Conjugation Reactions
Maintenance of rats upon a diet deficient in methionine produced a 
marked (80%) decrease in hepatic glutathione content regardless of treatment 
with B[a]P (Table 5.7). Accompanied with this decrease in hepatic glutathione 
concentration, dietary methionine deficiency also caused an increase in hepatic 
glutathione reductase activity of -30%. Furthermore, dietary deficiency 
induced a statistically significant decrease in hepatic superoxide dismutase 
activity which was unaffected by treatment with B[a]P. The activities of 
glutathione - S - transferase and glutathione peroxidases were unaffected by 
any of the above treatments (Table 5.7).
5.6.4 Methionine Deficiency on Tissue Metallothionein Concentration and 
Hepatic Cytosolic Protein Kinase C Activity in the Rat
Methionine deficiency was not found to modulate the expression of 
metallothionein or hepatic cytosolic protein kinase C activity in the rat (table 
5 8)
5.6.5 Effect of Methionine Deficiency on Renal Microsomal Monooxygenase
Activities:
Irrespective of the dietary regime chosen, administration of B[a]P 
caused marked increase in renal ethoxyresorufin - O - dealkylase activity (Table 
5.9). Furthermore, the induction by B[a]P was unaffected by the presence of a 
dietary methionine deficiency.
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Table 5.8: Impact o f Dietary Methionine Deficiency on the Expression of Hepatic
Metallothionein and Cytosolic Protein Kinase C Activity:
PARAMETER CONTROL DIET METHIONINE DEFICIENT
DIET
Tissue Metallothionein 0.73 ± 0.06 0:70 ± 0.06
(^ig/g liver)
Cytosolic Protein Kinase C 34.9 ±5.4 25.8 ±8.6
(pmoles ATP/hour/mg protein)
Data Represents the Mean ± Standard Deviation for five animals. Both assays were 
repeated, at least twice, with similar results
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In addition, methionine deficiency alone decreased the hydroxylation of 
lauric acid by -40%. Administration of B[a]P increased lauric acid hydroxylase 
activity in animals deficient in methionine but, in contrast activity was 
suppressed in animals on control diets.
5.6.6 Modulation of Renal Cytosolic Activities by Methionine Deficiency
No statistically significant differences were observed for glutathione 
levels as a result of methionine deficiency and/or treatment with 
benzo[a]pyrene. It is pertinent to point out that large interanimal variation in 
the renal levels of this tripeptide were noted (Table 5.10).
The activities of glutathione peroxidases, glutathione transferases and 
glutathione reductase were unaffected by dietary methionine deficiency, the 
administration of B[a]P or by combination of these treatments (Table 5.10).
5.6.7 Effects of Dietary Methionine Deficiency upon In Vitro Measurements of
Pulmonary Microsomal Monooxygenase Activity:
Assessment of the in vitro activity of ethoxyresorufin - O - dealkylase 
showed that dietary methionine deficiency had no net effect upon the rate of 
substrate dealkylation (Table 5.11). However B[a]P treatment caused a 
statistically significant increase irrespective of the diet. Pentoxyresorufin - O - 
dealkylase activity was unaffected by either dietary manipulation or the 
administration of B[a]P.
5.6.8 Effect of Dietary Methionine Deficiency upon the Activity of Pulmonary
Glutathione Reductase
Neither dietary methionine deficiency nor administration of a single 
dose of B[a]P caused a significant effeect on glutathione reductase (Table 
5.12). However when both treatments were combined, a statistically significant
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decrease of some 30% was evident in glutathione reductase activity when 
compared to animals maintained on a diet deficient in methionine alone.
5.6.9 Impact of Methionine Deficiency on the Expression of c - myc Oncoprotein
Western blot analysis of c - myc oncoprotein expression in liver 
homogenates revealed that dietary methionine deficiency increased the 
expression of c - myc oncoprotein (Figure 5.2). The positive control used, 15 - 
day - old neonatal rat liver, responded as expected.
5.7 Discussion
5.7.1 Animal Husbandry
Feeding diets deficient in the essential amino acid methionine did not 
impair animal growth. Rats were chosen at an initial weight of 60gm in order to 
maximise the dietary requirement for methionine; such young animals offered 
the greatest potential for growth and may therefore have presented the greatest 
burden upon the diet. This contradicts the findings of Sowers et al. (1972) and 
Shin et al. (1994) who emphasised that even modest reductions in methionine 
intake caused severe detriment to the growth of animals. Indeed complete 
absence of methionine from experimental diets was believed to result in a loss 
of body mass (Sowers et al. 1994). Moreover, even moderate deprivation of 
methionine was believed to halt growth in male rats (Orentreich et al. 1993) 
and decrease the food consumption for those animals on a diet deficient in 
methionine. Many of the detrimental effects of methionine - deficient diets, 
including the poor weight gain previously documented, could be obviated by 
addition of cysteine to the diet as an alternative source of sulphur amino acids 
(Sowers et al. 1972; Shin et al. 1994). In the present study such 
supplementation was not carried out.
Taken alone, these observations imply that the diet used during this 
experimental protocol may not have been deficient in methionine. The standard
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Figure 5.2: Western Blot analysis of the Expression of c - myc Oncoprotein in 
Hepatic Homogenates isolated from rats maintained on diets deficient in
Methionine:
M A  B  P  C  D
Immimoreactive bands correspond to c - myc oncogene products reactive towards Mouse 
Monoclonal Anti c - myc Antibodies (Biogenesis Ltd., Bournemouth U.K.) Legend: M - 
Markers correspond to molecular weights 180kd, 116kd, 84kd, 58kd, 48.5kd. 36.5kd and 
26.6kd; Lanes A, B, P were loaded with 12mg protein/track. A - Control Diet; B - 
Methionine deficient diet; P - Positive Control, 15 day old neonatal rat hepatic tissue.
Lanes C, D, E were loaded with 24mg protein/track. C - Control Diet; D - Methionine 
deficient diet; E - Positive Control, 15 day old neonatal rat hepatic tissue.
149
supplement of methionine (3g/kg) for rodent diets was omitted during the 
synthesis of the diet and moreover, lactalbumin was chosen as a protein source 
in order to keep dietary sources of methionine to a minimum (personal 
communication Dr. M. Coates, University of Surrey). Whilst not completely 
devoid of methionine, the diet utilised during these experiments should have 
been sufficiently deficient in methionine to cause some retardation of growth. 
However without direct measurement of dietary methionine concentrations or 
plasma methionine levels, unequivocal deficiency cannot be proved.
Investigations of organ weight revealed that animals maintained upon a 
diet deficient in methionine had a smaller liver, in agreement with the 
experimental findings of Henning et al. (1989).
Further scrutiny outlined that administration of a single dose of B[a]P 
induced growth of hepatic tissue in only methionine deficient animals. Similar 
observations have been documented for animals administered phénobarbital 
after a period of treatment with diets deficient in methionine, threonine, vitamin 
A, vitamin E and vitamin C (Nurmagambetov et al. 1991; Nurmagambetov et 
^  1992). This modest overgrowth of hepatic tissue in the presence of a dietary 
methionine deficiency appeared without cause.
5.7.2 Investigation of the In Vitro Activity of Hepatic tissue Enzymes
5.7.2.1 Impact of Dietary Methionine Deficiency on the Induction of 
Alkoxyresorufln - O - dealkylases
Regardless of the dietary regime, the administration of B[a]P caused a 
significant increase in the dealkylations of ethoxy-, methoxy- and 
pentoxyresorufin - O - dealkylase. The direct effects of a methionine deficient 
diet upon the induction appeared limited to methoxyresorufin - O - dealkylase, 
used as a sensitive marker for the activity of CYP1A2 (Burke and Mayer 
1974). Methionine deficiency appeared to potentate CYP1A2 activity in 
response to treatment with B[a]P. Similar responses have been established for
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the induction of CYP2B by phénobarbital in the presence of dietary threonine, 
methionine and vitamins A, C and E deficiencies (Nurmagambetov et al. 1991; 
Nurmagambetov et al. 1992). Western blot analysis using hepatic microsomes 
from both methionine deficient and control animals failed to detect any such 
changes in the microsomal concentration of apoprotein levels (Figure 5.1); 
however as the increase in activity may be only 50% over control animals such 
a small increase in activity may be difficult.
The presence of methionine deficiency was also without effect upon the 
activities of nitrophenol hydroxylase, erythromycin-N - demethylase and lauric 
acid hydroxylase indicating that CYP3A, CYP2E1 and CYP4A activities were 
not influenced. This appeared broadly in agreement with previous publications 
documenting that methionine deficiency had little effect on aniline - 4 - 
hydroxylase a substrate for both CYP1A2 and CYP2E1 (Takahashi and 
Horiguchi 1991).
5.T.2.2 Effects of Methionine Deficiency upon Hepatic Glutathione 
Concentration and Glutathione Metabolism
Deprivation of dietary methionine decreased profoundly hepatic 
glutathione concentration by some 80% and was accompanied by an increase 
in glutathione reductase activity. This increase in activity was probably an 
adaptive change as a result of low tissue glutathione levels. By increasing the 
activity of the reductase, the cell can maintain the available glutathione in the 
reduced form. These findings are in agreement with the observations of 
Henning et al. (1989) whom outlined that dietary deficiency in methionine 
depressed hepatic concentrations of glutathione as well as decreased tissue 
levels of S - adenosylmethionine (Henning et al. 1989; Shivapurkar and Poirier 
1983). Indeed complete deprivation of dietary methionine decreases hepatic 
tissue glutathione by 75% in seven days (Sendelbach et al. 1990). Depletion of 
tissue glutathione may result from breakdown of glutathione to yield amino
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acids for protein synthesis. However, depletion of dietary methionine may lead 
to a decrease in tissue cysteine and homocysteine concentrations (Shiapurkar 
and Poirier 1983). This may in part be due to the conversion of methionine to 
cysteine via the transmethylation - transulphuration pathway (Stipanuk 1986).
The impact of the decrease in hepatic tissue glutathione concentration is 
more clearly understood. For example, determination of glutathione peroxidase 
and glutathione transferase activities utilising endogenous glutathione (data not 
shown) demonstrated that enzyme activity may be severely impaired by a 
decrease in the availability of the cofactor glutathione. Possible consequences 
include a much decreased ability to combat free radical and active oxygen 
species mediated damage to cellular components (Comporti et al. 1991). 
Moreover, this manifestation of oxidative stress has been implicated in the 
progression of apoptosis - programmed cell death - in cultured neuronal cells 
(Ratan et al. 1994T
5.7.3 Effect of Methionine Deprivation on Drug - Metabolising Enzymes from 
Extrahepatic Tissues:
Investigation of extrahepatic tissues was carried out in order to 
investigate the hypothesis proposed by Nurmagambetov et al. (1991 and 1992) 
that, following treatment with phénobarbital, in the presence of a nutritional 
deficiency essential nutrients were sequestered from extrahepatic sources. This 
was assessed following administration of - labelled lysine and the progress 
of the label in liver subfractions was monitored. Measurement of enzyme 
activities from extrahepatic tissues was therefore carried out to assess the 
impact of dietary methionine deficiency upon the activity of both microsomal 
and cytosolic enzymes, and note any alteration to the inducing potential of 
B[a]P brought about by methionine deficiency.
152
5.7.3.1 Effects of Methionine Deprivation on Pulmonary Drug Metabolising 
Activities:
Irrespective of the dietary regime used, intraperitoneal administration of 
B[a]P caused an increase in the activity of ethoxyresorufin - O - dealkylase.
Examination of cytosolic activities demonstrated that despite 
methionine deficiency no change to the tissue concentration of glutathione or 
glutathione reductase activity was noted. However following the administration 
of B[a]P the activity of glutathione reductase decreased significantly for 
animals maintained upon a diet deficient in methionine.
It is attractive to speculate that in the presence of the B[a]P challenge 
the tissue requirement for methionine was sufficiently great to require the 
sequestration of this essential amino acid from enzyme proteins. However given 
that benzo[a]pyrene was administered in one single dose this appeared unlikely.
5.7.3.2 Effect of Dietary Methionine Deficiency on the Renal Microsomal Drug - 
Metabolising Enzymes
Dietary deficiency in methionine produced a 50% decrease in the in 
vitro dealkylation of ethoxyresorufin carried out by renal microsomal 
suspensions; however, due to large variations between individual animals 
statistical significance was not achieved. B[a]P treatment induced a ten - fold 
increase in the activity of CYPlAl, yet assessment of the impact of a dietary 
methionine deficiency revealed that dietary deficiency in this essential amino 
acid did not hinder the induction of CYPl Al. No effects were observed for the 
activities of both methoxy- and pentoxyresorufin - O - dealkylase during 
methionine deficiency.
The renal microsomal metabolism of lauric acid appeared to have been 
effected by both dietary deficiency and treatment with B[a]P. The 25% 
decrease in lauric acid hydroxylation following B[a]P treatment to control 
animals appeared difficult to resolve. The B[a]P may alter the profile of P450
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proteins in renal tissue, or may increase the rate of degradation of these 
proteins.
Lauric acid hydroxyation hydroxylation was decreased by some 40% 
following methionine deficiency. Taken alone, this observation may be 
indicative of severe methionine deprivation leading to the sequestration of 
essential amino acids from enzyme protein sources. However following 
treatment with B[a]P, in the presence of a methionine deficiency, the 
hydroxylation of lauric acid increased by 20%. Clearly this observation 
appeared to contradict the effects of both methionine deficiency and B[a]P 
administration individually, implying that it was unlikely that the liver were 
utilising methionine fi"om extrahepatic sources. If such sequestration of 
methionine by the liver were occurring it is conceivable that the combined 
challenge of methionine deficiency and benzo[a]pyrene may diminish lauric acid 
hydroxylase activity still further.
A note of caution must be addressed, that the method used for the 
investigation of lauric acid hydroxylase activity detects both © and co-l 
products of this hydroxylation. This method was used during the current 
studies as a probe for CYP4A activity, which is responsible for ©-hydroxylation 
of lauric acid only (Parker and Orton 1980). In view of the observations that 
other isoforms of cytochromes P450 are capable of ©-1 hydroxylation of lauric 
acid, namely CYP2E1 (Amet et al. 1994) and CYP2C2 (Fukuda et al. 1994), 
only tentative deductions on the expression of CYP4A can be drawn from this 
data. Further speculation may suggest that the fatty degeneration of hepatic 
tissue noted for both choline devoid and lipotrope deficient diets (Ghoshal and 
Farber 1993) may represent sufficient potential for the induction of CYP4A. 
This fat accumulation was believed to result fi'om perturbation in the synthesis 
of VLDL (Newbeme and Schager 1993) brought about by deficiencies in 
choline and/or methionine. However, in the current study histological analysis 
revealed no evidence of fatty degeneration for hepatic tissue (data not shown).
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In addition, if induction of CYP4A were a response to the deposition of 
triglycerides within hepatic tissue, why was such induction not evident in the 
liver and why was pure methionine deficiency not sufficient to precipitate such 
induction alone. It is conceivable that only under conditions of methionine 
deficiency and B[a]P treatment was protein synthesis sufficiently compromised 
to produce the fatty accumulation to promote the induction of lauric acid 
hydroxylase; this would however appear unlikely.
Indeed a more plausible explanation for such increases in the 
hydroxylation of lauric acid may focus upon the non - specific nature of the 
experimental technique used to quantify this metabolism. The hydroxylation of 
lauric acid at the 11- position has been associated with a variety of isoforms of 
cytochrome P450 including CYP2E1 (Amet et al. 1994) and CYP2C2 (Fukuda 
et al. 1994) and therefore without immunoblot information to corroborate the 
observations for the metabolism of lauric acid, explanation of the fluctuation in 
the hydroxylation of lauric acid for methionine deficiency, B[a]P treatment and 
a combination of the two treatments must be tentative at best. Moreover, the 
most probable cause for the modification of lauric acid hydroxylation may 
appear to be a modulation of one or more of the cytochrome P450 isoforms 
with the potential to metabolise lauric acid.
5.7.4 Effects of Methionine Deficiency Upon Hepatic c - myc Oncogene 
Expression
Analysis of the expression of c - myc protein in hepatic tissue 
homogenates was attempted by Western analysis blot using monoclonal 
antibodies raised to a single epitope in mouse cells (Biogenesis Ltd., 
Bournemouth, England). Figure 5.2 represents a typical observation from three 
repeated analyses of samples taken from control and methionine deficient 
animals. The two observed immunopositive bands corresponded to two
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fragments of c - myc protein, a 62-66kd 'nuclear associated' c - myc protein and 
also a 48-50kd cytoplasmic myc - related protein.
Comparison of control treated samples with a positive control isolated 
from 15 - day old neonatal rats revealed a marked decreased in immunoreactive 
protein in control animals compared with the positive control. Comparison of 
samples isolated from rats maintained on a diet deficient in methionine with 
control animals revealed that methionine deficiency could elevate the cellular 
concentrations of c - myc oncoproteins. This assessment does however give no 
indication whether the increase in protein concentration was a result of 
increased transcription of the mRNA or simply a decrease in the rate of 
degradation of the protein.
Previous experimental observations have described the ability of methyl 
donor deficient diets (typically deficient in both choline and methionine) to 
elevate the cellular concentrations of mRNA coding for c - myc and c - fos 
oncogenes (Dizik et al. 1991; Wainfan and Poirier 1992). However this is the 
first such study to focus upon the effects of diets deficient in methionine only 
and demonstrates for the first time that deprivation of methionine alone can 
result in an increase in the expression of c - myc oncoprotein. However studies 
by Lafarge - Frayssinet et al. (1993) in another system, namely hepatoma cells 
cultured in a methionine free growth media, demonstrated a decrease in c - myc 
oncogene expression, which was markedly elevated upon the return of 
methionine to the growth media.
Feeding methyl donor deficient diet to rodents has resulted in the rapid 
hypomethylation of DNA (Wainfan et al. 1989) including those regions coding 
for the oncogenes c - myc and c - fos (Christman et al. 1993a), leading to 
hypomethylation of transfer RNA (Wainfan et al. 1986) as well as increases in 
tRNA methyltransferase. In what way these changes to the méthylation pattern 
of the genome may impart effects upon gene expression is not clear; that direct
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méthylation may effect gene expression is without question (Verdine 1994; 
Jones and Buckley 1990).
Changes to the méthylation pattern and the activities of 
methyltransferase enzymes have also been proposed as possible targets that 
may precipitate tumour formation (Jones and Buckley 1990; Szyf 1994). 
Methyl donor - deficient diets can induce hepatocellular carcinoma in rodents 
(Lombardi and Smith 1994; Christman et al. 1993b). However, it is difficult to 
assess whether methionine deficiency alone may lead to similar neoplastic 
changes.
The impact of increased c - myc expression on cell growth has been 
established by studying the behaviour of normal human breast cell lines (Suto et 
al 1992) and has been linked to oestrogen - induced proliferation and 
anchorage - independent growth of human breast cells in culture (Leygue et al. 
1995). Moreover, the use of antisense DNA coding for the c - myc nucleotide 
sequences has suppressed the oestradiol - dependent increases in cellular c - 
myc protein concentration and has prevented c - myc - dependent cellular 
proliferation (Watson et al. 1991). Therefore the increase in c - myc 
oncoprotein demonstrated for hepatic tissue isolated from rats fed a methionine 
- devoid diet may suggest progression towards a proliferative state for the 
hepatocytes.
However, c - myc proteins have also been implicated in the process of 
apoptosis - programmed cell death - and are associated with a "high turnover 
state" in tissues (Wyllie 1993). Indeed under such conditions cellular 
proliferation and apoptosis co - exist and may yield no increase in cellular 
numbers, only an increase in cell turnover (Evan et al. 1992). Experimental 
observation that methionine deficiency caused a significant decrease in liver 
weight may favour this hypothesis. The modest overgrowth established 
following treatment with B[a]P may represent the mitogenic potential of B[a]P 
towards hepatocytes already maintained in a highly proliferating state and may
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simply act as a trigger for division. This hypothesis is however without 
experimental evidence and as such remains speculation.
5.7.5 Effect of Methionine Deprivation on the Activity of Cytosolic Protein 
Kinase C
The observations made in the present study on the effect of methionine 
deficiency protein kinase C (PKC) contradict previous studies for methyl 
donors (da Costa et al. 1993; da Costa et al. 1995). These previous 
investigations have concentrated on the effects of choline deficiency upon 
protein kinase C activity in the liver. The present study appeared to be the first 
such investigation of methionine deficiency and PKC activity and demonstrated 
that whilst methionine - deficient diets decreased the activity of cytosolic 
protein kinase C (PKC), the effect was not statistically significant (Table 5.8). 
By contrast, diets deficient in choline gave rise to an increase cytosolic PKC 
activity by -70% after only six weeks of dietary deficiency (da Costa et al.
1993). This was associated with massive increases in the activity of plasma 
membrane bound PKC activity.
PKC represents a large group of structurally similar proteins that can 
rapidly and reversibly associate with membrane - bound hormonal and 
neurotransmitter receptors (Azzi et al. 1992). They are associated with signal 
transduction through the cell by triggering a response within the cell to an 
external stimulus. A variety of ligands are believed to activate PKC, of 
endogenous importance being the diacylglycerols (Nishizuka 1984) and these 
may play a prominent role in tumour promotion. Of particular concern was the 
observation that choline deficiency could modify fatty acid composition of 
microsomal and nuclear membranes (Kapoor et al. 1992) and elevate plasma 
membrane and nuclear concentrations of diacylglycerol within rat hepatic tissue 
(da Costa et al. 1993). The observation that activation of PKC may elicit 
tumour promotion has led to the proposal that the increases to PKC mediated
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by choline deficiency may provide a promoting response to 
hepatocarcinogenesis (da Costa et al. 1993) and may be associated with the 
fatty accumulation within the liver which occurs during dietary choline 
deficiency (Ghoshal and Farber 1993)
Of interest was the absence of changes to PKC activity described for 
methionine deficiency. Without assessment of plasma membrane PKC activity it 
is difficult to determine whether an increase in the membrane binding of PKC 
to the plasma membrane had occurred. However in view of the absence of fatty 
accumulation within the tissue (data not shown) it is plausible that little 
accumulation of diacylglycerol may result from dietary methionine deficiency 
and that methionine deficiency may not elicit a promoting effect towards 
hepatocarcinogens.
5.7.6 Effect of Methionine Deficiency on Hepatic Metallothionein Concentrations
In previous studies even short - term deletion of methionine from the 
diet has led to an increase in liver metallothionein concentrations (Sendelbach 
et al. 1990). The data obtained this study contradict these observations, 
showing that dietary deficiency in methionine did not modulate hepatic 
concentrations of metallothionein (Table 5.8). It is possible explanation may 
propose that the dietary deficiency in methionine was not sufficiently severe to 
induce synthesis of metallothionein. Numerous studies document the growth 
retardation potential of methionine deficiency (Sowers et al. 1972; Shin et al.
1994) and similar observations were described by Sendelbach et al. (1990). No 
such observations were noted in the present study and may therefore add 
further evidence to the suggested mild degree of methionine deprivation 
present in this experiment.
Oxidative stress has been documented to result in the induction of 
metallothionein (Tacchini et al. 1995) and it is conceivable that the ability of 
methionine deficiency to decrease tissue glutathione concentration may result in
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a condition of oxidative stress (Ratan et al. 1990). However in view of the 
similar decreases in glutathione levels in previous investigations (Sendelbach et 
^  1990) speculation suggested that this oxidative stress alone was insufficient 
to induce metallothionein synthesis in this instance. The most plausible 
explanation may indeed relate to the severity of methionine deficiency and in 
this instance the present study may only infer mild deficiency in dietary 
methionine. This alone may not be sufficient to provoke the increase in tissue 
metallothionein concentration.
5.8 Conclusions
5.8.1 PART A: Methionine Supplementation
The effects transpiring from the supplementation of a nutritionally 
adequate diet with excess methionine (Ig/kg) are limited to the induction of 
hepatic microsomal CYP2E, denoted by an increase in the hydroxylation of p - 
nitrophenol which may be viewed with some concern with regard to the fiitile 
cycling of NADPH (Ekstrom et al. 1986). Such futile cycling may result in the 
production of superoxide anions leading to lipid peroxidation. Despite these 
observations, the effect of CYP2E may be transient; upon removal of a 
challenge, the induction of CYP2E1 has been documented to decrease rapidly 
(Ronis et al. 1991) initially by inactivation and subsequently by a more gradual 
process of apoprotein removal from the membrane of the endoplasmic 
reticulum.
Extrapolation of such observations to humans would indicate that 
dietary intervention with methionine offers no obvious benefit in combating 
chemical carcinogenesis.
In view of the large number of chemical compounds that have 
demonstrated the ability to induce CYP2E the small increase documented for 
dietary supplementation with methionine may be perceived as negligible. In
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addition, the potential for variation in the expression of CYP2E1 attributed to 
genetic polymorphism (Stephens et al. 1994: Uematsu et al. 1994) may imply 
that both genetic factors and xenobiotics may exhibit greater influence upon 
GYP2E1 expression compared to that of any single dietary component.
5.8.2 PART B: Methionine^ Deficiency
Throughout the study the important question over the severity of the 
methionine deficiency has remained unanswered. Previous observation has 
documented that severe dietary deficiency of methionine led to an arrest in the 
growth of animals (Orentreich et al. 1993; Shin et al. 1994). Clearly that has 
not been the case in this study as, despite the young age of the animals, all rats 
grew normally on both control and test diets, without the need for 
supplementation with homocysteine.
The observation that induction of CYPlAl was unaffected by dietary 
deficiency of methionine may suggest little impact upon the metabolic 
activation of planar carcinogens such as the polycyclic aromatic hydrocarbons. 
Interestingly, increases observed in CYP1A2 activity - characterised by 
methoxyresorufin - O - dealkylase - noted during methionine deficiency may 
predispose to the carcinogenicity of the heterocyclic amines encountered in 
food. The heterocyclic aromatic amines include a variety of precarcinogens 
derived from the diet (Sugimura 1982) and therefore may represent an increase 
in the metabolic activation of these precarcinogens.
The impact of methionine deprivation upon glutathione concentrations 
and the activity of glutathione reductase was profound. The dietary deprivation 
was associated with an 80% decrease in hepatic glutathione concentration. 
Interestingly comparison of renal and pulmonary tissues suggested that hepatic 
tissues were effected in isolation; no changes to the tissue concentrations of 
glutathione being recorded for both kidney and lung. Glutathione depletion is
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associated with an increase in hepatocellular damage (Comporti et al. 1991) 
and may, in part, contribute to the stimulus to induce apoptosis associated with 
oxidative stress (Ratan et al. 1994; Cascales et al. 1994). Moreover, this 
suggestion was given further credence with the demonstration of increased c - 
myc oncoprotein expression in the liver, believed to be a trigger for apoptosis 
or programmed cell death (Wyllie 1993).
In the context of human dietary needs, such methionine deprivation may 
indeed be extremely difficult to achieve. Methionine forms a component of a 
wide variety of protein - based foods and therefore achieving a dietary 
deficiency may be extremely difficult, requiring several weeks of abstinence. 
Whether the impact of dietary methionine deficiency upon the activities of renal 
and pulmonary drug - metabolising enzymes is of any biological relevance 
remains difficult to assess. The data presented represents no clear 
demonstration that methionine may be mobilised from extrahepatic sites in 
order to spare hepatic tissue from methionine deprivation (Nurmagambetov et 
al 1991 and 1992). However it is still plausible that xenobiotic - metabolising 
enzymes may be spared, the methionine sequestered from structural and other 
non - essential sources. Whether these changes may have any effect upon the 
whole organism appeared doubtful as hepatic tissue is believed to be the 
principal site of xenobiotic biotransformation and metabolic activation of 
chemical carcinogens (Wall et al. 1991).
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Chapter 6
EFFECTS OF VITAMIN E DEFICIENCY ON DRUG
METABOLISM
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6.1 Introduction
Vitamin E comprises a group of lipophilic antioxidant compounds 
present in the diet. It is composed of four tocopherols, namely a, P, y, 5 and 
four tocotrienols, namely a, P, y, Ô; all of which are structurally related and 
were first isolated from wheat germ oil. Of the tocopherols, a  tocopherol is the 
most potent antioxidant. Daily consumption of vitamin E has been estimated at 
5 - 20mg/day. After ingestion vitamin E is carried through the circulation by 
Low Density Lipoproteins (LDL) to the liver, where redistribution follows 
(Biomeboe et al. 1990).
Vitamin E is amongst the most important of the membrane bound 
antioxidants and can react rapidly with acylperoxyl radicals (ROO ) to yield a 
less reactive radical species and oxidised tocopherol (de Groot 1994). This 
oxidised tocopherol can further react with ascorbic acid to regenerate reduced 
tocopherol (Packer et al. 1979; Leung et al. 1981).
Vitamin E has established a very low toxicity in rats, substantial doses 
leading to disruption of the blood clotting process, yielding haemorrhage to a 
variety of tissues (Abdo et al. 1986; Takahashi et al. 1990; Takahashi 1995b).
Dietary supplementation studies carried out using vitamin E have 
described many beneficial effects for increasing vitamin E intake, including 
increased cell - mediated immunity (Moriguchi et al. 1990).
The effects of increasing dietary levels of vitamin E upon chemical 
carcinogenesis have however revealed a mixed response, showing both 
increased and decreased tumour incidence.
Dietary supplementation with 10,000ppm vitamin E was found to be 
ineffective at modulating the incidence of DMBA - induced mammary tumours 
in Sprague Dawley rats (Wattenberg 1972). Further investigations by the same 
author added that supplementary vitamin E was also without effect towards 
B[a]P - induced forestomach tumours in mice (Wattenberg 1972).
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Additional assessments document that increasing dietary intake of 
vitamin E (600mg/kg diet) did not effect the incidence or multiplicity of 
azaserine - induced pancreatic tumours in rats (Appel et al. 1991) or the 
incidence of multiorgan tumours in rats simultaneously initiated with oral 
MNNG, oral N - ethyl - N - hydroxyethylnitrosamine or subcutaneous 
dimethylhydrazine (Hirose et al. 1993). El - Nahas et al. (1993) also described 
the lack of effects for vitamin E against chromosomal aberrations in bone 
marrow cells from rats receiving whole body y irradiation.
Contradictory, beneficial effects have also been observed for increasing 
dietary levels of vitamin E. Nyandieka et al. (1990) noted a 40% decrease in 
the incidence of AFBj - induced liver tumours following dietary 
supplementation with vitamin E (1 mg/kg diet). Interestingly, Nyandieka et al. 
(1990) described no changes to the hepatic microsomal activities of NADPH 
Cytochrome P450 reductase, aniline hydoxylase or aminopyrine demethylase as 
a result of increased vitamin E consumption, suggesting this reduction in 
tumour incidence was not a result of increased detoxication metabolism of 
AFB].
Vitamin E has also established anti - promoting properties against 4 - 
nitroquinoline - 1 - oxide (NQO) induced lung tumours in ddY mice (Yano et 
al 1993). Vitamin E was observed to suppress the tumour promoting effects of 
glycerol upon NQO - induced tumours. Indeed similar findings were 
documented by Tsuda et al. (1994) outlining a chemopreventive effect for 
dietary a  tocopherol towards 2 - amino - 3 - methylimidazo [4,5-f] quinoline - 
induced liver tumours in rats.
Interestingly Mitchel and McCann (1993) established a contradictory 
tumour promoting potential for vitamin E towards DMBA - induced skin 
tumours. Compared to 12 - O - tetradecanoylphorbol - 13 - acetate (TPA) 
vitamin E was 40 fold less effective at promoting tumours, however the 
mechanism of promotion caused by vitamin E differed fi*om the promotion
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caused by TP A as vitamin E showed little ability to induce the inflammatory 
response in the skin documented for TP A.
Supplementation of rodent diets with excess vitamin E has also 
established the potential to increase the concentrations of hepatic total 
cytochrome P450 and increase the in vitro activities of NADPH Cytochrome 
P450 reductase and androstenedione 16a hydroxylase (Murray 1991) as well 
as protect microsomal proteins and lipid from peroxidative damage in vitro.
The effects of vitamin E deficiencies are more clearly understood. 
These include lipid peroxidation (Chen and Chang 1978; Chen et al. 1993) 
particularly within mitochondria (Sokol et al. 1991) and a potentiation of the 
acute toxicity and lethality associated with paracetamol (Peterson et al. 1992), 
this was fiirther exacerbated in the presence of a combined selenium and 
vitamin E deficiency.
In addition, vitamin E deficiency led to a decrease in the expression of 
cytochrome P450 isoform CYPlAl in rainbow trout (Williams et al. 1992). 
Indeed, vitamin E deficiency was associated with an increase in the in vitro 
covalent binding of [^H] - B[a]P - 7,8 - dihydrodiol to DNA caused by trout 
hepatic microsomal suspensions which appeared in direct contradiction with the 
findings for the expression of CYPlAl (Williams et al. 1992).
Interestingly, chronic dietary vitamin E deficiency amongst female 
Sprague Dawley rats was noted to have no effect upon the incidence and 
multiplicity of 1 - methyl - 1 - nitrosourea (MNU) - induced mammary tumours 
(Thompson 1991).
Vitamin E deficiency has established the ability to modulate the 
activities of hepatic cytochromes P450 in rats. Carpenter (1972) documented a 
decrease in the hydroxylation of codeine and aminopyrine for microsomal 
suspensions derived from hepatic tissue isolated from vitamin E deficient rats. 
Further investigations suggested that chronic vitamin E deficiency decreased 
hepatic total cytochrome P450 concentrations and increased hepatic
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glutathione concentrations (Williams et al. 1992) in Sprague Dawley rats; no 
changes were recorded for the activities of glutathione peroxidase or 
superoxide dismutase. Comparisons of the impact of dietary vitamin E 
deficiency upon both male and female rats (Iwasaka et al. 1993) confirmed the 
decrease in hepatic P450 concentration for male rats described by Williams et 
al (1992) but also noted that, for female rats, the hepatic concentrations of 
P450 were unaffected. Additional analysis revealed that for both male and 
female rats the activities of UDP - glucuronosyl transferase and 
sulphotransferase were also unaffected by vitamin E deficiency.
More recent developments have implicated dietary levels of vitamin E in 
the propagation of coronary heart disease. The observation that oxidation of 
LDL may precipitate atherosclerosis (Leake 1995) and the protection afforded 
to LDL, by supplementary vitamin E, against oxidative damage (Dieber - 
Rothendez et al. 1991) implied that supplementing a nutritionally complete diet 
with increased levels of vitamin E may afford some protection from 
atherosclerosis (Rice - Evans 1995).
The aims of this present study was to investigate whether a prolonged 
dietary vitamin E deficiency could effect the expression of cytochromes P450 
and, by inference, modulate the initiation step of chemical carcinogenesis. As 
both P450 isoforms CYPlAl (Borlakoglu et al. 1993) and CYP1A2 (Aryton et 
al 1990) have been implicated in the metabolic activation of precarcinogen 
species to yield reactive intermediates, any changes in the expression of these 
two isoforms of cytochromes P450 may effect the initiation process of chemical 
carcinogenesis. In addition, further assessment of the phase II conjugation 
enzymes and the enzymes for oxidant defence were also studied to determine 
whether vitamin E deficiency may influence the ability of hepatic tissue to 
combat an oxidative challenge.
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6.1 Materials and Methods
6.2.1 Materials
The vitamin E deficient semi - synthetic diet was produced 'in house' 
from individual components. The Polyclonal antibody used to detect CYP3A 
was a gift from the Imperial Cancer Research Fund (London, U.K.)
6.2.2 Methods
Twelve, weanling female Hooded rats were obtained fi’om the 
University of Surrey Experimental Breeding Colony (Guildford, Surrey). The 
rats were randomly divided into two groups of six animals and housed in 
polyethylene cages as outlined in the Methods chapter (Chapter 2). The rats 
were allowed ad libitum access to both food and water at all times during the 
experimental protocol. Fresh diet was placed in the cages each day.
The vitamin E - deficient experimental diet used was synthesised each 
week as outlined in table 6.1, using vitamin E stripped com oil. A control diet 
was synthesised using com oil to provide the dietary vitamin E. The diet was 
vacuumed sealed into polyethylene bags and stored at 4°C until needed.
The rats were maintained on the test diets for a total of eight weeks 
before sacrifice. At autopsy the rats were euthanased by suffocation in a carbon 
dioxide atmosphere and were then examined for gross anatomical abnormality. 
The livers were then removed, washed in ice cold KCl (1.15% (w/v)) and 
blotted dry and weighed. Homogenates and postmitochondrial suspensions 
were prepared, and stored at -20°C as outlined in chapter 2.
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Table 6.1: Composition of the Experimental, Semi - Synthetic diets fed to
Hooded Rats for the Period of Study
COMPONENT:
CORNSTARCH 
CASEIN 
CORN OIL 
TOCOPHEROL STRIPPED 
CORN OIL 
MINERAL MIX 
CHOLINE CHLORIDE 
METHIONINE 
ROVDvHX A 
CELLULOSE FIBRE 
VITAMIN MIX 
SUCROSE
VITAMIN E DEFICIENT 
DIET: (g/kg)
652
100
50
35
1.34
3.0
0.024
50
8.64
100
CONTROL DIET:
(g/kg)
652
100
50
35
1.34
3.0
0.024
50
8.64
100
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6.3 Results
6.3.1 Animal Husbandry
During the study period the animals remained alert and active and in 
good health. There was one fatality amongst the rats fed the vitamin E deficient 
diet and despite brief autopsy, no obvious cause of death was evident.
6.3.2 Influence of Vitamin £  deficiency on Hepatic Cytochrome P450
The effects of vitamin E deficiency on the hepatic microsomal 
cytochromes P450 - dependent monooxygenases is shown in table 6.2.
Whilst vitamin E deficiency did not influence the levels of microsomal 
protein or the total cytochrome P450 content, an increase in the N - 
déméthylation of erythromycin (P<0.01) and a decrease in the O - 
depentylation of pentoxyresorufin (P<0.01) were observed. Immunoblot 
analysis using antibodies to CYP3A revealed no changes to the apoprotein 
levels of this protein (Figure 6.1) between control and vitamin E - deficient 
animals. The positive control responded as predicted.
No statistically significant changes were recorded to the activities of 
ethoxyresoufin - O - dealkylase, p - nitrophenol hydroxylase or lauric acid 
hydroxylase.
6.3.3 Modulation of Cytosolic Enzyme Activities by Vitamin E Deficiency
Feeding rats vitamin E deficient diets gave rise to a modest, but 
statistically significant increase in catalase activity (Table 6.3). No significant 
changes were documented for the activities of glutathione - S - transferases or 
for glutathione peroxidases. In addition glutathione reductase activity was 
unaffected by dietary deficiency in vitamin E. The activity of superoxide 
dismutase recorded a 30% increase after treatment of rats with diets deficient in 
vitamin E, however examination revealed that this was not statistically 
significant.
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Table 6.2: Cytochrome P450 Activités in Vitamin E Deficient Rats;
PARAMETER: CONTROL DIET: VITAMIN E DEFICIENT
DIET:
Liver/Body Weight Ratio (%) 4.84 ±0.29 4.37 ±0.46
Microsomal Protein 40.0 ± 12.0 35.6 ± 4.9
(mg/g Liver)
Total Cytochrome P450 0.28 ± 0.07 0.28 ± 0.04
(nmoles/mg Protein)
Ethox>Tesorufin - O - dealkylase 8.42 ± 3.40 6.24 ± 1.85
(pmoles/min/mg Protein)
Pentox>Tesomfin - O - dealkylase 1.52 ± 0.32 0.94 ± 0.10**
(pmoles/min/mg Protein)
Methoxyresorufin - O - dealkylase 8.80 ± 3.63 9.48 ± 1.79
(pmoles/min/mg Protein)
p - Nitrophenol Hydroxylase 0.48 ± 0.13 0.57 ± 0.16
(nmoles/min/mg Protein)
Erythromycin - N - demethylase 0.50 ± 0.13 0.91 ± 0.22**
(nmoles/min/mg Protein)
Lauric Acid Hdroxylase 1.17 ± 0.20 0.98 ± 0.30
(nmoles/min/mg Protein)
* 0.05 > P > 0.01; ** 0.01 > P > 0.001; *** 0.001 >P
Data Represents Mean ± Standard Deviation for Six animals in the Control
Group and Five Animals in the Vitamin E Deficient Group
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Figure 6.1: Western Blot to Show the Expression of CYP3A Apoprotein from 
Hepatic Microsomes isolated from Rats Maintained on Diets Deficient in
Vitamin E;
M  C 1  C 2  P  D 1  D 2
Immunopositive bands correspond to Apoprotein levels reactive to Anti 
CYP3A Antibodies. Each track corresponds to 40pg of Solubilised 
Microsomal Protein. Legend: M - Marker corresponds to molecular weights of 
180kd, 116kd, 84kd, 58kd, 48.5kd, 36.5kd and 26.6kd; C - Control Diet; D - 
Vitamin E Deficient Diet; P - Positive Control, Dexamethasone - treated Rat 
Liver Microsomes.
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Table 6.3: Perturbation of Cytosolic Enzymes by Vitamin E Deficiency
PARAMETER: CONTROL DIET: VITAMIN E DEFICIENT
DIET:
Cytosolic Protein 96.6 + 20.2 105.6 + 7.4
(mg/g Liver)
Glutathione - S - Transferase (DCNB) 18.4 + 1.73 18.4 ±3.5
[nmoles/min/mg Protein]
Glutathione - S - Transferase 980 ± 136 952 ± 108
(CDNB)
[nmoles/min/mg Protein]
Catalase 6.25 ±0.52 8.12 ±1.02*
(mmoles/min/mg Protein)
Selenium - Dependent Glutathione 143.1 ± 13.1 156.7 ± 10.8
Peroxidase (nmoles/min/mg Protein)
Selenium - Independent Glutathione 64.9 ± 14.0 73.3 ± 8.9
Peroxidase (nmoles/min/mg Protein)
Glutathione Reductase (nmoles/min/mg 31.7 ± 2.7 31.1 ± 3.2
Protein)
Superoxide Dismutase 23.3 ± 4.0 30.2 ± 6.3
(U/mg Protein)
Total Glutathione (mM) 3.88 ± 1.28 5.10 ± 1.10
* 0.05 > P > 0.01; ** 0.01 > P > 0.001; *** 0.001 > P
Data Presented as Mean ± Standard Deviation for Six Animals in the Control 
Group and Five Animals in the Vitamin E - Deficient Group
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6.3.4 Influence of Vitamin E Deficiency on Hepatic Peroxisomal p - Oxidation
Maintaining rats on a diet deficient in vitamin E did not alter the 
homogenate protein levels. However cyanide - insensitive palmitoyl Co A p - 
oxidation, a marker selective for peroxisomal function, indicated a modest, 
statistically significant decrease in p - oxidation activity occurred (Table 6.4).
6.4 Discussion
6.4.1 Influence of Vitamin E - Deficiency upon the Cytochrome P450 - 
Dependent Monooxygenases
Previous studies have shown that maintaining rats on a diet deficient in 
vitamin E can produce numerous modifications of both microsomal and 
cytosolic xenobiotic - metabolising enzymes (Carpenter 1972; Iwasaka et al. 
1993). However these changes appeared largely confined to male rats, female 
rats remaining insensitive to the deficiency.
The data in this study indicated that a deficiency in vitamin E can 
modulate the activities of hepatic xenobiotic - metabolising enzymes in an 
isoform - specific manner. An increase was seen in Erythromycin - N - 
demethylase, a probe for CYP3A (Wrighton et al. 1985) whereas the O - 
dealkylation of pentoxyresorufin, a probe for CYP2B (Lubet et al. 1985) was 
modestly decrease. In contrast, no changes to the activities of CYPIA and 
CYP4A were evident.
Iwasaka et al. (1993) reported that although a four month period of 
vitamin E deficiency suppressed total cytochrome P450 in male rats, female 
rats were largely unaffected. Despite the differences in strain used between the 
two studies, the data presented appeared to confirm these observations.
Examination of the Immunoblot information to assess the expression of 
apoprotein coding for CYP3A (figure 4.1) indicated that vitamin E deficiency 
did not effect the expression of CYP3 A apoprotein. TMs data appeared to
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Table 6.4: Peroxisomal P - Oxidation in the Liver of Vitamin E - Deficient
Rats:
PARAMETER; CONTROL DIET: VITAMIN E DEFICIENT 
DIET:
Homogenate Protein 
(mg/g Liver)
Cyanide Insensitive Palmitoyl 
CoA p - Oxidation 
(nmoles/min/mg Protein)
175.0 ±48.9
8.25 ± 1.0
193.2 ±15.5
5.41 ±0.76 * *
* 0.05 > P >0.01; **0.01 > P >  0.001; *** 0.001 >P
Data Represents Mean ± Standard Deviation for six Animals in the Control 
group and Five Animals in the Vitamin E - Deficient Group
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contradict the observations for the in vitro metabolism of erythromycin, used as 
a probe for the activities of CYP3A (Wrighton et al. 1985).
Interpretation of these contradictory findings would appear difficult. 
Cytochromes P450 have established different responses to the presence of an 
oxidative stress in vitro. Kitada et al. (1989) have shown that lipid peroxidation 
of microsomal membranes decreased total cytochrome P450 in a time - 
dependent manner. Also, the activities of individual cytochromes P450 
isoforms were effected differently during lipid peroxidation. The N - 
déméthylation of ethylmorphine, a probe for CYP3A (Kolars et al. 1990), was 
found to be the most sensitive to lipid peroxidation; whereas the hydroxylation 
of aniline, a probe for CYP2E, was found to be least sensitive to an in vitro 
lipid peroxidising environment.
Vitamin E is responsible for the protection of lipid materials from the 
oxidising potential of free radicals (Kappas and Diplock 1992). However the 
small quantities of a  - tocopherol present in biological membranes - one 
molecule for every 1 - 2000 molecules of polyunsaturated fatty acid (Van 
Acker et al. 1993) - would appear unable to protect microsomal membranes 
which undergo spontaneous lipid peroxidation in the presence of NADPH 
(Ekstrom and Ingelman - Sundberg 1989) without regeneration of the reduced 
form of vitamin E by ascorbic acid (Packer et al. 1979). Research appears to 
suggest that vitamin C may form an important cofactor in this regeneration of 
reduced vitamin E (Leung et al. 1981; Packer et al. 1979).
Accepting these observations, these published data would appear to 
contradict those findings presented for this study. If CYP3A were the most 
sensitive isoform of cytochrome P450, the lipid peroxidation described to result 
fi-om vitamin E deprivation (Chen and Cheung 1978; Hu et al. 1989) could, 
conceivably, decrease the in vitro déméthylation of erythromycin by 
inactivation of the CYP3A apoprotein. The apparent absence of changes to 
apoprotein concentration may represent inactivation of CYP3A rather than
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removal of apoprotein from the membrane of the endoplasmic reticulum. 
Clearly, this discrepancy remained unresolved. Additional observation 
established that NADPH cytochrome P450 reductase was unaffected by lipid 
peroxidation (Kitada et al. 1989) therefore suggesting that changes to enzyme 
activity resulted from changes to individual isoforms of cytochromes P450 
rather than to electron transfer to the cytochromes P450.
In the absence of Western blot information it was difficult to confirm 
the changes to CYP2B, as documented by decreased O - depentylation of 
pentoxyresorufin. The data would appear to suggest a decrease in the 
expression of CYP2B. Similar investigation carried out using vitamin E - 
deficient guinea pigs established no changes to the expression of apoprotein 
levels coding for CYP2B1, CYP1A2 or CYP3A4 when assessed by 
immunoblot (Mori et al. 1992). However, without in vitro enzyme activity data 
to accompany these observations, comparison of the findings remained difficult.
6.4.2 Modulation of Cytosolic Catalase Activity by Vitamin E Deficiency
Early investigations have implicated vitamin E deficiency as a possible 
caused of decreased haem synthesis in rodents. This was also accompanied by a 
decrease in the activities of numerous haem - containing enzymes, namely 
catalase, tryptophan oxidase, cytochromes P450 and cytochrome b$ (Caasi et 
al. 1972) Subsequent studies by the same authors revealed that the modulation 
of catalase activity was both strain and age dependent. Sprague Dawley rats 
maintained on a diet deficient in vitamin E exhibited a modest increase in 
catalase activity, followed by a subsequent decline below control levels. The 
data in the present study would appear to correlate with the transient increase 
in catalase activity observed in a different strain to those previously studied 
(Caasi et al. 1972).
Whether the increase in catalase activity is caused by the deficiency of 
vitamin E directly or as a result of secondary perturbation of other cellular
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fiinctions is unclear. However increasing levels of cytosolic catalase could be 
regarded as a beneficial adaptation, since cell lines expressing increased 
catalase activity showed greater resistance to oxidative damage to the DNA 
(Martins et al. 1991). However increasing the concentration of hydrogen 
peroxide did not stimulate lipid peroxidation, measured as increased 
malondialdehyde production in cultured neuronal cells (Buckman et al. 1993), 
suggesting that hydrogen peroxide is not the membrane damaging Reactive 
Oxygen Species (ROS).
Sun (1990) outlined that hydrogen peroxide is a relatively long - lived 
ROS possessing the potential to dissociate to hydroxyl free radicals (HO ) a 
very reactive, short - lived species. The membrane damaging ability of these 
hydroxyl radicals is unclear. Therefore the elevated levels of cytosolic catalase 
activity could improve the tolerance of individual hepatocytes to an oxidative 
challenge presented by hydrogen peroxide, but little protection could be 
afforded to cellular membranes, the point at which the oxidative damage 
associated with a vitamin E deficiency would occur.
The present data did not indicate the levels of catalase expression within 
the whole cell - 80% of the catalase activity is compartmentalised within 
peroxisomes, the remained 20% within the cytosolic fraction (Sun 1990). As 
cytosolic catalase activity was determined during this present investigation, no 
indication was given as to whether the increase in catalase activity was 
compartment - specific or found throughout the cell.
6.4.3 Peroxisomal P - Oxidation in Vitamin £  - Deficient Rats
Moody et al. (1991) have implicated vitamin E deficiency as just one of 
an array of dietary factors that initiate peroxisome proliferation in rodents. An 
increase in peroxisome number and size has been associated with a high 
incidence of hepatocellular carcinoma in rodents, believed to be caused by an
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imbalance in the expression of enzymes within the peroxisome, leading to 
oxidative damage to the DNA. Circumstantial evidence to support this 
hypothesis suggesting that peroxisome proliferators, a class of compounds 
known to increase the number of peroxisomes within a cell, increased the 
incidence of 8 - hydroxydeoxyguanosine adducts found in hepatic DNA 
(Tagaki et al. 1991). If such increases in peroxisome number were confirmed, 
the elevations in cytosolic catalase activity reported could be considered an 
adaptive change to compensate for the increase in hydrogen peroxide 
production.
The data presented within this study implied that a dietary deficiency in 
vitamin E decreased peroxisomal activity, as monitored by P - oxidation of 
palmitoyl CoA. This contradicts previous studies (Moodv et al. 1991). It would 
be informative to extend the present studies to investigate morphological 
changes as well as utilise techniques, in the form of Western blot for the 
trifimctional protein, in investigate these changes fiirther.
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6.5 Conclusions
The implications of the changes recorded in this study focused upon the 
potential metabolism of endogenous steroid hormones. Ryan and Levin (1990) 
reported that in female rats, the predominant species responsible for the 16a - 
hydroxylation of progesterone was CYP2B; therefore the 40% decrease in the 
activity of pentoxyresorufin - O - dealkylase following vitamin E deficiency 
would imply a reduction in endgenous steroid metabolism.
The changes observed for CYP3A, namely an increase in in vitro 
activity in the absence of increases to microsomal apoprotein levels, may be 
more difficult to interpret. However CYP3A may also have some impact upon 
steroid hydroxylations (Ryan and Levin 1990; Ziminak et al. 1991; Chang et al. 
1993).
The increase in the observed activity of catalase may be beneficial 
protecting against hydrogen peroxide - induced oxidative damage. However 
against a background of vitamin E deficiency and the greater potential for 
peroxidative damage to lipid membranes this modest increase may prove of 
little consequence to the survival of cells.
The data presented indicates that whilst dietary deficiencies in vitamin E 
can modulate the activities of xenobiotic - metabolising enzymes, the effects 
may be modest in comparison to other genetic or environmental factors. Indeed 
widely used xenobiotics are established as potent inducers of many xenobiotic - 
metabolising enzymes.
The apparent lack of effects demonstrated for both CYPIA and the 
phase II conjugation enzymes may suggest little, if any, impact for a vitamin E 
deficiency upon the metabolic activation of many procarcinogen species leading 
to the initiation of chemical carcinogenesis. Indeed the effects of vitamin E 
deficiency may have greater significance in the presence of an oxidative stress 
and for the prevention of atherosclerosis. Oxidation of LDL may be a necessary 
step in the pathogenesis of atherosclerosis (Leake 1995). Dietary
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supplementation with vitamin E has established a protective effect towards the 
oxidation of LDL (Dieber - Rotheneder et al. 1991; Rice - Evans 1995) and 
therefore deficiency in this essential vitamin may exacerbate atherosclerosis. 
This may have greater impact upon human subjects than any influence upon 
xenobiotic metabolism.
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Chapter 7
IMPACT OF CHLOROPHYLLIN ON DRUG 
METABOLISM AND MUTAGENESIS
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7.1 Introduction
Recent reviews document the potential of diet to influence both the 
incidence and the progression of spontaneous and chemically induced 
carcinogenesis (Hocman 1989; Wattenberg 1992; Rogers et al. 1993).
Lai et al. (1980) demonstrated the potential of extracts from green 
vegetables to inhibit the mutagenicity of benzo(a)pyrene and 3- 
methylcholanthrene in the Ames mutagenicity assay. A correlation was 
observed between the chlorophyll content of the extracts and the antimutagenic 
potency of each extract. Parallel activity was reported for sodium/copper 
chlorophyllin. Similar inhibitory effects were recorded by Ong et al. (1986) for 
a range of environmental and dietary mutagens treated with chlorophyllin. 
Chlorophyllin was found to be effective towards 8 of the 10 mutagens tested 
and this antimutagenic potential was heat stable.
In a separate mutagenicity system, chlorophyllin decreased the 
incidence of Drosophila wing hair spot mutations induced by treatment with 
Trp-P-2 in a dose dependant manner (Negishi et al. 1989; Negishi et al. 1994) 
giving maximal inhibitory effects at a mole ratio of 80:1 chlorophyllin to 
mutagen. The mechanism suggested for the antimutagenic potential involved 
complex formation between the Trp-P-2 (or active species) and chlorophyllin, 
thereby limiting the availability of mutagen to the organism. Affinity studies 
using different metal chlorophyllins immobilised onto sepharose supports were 
carried out using 37 different compounds. Adsorption of the compounds was 
found to be dependent upon the presence of aromatic ring structures, three or 
more fused rings producing the strongest associations. The central metal atom 
did not appear to influence the binding. Further studies have recorded that 
those compounds most strongly adhered to the chlorophyllin - sepharose 
support were most effectively inhibited from producing mutations, by 
chlorophyllin, in the Ames test (Arimoto et al. 1993).
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Investigation of the in vivo binding of carcinogens to DNA in the 
presence of chlorophyllin has revealed that administration of chlorophyllin in 
the diet produced a dose dependent decrease in the adduct formation between 
aflatoxin B | and DNA in the trout. (Dashwood et al. 1991). The highest dose 
of chlorophyllin used produced a 70% decrease in DNA-adduct formation. 
Similar investigations in the rat revealed orally administered chlorophyllin 
reduced the level of DNA - adduct formation induced by the intraperitoneal 
dosing of aflatoxin B | .
Dashwood and Liew (1992) reported that oral administration of 
chlorophyllin, in the drinking water given to rats, increased the urinary and 
faecal elimination of a bolus, oral dose of IQ. Mutagenic activity in the urine 
and faeces required the presence of an activation system to produce mutations, 
and treatment with glucuronidase and sulphatase did not increase the 
mutagenicity; the interpretation suggested that the chlorophyllin acted as an 
interceptor molecule, decreasing the bioavailability of the procarcinogen. 
Whether this was a result of enhanced elimination or decreased absorption 
remained unclear.
In vitro investigations have proposed that the decrease in DNA - adduct 
formation associated with chlorophyllin was a result of non - covalent complex 
formation between chlorophyllin and procarcinogens (Dashwood and Guo 
1992) and occurred in the molar ratio 2:1 chlorophyllin to IQ Time course 
studies have shown that the greatest inhibition in adduct formation resulted 
form simultaneous exposure to carcinogen and chlorophyllin, decreasing with 
increasing time after chlorophyllin administration (Guo and Dashwood 1994) 
implying inhibition by direct interaction in the digestive tract.
Further investigations revealed that intraperitoneal administration of 
chlorophyllins caused marked decreases in lipid peroxidation within 
microsomes and mitochondria in the presence NADPH and ascorbic acid, 
suggesting putative antioxidant properties (Sato et al. 1984). Subcellular
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fractions of liver demonstrated the presence of an absorption peak at 633nm 
(associated with chlorophyllins) in mitochondria, microsomes and cytosol.
More recently, oral administration of chlorophyllin in drinking water 
decreased the levels of nuclear damage for colonic epithelial cells, following a 
single, intraperitoneal dose of dimethylhydrazine, demonstrating the potential 
for chlorophyllin to limit the nuclear damage associated with carcinogens 
despite differing routes of administration. (Robins and Nelson 1989) 
Subsequent study, using chlorophyllin in drinking water to modify the 
tumorigenicity of dimethylhydrazine, revealed that chlorophyllin may act as a 
tumour promotor (Nelson 1992), possibly be decreasing the acute toxicity and 
the incidence of lethal mutations to colonic epithelial cells, allowing non - lethal 
mutations to persist.
Intraperitoneal administration of a single dose of chlorophyllins 
produced a dose dependant decrease in the activities of hepatic aminopyrine-N- 
demethylase and aniline-4-hydroxylase, along with a decrease in the total 
cytochrome P450 levels. This proved to be a transient change, reaching a 
maximum after 24 hours, returning to control levels after 72 hours. 
Substitution of different central metal atoms in the chlorophyllin molecule was 
of limited effect. This raises the possibility that the antimutagenic activity of 
chlorophyllin may be mediated partly by inhibition of cytochrome P450 - 
dependent bioactivation of promutagen species (Imai et al. 1986).
The potential effects of the oral administration of chlorophyllins upon 
the hepatic xenobiotic - metabolising enzymes has, as yet, remained 
unexplored. The aims of this current study were to investigate any effects of 
sodium/copper chlorophyllin upon the profile of xenobiotic - metabolising 
enzymes and to elucidate potential changes to chemical carcinogenesis that may 
be mediated through such mechanisms.
185
7.2 Materials and Methods
7.2.1 Materials
Sodium/copper chlorophyllin (commercial grade) was obtained from Sigma 
Biochemicals (Poole, Dorset, UK.). Salmonella typhimiirium strains TA98, 
TAIOO and TA1530 were generous gifts from Dr. B. Ames.
7.2.2 Methods
Fifteen male, Wistar, albino rats (200-220gm) were obtained from the 
Experimental Biology Unit, University of Surrey (Guildford, Surrey.) The rats 
were randomised and divided into groups of 5 animals and housed as outlined 
in chapter 2. The animals were allowed ad libitum access to food (LAD-1, 
Special Diet Services) and water throughout the experimental period.
Two groups of rats received daily administration of chlorophyllin at two dose 
levels (20mg/kg and lOOmg/kg body weight respectively,) in water by gavage, 
for three consecutive days. 24 hours after the final dose of chlorophyllin the 
animals were sacrificed by cervical dislocation and the livers excised and post 
mitochondrial suspensions prepared as outlined in chapter 2. Microsomal 
suspensions and cytosolic fractions were also prepared as outlined in chapter 2 
and enzymes activities were determined as described in the Methods chapter.
7.2.2.1 Investigation of the Antimutagenic Potential of sodium/copper 
Chlorophyllin by Ames Test
Ames mutagenicity assays were carried out essentially by the method of 
Maron and Ames (1983), as outlined in chapter 2.
Briefly, fresh overnight bacterial culture (0.1ml), mutagen dissolved in 
DMSO (0.1ml), activation system (0.5ml) and increasing concentrations of 
chlorophyllin were incubated in capped polyethylene tubes in a shaking water 
bath at 37°C for 20 minutes. Following incubation, an aliquot of molten top 
agar (2.0ml) was added to each tube, the tubes were vortexed and poured onto
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minimal agar plates. Incubations were carried out as outlined previously in 
chapter 2. Sodium/copper chlorophyllin stock solution (lOmg/ml) was made up 
freshly in distilled water and sterile filtered, prior to dilution with distilled water 
and use in Ames tests.
7.3 Results
7.3.1 Animal Husbandry
Throughout the study period the administration of chlorophyllin was 
well tolerated; the animals remained alert and active and no fluctuations in 
weight gain were evident (Table 7.1).
At autopsy, no gross abnormalities were recorded for any of the organs; 
however, the digestive tract contained large amounts of a dark coloured 
material believed to be unabsorbed chlorophyllin. The results indicated that no 
statistically significant changes to absolute liver weight or to liver weight as 
expressed as a percentage of body weight were recorded (Table 7.2).
7.3.2 Effects of Chlorophyllin Treatment on Hepatic Microsomal Cytochrome
P450 Activities
Investigation of the in vitro enzyme activity with respect to substrates 
selective for individual isoforms of cytochrome P450 were carried out (Table 
7.2).
Small changes to the activities of ethoxyresorufin and methoxyresorufin 
O - dealkylase were recorded for those animals receiving the lowest dose of 
chlorophyllin (20mg/kg), but these were not statistically significant. This effect 
appeared to be confined to the lowest dose group (20mg/kg) and no change 
was recorded in either of these activities for the high dose group (lOOmg/kg).
The highest dose of chlorophyllin gave rise to a slight, statistically not 
significant, decrease in total cytochrome P450.
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Table 7.1: Results to show findings at Autopsy for animals administered 
increasing Concentrations of sodium/copper Chlorophyllin (CHL):
PARAMETER: Control: Chlorophyllin: Chlorophyllin:
(20mg/kg) (lOOm^g)
Body Weight; (gm) 269.1 ± 11.9 263.8 + 11.6 262.4 ±8.5
Liver Weight: (gm) 18.9 ± 1.43 14.33 ± 1.04 13.13 ±1.75
Liver/Body Weight (%) 5.16 ± 0.36 5.43 ±0.18 4.99 ± 0.55
Microsomal protein: 31.2 ± 1.35 31.8 ±7.09 34.7 ±3.96
(mg/gm liver)
Cytosolic protein: 84.0 ±4.6 75.8 ±3.3* 86.2 ±4.6
(mg/gm liver)
Hepatic Total P450: 0.25 ± 0.05 0.26 ± 0.06 0.22 ± 0.04
(nmole/mg Protein)
* 0.05 > P > 0.01; ** 0.01 > P > 0.001; 0.001 > P
Values listed above show mean ± standard deviation for five animals from each
group.
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Table 7.2: Effects of Chlorophyllin upon Hepatic Microsomal Monooxygenase and
Glucuronide Conjugation Activités in the Rat
PARAMETER CONTROL CHLOROPHYLLIN CHLOROPHYLLIN
(20mg/kg) (lOOmg/kg)
Ethoxyresorufin - O - dealkylase 5.89 ± 1.54 4.24 ± 1.00 5.00 ± 1.39
(pmoles/min/mg protein)
Methoxyresorufin - O - dealkylase 9.14 ±1.20 7.32 ±1.82 9.78 ±1.51
(pmoles/min/mg protein)
Pentoxyresorufin - O - dealkylase 1.32 ±0.34 1.37 ±0.37 1.52 ±0.13
(pmoles/min/mg protein)
Nitrophenol Hydroxylase 0.33 ±0.09 0.41 ±0.12 0.33 ±0.07
(nmoles/min/mg protein)
Erythromycin -N  - demethylase 0.75 ± 0.09 0.91 ± 0.16 0.74 ± 0.13
(nmoles/min/mg protein)
Laurie Acid Hydroxylase 0.62 ± 0.15 0.61 ± 0.24 0.59 ±0.11
(nmoles/min/mg protein)
1 - Naphthol Glucuronide 3.04 ± 0.76 3.35 ± 1.23 3.02 ± 0.41
(nmoles/min/mg protein)
4 - methyl umbelliferone 0.28 ± 0.05 0.31 ± 0.07 0.23 ± 0.07
(lunoles/min/mg protein)
Data Represents Mean ± Standard Deviation for Five Animals
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7.3.3 Effects of Chlorophyllin on Hepatic Cytosolic Conjugases and Antioxidant
Enzymes in the Rat
The lowest dose of chlorophyllin (20mg/kg) produced a decrease of 
10% in the total cytosolic protein content (Table 7.2), this was found to be 
statistically significant (P<0.02) were assessed by student'T' test. However, no 
change was recorded to the cytosolic protein concentration for the high dose 
group (lOOmg/kg).
Chlorophyllin administration at the lower dose, significantly increased 
glutathione - S - transferase activity towards the substrate 3,4 dichloro - 
nitrobenzene, (DCNB) (P<0.001). However administration of a higher dose 
(lOOmg/kg) did not influence this activity (Table 7.3)
Administration of chlorophyllin to rats also produced a dose dependant 
decrease in the total hepatic glutathione content, however the extent was 
modest being only 10% and 30% for the low (20mg/kg) and the high dose 
(lOOmg/kg) respectively and were not found to be statistically significant. The 
activities of catalase, superoxide dismutase and glutathione peroxidases were 
unaffected by administration of chlorophyllin at both doses studied.
Examination of the data for both glucuronide and sulphate transferase 
enzymes indicated that the administration of chlorophyllin at the doses studied 
did not affect the activities of these enzymes (Figure 7.3). These differences 
were not statistically significant and may represent experimental tolerances.
7.3.4 Investigation of the Antimutagenic Potential of Chlorophyllin
7.3.4.1 Effects of Chlorophyllin on the Mutagenicity of Various Compounds
As expected, all the mutagens tested caused an increase in the number 
of histidine revertants in the strain of Salmonella typhimurium in which it was 
tested. However, over the range of concentrations tested, sodium/copper 
chlorophyllin did not cause a decrease in the mutagenicity for all the mutagens 
tested but the effect was substrate - specific.
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Table 7.3:Results to show the Effects of Sodium/copper Chlorophyllin on Individual 
enzymes within the hepatic 25%(w/v) Cytosolic Fraction:
PARAMETER: CONTROL:
Catalase: (pmoles/min/mg protein) 45.1 ±7.4
Glutathione-S-Transferase: CDNB 2049 ±201
(nmoles/min/mg protein)
Glutathione-S-Transferase: DCNB 65.6 ± 1.81
(nmoles/min/mg Protein)
Glutathione Reductase: 75.2 ±5.1
(nmoles/min/mg protein)
Total Glutathione: (mM) 6.66 ±1.81
Selenium dependent Glutathione 180.9 ± 20.4
Peroxidase: (nmoles/min/mg 
protein)
Selenium independent Glutathione 89.6 ± 15.8
Peroxidase: (nmoles/min/mg 
protein)
Superoxide Dismutase: 37.5 ± 3.8
(U/min/mg protein)
Chlorophyllin:
( 2 0 m g ik g )
46.2 ± 9.9
2039 ± 229
83.5 ±4.1 * * *
80.5 ±6.7
5.95 ±1.91
201.5 ±14.1
84.7 ± 9.2
41.5 ±1.71
Chlorophyllin:
( lO O m g ^ g )
43.5 ±7.8
1923 ± 163
66.3 ± 3.3
77.8 ±3.3
4.74 ±0.53 
186.6 ±26.9
75.9 ±7.9
38.4 ±3.8
* 0.05 > P > 0.01; ** 0.01 > P > 0.001; *** 0.001 > P
Values listed above show mean ± standard deviation for five animals in each group.
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Table 7.4: Effects of Culturing Salmonella typhimurium strain TA98 in Nutient Broth 
innoculated with Chlorophyllin (lOmg/ml) upon the Viability of the bacteria, following
incubation for 16 hours at 31°C.
PARAMETER:
Viability
(Colonies/plate)
Calculated Cell Count 
(Bacteria per millilitre of 
Culture)
CONTROL: CHLOROPHYLLIN:
(lOmg/m!)
47 ±8
4.8x lOlO
1010 ±43
1.01 X 10l2
Data Above Represents Mean ± Standard Deviation for Triplicate plates
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Incorporation of the chlorophyllin into the activation system used for 
nitrosopiperidine (Figure 7.1) and the incubation mixture used for MNNG 
(Figure 7.2) resulted in no inhibition of the mutagenicity of these compounds. 
In contrast, chlorophyllin caused a marked decrease in the mutagenicity of 2- 
AA (Figure 7.3), B(a)P (Figure 7.4), IQ (Figure 7.5), Glu-P-1 (Figure 7.6) and 
Trp-P-2 (Figure 7.7). This decrease in mutagenicity was found to be 
concentration dependent with respect to the chlorophyllin.
7.3.4.2 Effects of Culturing Salmonella typhimurium TA98 in the presence of 
Chlorophyllin on the Mutagenicity of IQ
Culturing the Salmonella typhimurium (strain TA98) in nutrient both 
innoculated with chlorophyllin (lOmg/ml) did not inhibit the growth of the 
bacteria (Table 7.4). Subsequent washing of the bacteria with nutrient broth to 
remove excess chlorophyllin yielded a bacterial suspension of green 
colouration, suggesting uptake of the chlorophyllin into the bacteria. This 
pretreatment was found to offer no protection against the mutagenicity of 
increasing concentrations of IQ (up to lOng/plate) when investigated by Ames 
test.(Figure 7.8)
7.3.4.3 The Antimutagenic Potential of Chlorophyllin towards the Putative 
Mutagenic Species derived from the Promutagen IQ
Investigation of the potential antimutagenic activity of chlorophyllin 
towards the reactive, electrophilic intermediates generated from IQ by an 
Aroclor 1254 - induced hepatic microsomal activation system was investigated 
by incubating the microsomal activation system in the presence of menadione to 
terminate microsomal metabolism; this was followed by further incubation in 
the presence of chlorophyllin. The data demonstrated that chlorophyllin 
produced a concentration dependent decrease in the mutagenicity of these 
reactive electrophilic intermediates, however this was found to be no more
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efifective as an antimutagen when tested concurrently against a microsomal 
activation system in the absence of menadione (Figure 7.9). The data did 
however demonstrate that incubation of IQ and activation system in the 
presence of menadione alone was more mutagenic than incubation in the 
absence of menadione.
7.5.4.4 Inhibition of IQ Mutagenicity by a Series of Chlorophyllin 
Concentrations
Analysis of the concentration dependent nature of the antimutagenicity 
was carried out using increasing concentrations of chlorophyllin to inhibit a 
concentration of IQ (lOng/plate) as illustrated in Figure 7.10. In order to 
achieve a 50% reduction in the mutagenicity, a molar ratio of chlorophyllin to 
IQ of about 5000 was required
7.4 Discussion
7.4.1 Modulation of Hepatic Xenobiotic - Metabolising Enzymes by 
Chlorophyllin
7.4.1.1 Hepatic Microsomal Cytochrome P450
Previous studies concerned with the effects of chlorophyllin, 
administered to rodents, on the cytochrome P450 system has focussed upon the 
modulations resulting from intraperitoneal administration of chlorophyllin. To 
date this would appear to be the first study to investigate the potential effects 
of chlorophyllin on hepatic xenobiotic - metabolising enzymes following oral 
administration which is of course more more pertinent to the human situation. 
Previous studies have revealed that intraperitoneal administration of 
chlorophyllin to rats resulted in its uptake by hepatic tissue and distribution to 
microsomes, mitochondrial and cytosolic fractions, and demonstrated a 
protective effect for chlorophyllin against lipid peroxidation in vitro. (Sato et 
^  1984). Subsequent investigations demonstrated that chlorophyllin produced
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a dose - dependent decrease in the activities of aminopyrine - N - demethylase 
and aniline - 4 - hydroxylase as well as cytochromes P450 and following 
intraperitoneal adminisration of chlorophyllin (Imai et al. 1986)
The results presented in this study report contradictory findings, despite 
utilising similar doses (lOOmg/kg), indicating that oral administration of 
chlorophyllin had no effect upon the isoforms of cytochromes P450 
investigated. Imai et al. (1986) outlined that the decreases in the activities of 
aminopyrine - N - demethylase and aniline - 4 - hydroxylase observed, resulting 
from a single dose of chlorophyllin, were transient in nature, reaching a 
minimum after 24 hours and returning to control levels after 72 hours. 
Therefore the findings presented in this report, where chlorophyllin 
administration was maintained for 72 hours, may simply confirm these 
observations. Alternatively, the effects of a single dose of chlorophyllin may be 
limited by the apparent short duration of inhibition. The enzyme activities 
recovering after removal of the chlorophyllin.
A more plausible explanation for these findings is the poor absorption 
of chlorophyllin from the gut. Subjective observation that the digestive tract 
contained a dark pigment, green in colouration would be supportive of this 
assertion that a majority of the chlorophyllin remained in the digestive tract.
Porphyrins possess an active uptake mechanism within the duodenum to 
recover iron from haemoglobin. Conrad et al. (1966) documented that of a 
bolus dose of haemoglobin administered to rats, only 0.5% was absorbed, and 
as the dose of haemoglobin was increased the degree of absorption decreased 
still further. The uptake of porphyrins also appeared to be dependent upon the 
iron status of the body, and Roberts et al. (1993) demonstrated that a 
deficiency in dietary iron caused an increase in the uptake of porphyrins by 
mucosal cells isolated form the small intestine of rats. Thus gastric intubation of 
a large dose of chlorophyllin may limit the absorption of porphyrins by 
saturating the uptake mechanism.
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7.4.1.2 Chlorophyllin induced Modulation of Glutathione - S - Transferase 
Activity
The above interpretation may also offer an explanation for the increase 
in hepatic cytosolic glutathione - S - transferase activity recorded for the low 
dose group (20mg/kg) only. A readily saturable uptake mechanism could be 
inhibited at the higher dose of chlorophyllin administered.
The form in which the chlorophyllin was absorbed may also be a source 
of conjecture. Conrad et al. (1966) reported that porphyrins absorbed from the 
gut were transported through the plasma and sequestered by the liver. However 
studies carried out using isolated epithelial cells from rat small intestine have 
indicated that porphyrins could be converted to bilirubin in vitro (Hartmann 
and Montgomery Bissell 1982). Chlorophyllin, a water soluble porphyrin 
sulphated during the process of chemical synthesis, would remain free in the 
plasma rather than associate with Low Density Lipoprotein (LDL), the putative 
transport mechanism for unconjugated porphyrins (de Smidt et al. 1993)
In light of these recorded observations the data would suggest that, at 
low doses, chlorophyllin would be absorbed and transported to the liver. The 
form in which the transport occurred, porphyrins or bilirubin, remains unclear. 
The increased activity of glutathione - S - transferase may represent a pathway 
responsible for the elimination of the absorbed chlorophyllin species.
Extrapolation of these findings to the human situation would appear 
very difficult. Estimation of the chlorophyll content of plant material suggested 
that the pigment may comprise as much as - 0.1% (w/w) for the wet weight of 
plant tissue (personnal communication. Dr. M. Clifford, University of Surrey.). 
Based upon a daily intake of some 250gm/day for green vegetables this would 
imply a daily consumption of 250mg of chlorophyll. Thus the daily human dose 
approaches 4mg/kg. Clearly there is much discrepency between this suggested 
consumption and the dosing regime utilised within the present experiments.
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Based upon the inverse correlation between dietary porphyrins and porphyrin 
uptake from the gut (Conrad et al. 1966; Roberts et al. 1993) speculation 
would support the notion for greater absorption of porphyrin products than 
was proposed for this study. The implication of this is pure conjecture but may 
provide a rationale for induction of the glutathione - S - transferase enzymes; a 
plausible conclusion would involve increased glutathione conjugation and 
elimination of electrophilic xenobiotics following metabolism by the 
cytochrome P450 dependent monooxygenases (Ketterer 1988), giving rise to a 
potential increase in detoxication.
Whilst not providing specific information upon the individual class of 
glutathione - S - transferase increased by chlorophyllin treatment, the elevated 
metabolism of DCNB in vitro has been associated with the 'mu' class of 
glutathione - S - transferase.(Ketterer 1988). It has been speculated that an 
inherited deficiency in mu class GST may increase the likelihood of bronchial 
tumours amongst smokers (Seidegard et al. 1986). Experimental evidence has 
revealed that deficiencies of mu GST amongst smokers led to an increase in 
DNA damage (Van Poppel et al. 1992) and a correlation was observed 
between increasing DNA-B(a)P adduct formation and tissues possessing the 
mu GST null genotypes (Shields et al. 1993). It remains unclear whether the 
small increase in GST activity documented for chlorophyllin treatment would 
represent any realistic protection from such DNA - damaging events.
7.4.2 Potential Antimutagenic Effects of Chlorophyllin
Chlorophyllin has demonstrated antimutagenic effects towards a variety 
of mutagens in the Ames test (Arimoto et al. 1993). The same workers have 
attempted to characterise this protective effect and have concluded that the 
inhibition was due to interaction of planar compounds with the planar 
chlorophyllin nucleus. This binding appeared limited to planar compounds with 
three or more fused rings (Arimoto et al 1993).
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The work presented in this study is largely in agreement with these 
reported observations, indicating that chlorophyllin possessed the potential to 
decrease the incidence of mutation caused by 2-AA, B(a)P, IQ, Glu-P-1 and 
Trp-P-2, which are largely planar in structure. Chlorophyllin did not however 
decrease the number of histidine revertants caused by MNNG or 
nitrosopiperidine, both of which are non planar in steric arrangement.
This antimutagenic property does not appear to be limited to 
chlorophyllin as early reports have documented similar effects for haem 
(Arimoto et al. 1980a), bilirubin and biliverdin (Arimoto et al. 1980b) and for 
haemoglobin, cytochrome C and myoglobin (Arimoto et al. 1987). These 
observations suggest the possible mechanism that the antimutagenic potential 
was not solely limited to chlorophyllin but may be a property of planar 
porphyrin and pyrrole type compounds.
Preincubation of an activation system with menadione was done to 
deplete the cofactor concentrations (figure 7.11) present in the incubation 
mixture (Floreani and Carpenedo 1990). In addition, the formation of reactive 
intermediate from the promutagen IQ, demonstrated that chlorophyllin had the 
potential to decrease the number of revertants caused by reactive electrophilic 
intermediates of IQ as well as the promutagen. This would appear to be the 
first such investigation with respect to chlorophyllin but haem, haemoglobin, 
cytochrome C and myoglobin have all decreased the mutagenicity of 
metabolically activated heterocyclic aromatic amines (Arimoto et al. 1980a; 
Arimoto et al. 1987). Coupled with the previous information outlined above 
this would appear further confirmatory evidence for the protective effects 
afforded by porphyrins and pyrrole - type compounds.
The CO - culturing of Salmonella typhimurium in nutrient broth 
containing chlorophyllin caused no inhibition of growth of bacteria (Table 7.4). 
The green colouration of the resultant bacteria implied that the chlorophyllin 
became incorporated into the bacteria. Subsequent experimentation revealed
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that incubation of the chlorophyllin - cultured bacteria with mutagen (IQ) in the 
presence of an activation system did not afford any protection form mutation 
caused by the compound. This would imply that presence of chlorophyllin 
within the bacterial cell did not offer protection to the DNA from mutation 
caused by IQ. Salmonella typhimurium strain TA98 is to be sensitive to 
frameshift mutations (Ames et al. 1975) and whilst not causing a shift in the 
reading frame of the genome, chlorophyUin was ineffective at protecting the 
DNA from adduct formation with the electrophilic intermediates produced by 
metabolic activation of IQ.
Of interest was the observation that chlorophyllin may have increased 
the growth of the bacterial cells (Table 7.4). Possible explanations appear 
limited but may relate to the crude preparation of chlorophyllin used. 
Chlorophyllins are synthesised by treating preparations of chlorophyll with 
sulphuric acid (personal communication, Prof. Pratt, University of Surrey) and 
therefore the presence of phytyl residues of sulphate contaminants in the 
chlorophyllin may enhance the growth of the bacterial.
Investigation of the molar ratio between chlorophyllin and mutagen 
necessary to decrease the incidence of histidine reversion in the Ames test has 
revealed much variation. Previous reports list that to reduce mutations by 50% 
an excess of some 40 fold is needed for chlorophyllin to be effective (Negishi et 
^  1989) whereas the stoichiometric ratio for chlorophyllin and IQ was 
determined to be 2:1 (Dashwood and Guo 1992), however in both cases a 
different activation system was employed. In this study a molar excess of some 
5000 fold was required to decrease the mutagenicity of IQ by 50%. Despite 
observations that commercial preparations of chlorophyllin as used here are 
only 14% chlorophyllin by weight (Arimoto et al. 1993), this would still imply a 
molar excess of some 700 fold. This discrepency may conceivably arise form 
the experimental procedure used - this protocol utilised a series of 
preincubations, before finally adding agar, to produce the mutations whereas
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other investigations do not. The use of a preincubation step may maximise the 
number of mutations encountered by bacterial cells and therefore increase the 
apparent concentration of chlorophyllin necessary to inhibit mutation. However 
ultimately, the variability of sources of chlorophyllin used may offer appropriate 
explanation for these findings.
7.5 Conclusions
Without doubt, chlorophyllin exhibits antimutagenic activity towards a 
variety of planar mutagens (Negishi et al. 1989; Dashwood et al. 1991) and this 
appears to be a property common to porphyrin compounds in general (Hyatsu 
et al. 19931
In vitro studies revealed that chlorophyllin has the potential to limit the 
conversion of promutagens to the mutagenic electrophilic species, by inhibiting 
cytochromes P450 and this appeared limited to effects upon cytochrome P450 
reductase rather than effects on the individual isoforms of cytochromes P450 
(Tachino et al. 1994)
Chlorophyllin has also been demonstrated to decrease the covalent 
binding of IQ to hepatic DNA in rodents (Dashwood 1992), this effect being 
time dependent, maximum inhibition arising from simultaneous administration 
of chlorophyllin and IQ. (Guo and Dashwood 1994). Moreover, chlorophyllin 
facilitates the excretion of IQ in the urine and faeces when administered in the 
drinking water. (Dashwood and Liew 1992)
The in vivo effects of chlorophyllin included the suppression aflatoxin 
- induced hepatocarcinogenesis in trout (Breinholt et al. 1995) and decrease 
dimethylhydrazine induced nuclear damage to colonic epithelial cells in rats 
(Robins and Nelson 1989); under similar conditions chlorophyllin has 
demonstrated tumour promoting potential - probably by decreasing the 
incidence of lethal mutations (Nelson 1992).
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The efficacy with which chlorophyllin may decrease the incidence of 
tumours in humans may be limited. The poor consumption of chlorophyllin (~ 
250mg/day) and the lack of any positive effects upon hepatic xenobiotic - 
metabolising enzymes outlined here, probably resulting from poor absorption of 
chlorophyllin from the diet, would leave only the binding of potential 
carcinogens to the chlorophyllin nucleus as a protective mechanism. Studies 
carried out using trout have observed that massive excesses of chlorophyllin 
(up to 100,000 fold) are required to cause significant decreases in the tumour 
incidence (Breinholt et al. 1995) Estimations of human carcinogen consumption 
derived from the cooking process involved during the preparation of food vary 
widely but may be as high as 70ng/g for broiled meat products yielding an 
average daily intake of between 0.4pg - 16pg of carcinogenic heterocyclic 
aromatic amines (Wakabayashi et al. 1992). Based upon human consumption 
figures for chlorophyll of 250mg/day and dietary derived carcinogens of 12.5|a 
g/day (Felton et al. 1992), chlorophyll appears to be in molar excess (-20,000 
fold) and therefore binding of potential carcinogens to chlorophyll may afford 
protection form the carcinogenic potential of heterocyclic aromatic amines, 
given the high molar ratio required to decrease mutations in vitro. In addition, 
given the time - dependent nature of this antimutagenic activity, both mutagen 
and chlorophyll should be consumed together to maximise protection.
Further investigation is required to ascertain whether administation of 
both chlorophyll and carcinogens at realistic doses, based upon human 
consumption data, would offer potential to modulate the incidence of chemical 
carcinogenesis significantly.
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Chapter 8
DIETARY ANTIMUTAGENS AND 
ANTICARCINOGENS: A CRITICAL APPRAISAL
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8.1 Introduction
Health care professionals have cited the benefits of a nutritionally 
balanced diet as a panacea against many ailments. The necessity of maintaining 
the correct balance of vitamins and minerals within the body is without 
question and the documentation regarding the effects of such deficiencies are 
now legion.
Over recent years the emphasis of research has switched to prophylaxis 
or prevention of many of the degenerative diseases rather than treatment of 
overt medical conditions. Doll and Peto (1981) estimated that some 30% of all 
cancers may be attributable to the adverse effects of diet. This coupled with the 
countless epidemiological investigations attesting to the beneficial effects of 
fhiit and vegetables as well as anutrients against such diseases as cancer (Ames 
1983; Hocman 1989; Ziegler 1991; Rogers et al. 1993) and heart disease 
(Hertog et al. 1995). These have led to a resurgence in analysis of components 
within the diet and their potential antimutagenic and anticarcinogenic effects 
(Wattenberg 1992).
Countless authors have cited both antimutagenic and anticarcinogenic 
effects for a variety of dietary components and whilst adding to the overall 
understanding of the subject many such assessments give little thought to any 
biological relevance to these investigations. Are the doses to which humans are 
exposed of any real significance when compared to those assessed by in vitro 
mutagenicity assays or by long term carcinogenicity assays ? Such research may 
have finally lost sight of the initial aims of cancer prevention - solvent 
extractions of any plant material may be of apparent benefit. Without appraisal 
of realistic exposure to such anutrient species the investigations risk the ridicule 
of many researchers.
This treatise seeks to assess the potential antimutagenic and 
anticarcinogenic potential of a variety of anutrient components within the diet
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whilst maintaining some regard for the levels of exposure to which humans 
receive within a normal diet.
Several classification systems have been proposed for dietary 
antimutagens and anticarcinogens, largely by chemical class (Hayatsu et al.
1988) or by the biological functionality of the chemical species (De Flora and 
Ramel 1988). However in order to limit the complexity of these classifications 
this review will adopt a classification based upon steps within the process of 
chemical carcinogenesis (Johnson et al. 1994).
8.1.1 What is Chemical Carcinogenesis ?
Chemical carcinogenesis is the process which describes the 
transformation of a quiescent, growth arrested cell possessing a normal 
phenotype to a cell possessing an abnormal phenotype with the potential for 
uncontrolled and invasive growth. This process is regarded as a multistage 
event resulting from initiation of a cell followed by a longer period of 
promotion
8.1.2 Initiation
Initiation is described as a persistent and heritable alteration to the 
genome of a cell and creates the potential for the cell, or those derived from 
subsequent divisions, to undergo malignant transformation following 
promotion. Such initiated cells are themselves not malignant.
Initiation results from the interaction of a chemically active species with 
the DNA of the genome and requires a period of cell division in order to fix the 
mutation to the host cell genome. If division does not occur the damaged 
portion of the DNA can be excised and repaired by DNA polymerase I.
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8.1.3 Promotion
Promotion is characterised by the selection and clonal proliferation of 
an initiated cell. Phenotypic differences from the parent stock, including 
incomplete control of the restraints of the host environment, characterise 
initiated cells for promotion; however these cells are not necessarily malignant 
in nature. This clonal selection results in the production of foci of autonomous 
cells which demonstrate the potential to divide, unhindered by the restrictions 
of the surrounding cells.
8.1.4 The Role of the Xenohiotic - Metabolising Enzymes
The xenohiotic - metabolising enzymes (XME) play a crucial, central 
role in the progression of chemical carcinogenesis and are principally involved 
in the initiation step. Classical interpretation of the functions of the XME infers 
that these enzymes are involved in the excretion of potential xenobiotics and 
toxicants by increasing the hydrophilic nature of these components to aid 
excretion in the urine of the bile.This process involves two distinct phases, the 
functionalisation and the conjugation of chemical species.
The cytochromes P450 are involved in the functionalisation of 
xenobiotics. They provide a class of inducible, highly substrate specific haem - 
containing enzymes which are bound to the membranes of the endoplasmic 
reticulum. They are involved in the monooxygenation of chemical species 
offering the potential to increase the reactivity of such substrates. This process 
of metabolic activation also yields the potential to produce reactive chemical 
intermediates from chemically inert compounds within the diet. These include 
the heterocyclic aromatic amines, a class of procarcinogens present in the diet 
(Sugimura 1982) derived from the temperature - dependent pyrolysis of amino 
acids and creatinine (Overvik and Gustafsson 1990). Many such initiation 
events occurring within a cell may result from this metabolic activation of 
procarcinogen species.
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The conjugation reactions result from the activity of transferase 
enzymes that combine the fimctionalised xenohiotic species with glucuronic 
acid, sulphate, acetate or glutathione to yield conjugation. Such derivatisation 
yields compounds with increased solubility in water and therefore enhancing 
the potential for elimination in the urine and the bile.
These observations infer that altering the activities of XME may offer 
the potential to modulate the progression of chemically induced tumours. 
Increasing the activities of the cytochromes P450 may be responsible for either 
increasing or decreasing the chemical reactivity of xenobiotics towards the 
DNA whereas the conjugation enzymes may enhance the elimination of 
xenobiotics and of their reactive intermediates. Both systems offer the potential 
for modification by dietary components.
Operational classification of dietary anticarcinogens led to the 
description of two classes of dietary component, the Blocking agents - involved 
in preventing or hindering the initiation process - and the suppressing agents - 
involved in the progression of initiated cells to neoplastic lesions (Wattenberg 
1985). For the simplicity of interpretation these two classes of compound will 
be discussed first.
8.2 Blocking Agents
8.2.1 Direct Blockade
Offering possibly the first mechanism of protection against chemically 
induced tumours direct blockade of carcinogen uptake involves the interaction 
of potentially mutagenic species within the diet with components of the diet to 
hinder or inhibit their uptake.
Potentially the simplest demonstration of this effect resulted from 
supplementation of rodent diets with increasing concentrations of wheat bran 
fibre, producing a decrease in the incidence and multiplicity of carcinogen - 
induced intestinal tumours (Reddy and Mori 1981; Wilson et al. 1977; Reddy et
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^  1981a). The observed potential for vegetable fibres to decrease the 
mutagenicity of heterocyclic aromatic amines in vitro (Kada et al. 1984) and 
coupled with the demonstration of direct binding of food mutagens IQ, MelQ 
and MelQx to dietary fibre m vitro (Sjodin et al. 1985; Ryden and Robertson 
1995) led to the elucidation of the putative mechanism by which fibre may 
influence carcinogen uptake and, ultimately, chemical carcinogenesis.
However the typical diets utilised within these studies record fibre 
contents of some 20%(w/w) (Reddy and Mori 1981). Human fibre 
consumption has been estimated at 10-14gm/day (Bingham 1990) which, when 
assessed with regard to food intake of some 2.0kg/day (personal 
communication N. Gilbert, University of Surrey), translates into a human fibre 
intake of less that 1.0%(w/w). Of increasing interest was the assertion that 
replacement of the diet with increased fibre constitutes calorie restriction 
which, even at modest levels, has been documented to decrease the incidence 
of tumours at least in rodents (Kritchevsky 1990; Fu et al. 1994). Whether the 
anticarcinogenic effect is caused by direct binding of the precarcinogenic 
species to the fibres and/or by the modulation of XME by the modest calorie 
restriction (Wall et al. 1992; Chou et al. 1993a) remains unclear.
Porphyrin compounds such as haem, myoglobin and chlorophyllin have 
been reported to decrease the mutagenicity of a variety of environmental 
contaminants (Ong et al. 1986) and mutagenic species (Arimoto et al. 1980a; 
Arimoto et al. 1980b; Arimoto et al. 1987; Hayatsu et al. 1993) in both Ames 
test and Drosophila genotoxicity tests (Negishi et al. 1994), potentially by a 
mechanism involving binding and complex formation between planar 
carcinogens and chlorophyll (Arimoto et al. 1993; Tachino et al. 1994). This 
also led to a decrease in the levels of observed DNA adducts formed between 
mutagens and hepatic DNA in vivo in rats (Dashwood 1992) and a reduction in 
the tumour incidence of Aflatoxin B \ recorded for trout (Breinholt et al. 1995)
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as well as a decrease in the dimethylhydrazine - induced nuclear damage 
observed for colonic epithelial cells (Robins and Nelson 1989).
The poor intestinal absorption of the porphyrins (Conrad et al. 1966; 
Roberts et al. 1993) would suggest that the effect was localised primarily 
within the GI tract. However the ratio of porphyrin molecules to carcinogen 
molecules may be of consummate importance. Research from this laboratory 
implied that a molar ratio of 5000:1 of chlorophyll to mutagen was needed in 
order to decrease the mutagenicity of IQ, in the Ames test, by 50% whereas a 
40 fold molar excess has also been proposed (Negishi et al. 1989). Cooked 
food mutagens, the heterocyclic aromatic amines, derived from the pyrolysis of 
amino acids may be present at concentrations approaching 80ng/g for 
individual compounds from meat products (Felton and Knize 1991; 
Wakabayashi et al. 1992; Skog et al. 1995) suggesting a tentative overall 
human consumption of carcinogen species approaching 12.5pg /day (Felton et 
al 1992). Assessment of chlorophyll intake is difficult due to the plant species 
and seasonal variations but based upon a content of 0.1%(w/w), intake of 
chlorophyll may be estimated at 250mg/day (personal communication Dr. M. 
Clifford, University of Surrey). This data would infer a molar excess of 20,000 
times with respect to the chlorophyll content. However this calculation takes 
into consideration the consumption of only one mutagenic species. This 
assessment was also based upon the premise that both chlorophyll and 
mutagenic species were consumed together.
Similar effects have been observed for a variety of the plant phenolic 
compounds in response to a host of carcinogen treatments. Amongst some of 
the most potent protective agents have been tannic acid (Mukhtar et al. 1988; 
Hirose et al. 1991), extracts of green tea (Kahn et al. 1988; Wang et al. 1989; 
Katiyar et al. 1993) and a variety of hydroxylated cinnamic acids (Huang et al. 
1988; Tanaka et al. 1993; Asanoma et al. 1994) towards carcinogen induced 
skin tumours: even extracts of the herb rosemary have afforded protection from
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skin tumours (Huang et al. 1994). There appeared much corroboration between 
the findings of all these studies demonstrating that a protective effect against 
initiation of skin tumours was only observed if the compounds were 
administered immediately or very shortly before application of the carcinogen; 
suggesting a critical short period of effect; and also a vast excess of putative 
antimutagen was required, typically two or three orders of magnitude greater. 
It is conceivable that many such antimutagenic and anticarcinogenic 
compounds may only be effective by providing a physical barrier to prevent 
initiation from occurring. Hartman and Hartman (1993) highlight that such 
hinderance of potential carcinogens may, in quantitative terms, be the most 
effective method of anti - initiation, rather than relying on steric or chemical 
properties of putative anticarcinogens.
Phenolic compounds (Ping et al. 1994) and antioxidants have also 
displayed the potential to inhibit the formation of nitrosamines from dietary 
amines and nitrite in situ (Astill and Mulligan 1977) and a negative correlation 
has been established between vitamin C intake on the one hand and the 
incidence of certain cancers and nitrosamine formation on the other (Mirvish et 
al 1994; Xu et al. 1993). Experimental studies revealed that vitamin C (Licht 
et al. 1988a) tomato phenolic compounds (Helser and Hotchkiss 1994) and 
caffeic and ferulic acids (Kuenzig et al. 1984) could inhibit nitrosamine 
formation in the stomach. Kinetic studies have demonstrated that the 
stoichiometry of the reaction is not fixed but leads to the destruction of 
ascorbate (Licht et al. 1988b). Quantitation of such reactions remained 
difficult, but, the inhibition of nitrosamine formation was found to be 
principally dictated by the initial concentrations of ascorbate. Given that human 
nitrosamine production, measured as excreted N - nitrosoproline, approaches 3 
pg/day (Xu et al. 1993) and that 75mg of vitamin C significantly decreased N - 
nitrosoproline synthesis (-63%), intake of a diet high in fruit and vegetables, 
rich sources of vitamin C, may indeed offer prophylactic protection from
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nitrosamine - induced cancers; however dietary intake of vitamin C may be 
subject to seasonal variations (Vanderslice and Higgs 1991). Whether the 
polyphenolic compounds prove as effective is as yet unresolved.
Clearly the initial point of exposure to carcinogens within the diet does 
offer the greatest potential for protection from genotoxic events and current 
research documents many potential protective agents already present in the 
daily diet. For most, the timing of exposure to both carcinogenic species and 
anticarcinogen appears critical, maximum inhibitory effect afforded following 
simultaneous exposure. In essence, current dietary habits in themselves do 
appear to offer maximum protection from genotoxic events and, given the 
abundance of plant fibres, phenols and antioxidants present in the diet, 
maximum protection may already have been achieved without the need for 
prophylaxis.
8.2.2 Phase I Xenohiotic Metabolising Enzymes
The cytochromes P450 are the principal enzyme system responsible for 
metabolic activation of a variety of carcinogens, including the polycyclic 
aromatic hydrocarbons and the heterocyclic aromatic amines, both dietary 
contaminants respectively. Typically these compounds undergo epoxidation or 
N - hydroxylation to yield highly reactive electrophilic intermediate compounds 
which possess the ability to react with cellular macromolecules including 
proteins, RNA and DNA inducing genotoxicity and other forms of toxicity.
Therefore the cytochromes P450 offer a putative site for modification 
by dietary constituents. Indeed proteins, fats, carbohydrates and vitamins have 
the potential to modulate enzyme expression (Parke and loannides 1981). 
However, the most potent modulations of the profile of cytochromes P450 
monooxygenases has been attributed to anutrient components of the diet. This 
is typically characterised by ethanol, causing induction of CYP2E1 (French et 
al 1993; Park et al. 1993), or by such products as garlic and the sulphur
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compounds contained therein which have been reported to decrease tumour 
incidence (Takahashi et al. 1992) by inhibiting CYP2E1 activity and decreasing 
the levels of DNA adducts formed following treatment of rats with DMBA 
(Amagase and Milner 1993).
The most widely studied groups of compounds included the plant 
polyphenolics and the glucobrassicins derived from green vegetables. Several 
studies have documented the behaviour of flavone to induce the cytochromes 
P450 in vivo - this was characterised by increases in ethoxyresorufin, 
pentoxyresorufin and methoxyresorufin - O - dealkylases (Brouard et al. 1988; 
Siess et al. 1989a; Siess et al. 1992). In contrast, flavanone was found to be 
ineffective at modulating the cytochromes P450 (Brouard et al. 1988; Trela and 
Carlson 1987; Siess et al. 1989a).
The flavanoids, structurally related compounds; were far less effective 
at modulating the in vivo cytochrome P450 activities although they exhibited 
profound antimutagenic activity in vitro (Francis et al. 1989), only quercetin 
and catechin enhanced the activity of aminopyrine - N - demethylase in rats. 
Supplementation of diets with caffeic and chlorogenic acids or turmeric, a rich 
source of curcumin, had little effect upon the cytochromes P450 
monooxygenases in vivo (Kitts and Wijewickreme 1994).
These observations appear to contradict those conclusions, drawn from 
in vitro investigations, which outline that flavones and flavanols have the 
potential to inhibit the activities of ethoxyresorufin and pentoxyresrufin - O - 
dealkylases (Siess et al. 1989b; Vemet and Siess 1986) probes for CYPlAl 
and CYP2B respectively and that the flavanoids possess potent antimutagenic 
properties when assessed by Ames mutagenicity assay (Steele et al. 1985; 
Kanazawa et al. 1995: Samejima et al. 1995).
The most plausible interpretation of these findings arises from 
pharmacokinetic considerations of flavanoid and polyphenol metabolism. Many 
authors observed that flavanoids require metabolism by the gut flora to yield
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the breakdown products dihydroxyphenylacetic acid, hydroxyphenylacetic acid 
and homovanillic acid (Booth et al. 1956; Das 1969). Das and Sothy (1971) 
noted some metabolism of quercetin in rats, but only after intravenous 
injection, urinary excretion reaching a maximum within 90 minutes. Griffiths 
(1982) reported that of a dose of catechin only some 2-3% may be absorbed in 
an unchanged form, and consequently it is doubtful whether tissue 
concentrations would reach levels sufficient to achieve antimutagenicity. Given 
that the IC50 for catechin towards 4 - aminobiphenyl induced mutagenicity was 
achieved at lOOmM (Steele et al. 1985) and that only 3% of a single dose 
appears to be absorbed (Griffiths 1982) the human consumption would need to 
be in the order of kilograms to achieve such plasma concentration.
Dietary consumption of mixed flavanoids is believed to approach 
l.Og/day (Middleton 1984) inferring that perhaps only 20-3Omg may actually 
be absorbed, far short of the doses documented to inhibit chemically - induced 
mutation in vitro or modulate the expression of cytochromes P450 in vivo.
Similar conclusions could be drawn for ellagic acid, a dietary 
polyphenol that has received much attention. In vitro investigations showed 
that ellagic acid decreased the mutagenicity and DNA binding of aflatoxin Bj 
(Mandel et al. 1987) and benzo(a)pyrene in vivo (Smart et al. 1986a) and could 
inhibit the in vitro activities of constitutively expressed cytochrome P450 
isoforms CYP2A2, 3A1 2C11, 2B1, 2B2 and CYP2C6 (Zhang et_d. 1993a). 
Both chronic and acute administration of ellagic acid decreased total hepatic 
cytochrome P450, aryl hydrocarbon hydroxylase and ethoxcoumarin - O - 
dealkylase activities in vivo (Das et al. 1985). However, despite feeding a diet 
containing l%(w/w) ellagic acid for seven days no ellagic acid was detected in 
the blood, hepatic or pulmonary tissues (Smart et al. 1986b). It seems 
inconceivable that a compound demonstrating such poor pharmacokinetic 
characteristics may produce such marked effects upon enzyme activity and 
chemical carcinogenesis (Aryton et al. 1992) and, surprisingly, reports still
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document the inhibitory properties of ellagic acid towards CYPlAl without 
altering the levels of CYPlAl apoprotein or mRNA in vivo (Barch et al.
1994).
Similar observations were made for the phenylethyl isothiocyanates 
derived from watercress; in vitro studies demonstrated the potential of these 
compounds to inhibit the activity of CYP2D6; but, in contrast, in vivo studies 
in humans revealed no such inhibitory potential (Caporaso et al. 1994).
Consumption of brassica vegetables has also been associated with 
modulation of XME (Pantuck et al. 1976; Bradfield et al. 1985; M^Danell et al.
1989) in both liver and intestine enzymes. The principal candidate responsible 
for these changes, indole - 3 - carbinol, has anticarcinogenic properties as 
evidenced by its ability to decrease the level of NNK induced tumours in mice 
(Morse et al. 1990) purportedly by preventing carcinogen binding to the DNA 
in lung tissue. Similar findings were recorded for aflatoxin B% metabolism by 
hepatic microsomes in vitro (Whitty and Bjeldanes 1987; Fong et al. 1990).
Interpretation of these observations requires a degree of caution since 
diets utilising plant materials from cabbage, broccoli and sprouts typically made 
to 25%(w/w) of the diet which may constitute some degree of calorie 
restriction which has itself been documented to modulate XME alone (Leakey
et al 1989; Manjgaladze et al 1993). Furthermore, much of the
chemopreventive response of the dietary indoles has been, at least initially, 
attributed to the induction of the CYPlAl and CYP1A2 isoforms of 
cytochromes P450. Both cytochrome P450 isoforms have been closely linked 
to the metabolic activation of many carcinogens - including the polycyclic 
aromatic hydrocarbons like B[a]P for CYPlAl (Borlakoglu et al. 1993) and 
the heterocyclic aromatic amines like IQ or Glu-P-1 for CYP1A2 (Aryton et al
1990). Therefore increasing the expression of CYPIA isoforms may be viewed 
as being detrimental to the host organism, affording the potential for increased 
metabolic activation and possibly enhanced initiation. A potential mechanism to
220
resolve this apparent discrepancy may focus on the continuous presence of 
indoles within the diet - providing alternative substrates for the CYPIA 
isoforms of cytochromes P450 and competing with the carcinogenic species.
Human consumption patterns for hrassica do not mirror those used in 
experimental protocols, humans adopting a sporadic pattern of food intake; 
also eating up to 500gm of brassica each day (25%(w/w) of total food intake) 
may test the compliance of any individual. Prophylactic prescription of purified 
indoles may offer an alternative, however even moderate consumption of green 
vegetables (-200gm/day) could provide approximately 40mg of glucobrassicins 
(Heaney and Fenwick 1980; Lewis and Fenwick 1987) and daily human 
consumption of glucosinolates has been estimated at 300mg/day (Sones et al. 
1984). This suggests a average human dose of approximately 5mg/kg or up to 
ISOppm in the diet. Bradfield and Bjeldanes (1984) detailed a No Observable 
Effect Level' (NOEL) of between 16-25ppm for the intestinal mucosa thereby 
implying that present human consumption may itself be sufficient to offer 
chemopreventive effect. It may be pertinent to point out that recent reports 
have outlined that induction of CYPIA by indole - 3 - carbinol may be a 
transient phenomenon upon continuous feeding (Takahashi et al. 1995a) and, 
therefore, any potential "benefits" afforded by induction of CYPIA may indeed 
be short - lived.
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8.2.3 Phase H Conjugation Enzymes
Phase II conjugation reactions increase the hydrophilic nature of 
xenobiotics to aid their elimination from the cell and in many cases, follows 
after a functionalisation step carried out primarily by cytochromes P450; indeed 
the hypothesis has been proposed that the glutathione - S - transferases (GST) 
may have evolved to exploit the ability of cytochromes P450 to produce 
reactive electrophilic intermediates which react with the nucleophile glutathione 
(Ketterer 1988).
The phase II transferase enzymes include glutathione, glucuronosyl and 
sulphate transferases; a number of studies have demonstrated that these 
enzymes can be influenced by macronutrient components of the diet, examples 
including glucuronosyl transferase which can be modulated by dietary 
carbohydrate levels (Sonawane et al. 1983) and by dietary fat (Yoo et al. 1991;
1992). Deficiency of these enzymes has been associated with changes in the 
ability of organisms to combat xenohiotic - induced damage - human smokers 
expressing GST null genotypes are more susceptible cytogenetic damage (Van 
Poppel et al. 1992) and, moreover, exhibit an increased risk of lung cancer 
(Kihara et al. 1994; Shields et al. 1993). Cell lines deficient in glucuronosyl 
transferase expression demonstrated increased micronucleus formation 
following B[a]P treatment (Vienneau et al. 19951.
Both drugs (Aniya et al. 1993) and phenolic antioxidants (Kashfi et al.
1994) increase the expression of glucuronosyl transferase enzymes in vivo. 
Similarly, a variety of dietary anutrients including the terpenes limonene and 
sobrerol (Elegbede et al. 1993), indole - 3 - carbinol (Shertzer and Sainsbury 
1991a) and water extracts of green tea (Kahn et al. 1992; Bu Abbas et al.
1995) also modulate this activity.
Of particular interest was the observation that a variety of 
organosulphur compounds, lowered the colonic tumour incidence caused by 
azoxymethane which may be related to their ability to increase the glucuronosyl
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transferase activities of liver and colonic mucosa (Reddy et al. 1993). The most 
effective compounds are diallyl sulphide and anethole trithione, both found in 
onion and garlic products. The dose administered in the diet, 2000ppm, would 
correspond to a human intake of some 400mg/day - well in excess of the 
recorded daily consumption of humans.
Glutathione - S - transferase enzymes provide the most widely studied 
class of enzymes to be perturbed by dietary anutrient compounds (Spamins et 
^  1982). Inducers include, phthalides from celery seed oils (Zheng et al.
1993), myrisiticin from parsley seed oil (Zheng et al. 1992), organosulphur 
compounds from garlic and onions (Spamins et al. 1988) and even ellagic acid 
(Barch et al. 1995) despite the poor absorption discussed previously.
The compounds most consistently associated with induction of GST 
have been the indoles, principally indole - 3 - carbinol, isolated from the 
brassica vegetables. Administration of diets containing either vegetable 
materials or purified indole - 3 - carbinol induced GST activity (Spamins et al. 
1982; Wortelboer et al. 1992; Bradfield and Bjeldanes 1984). Closer scmtiny 
has revealed that dietary indole - 3 - carbinol induces a particular subunit Yc2 
which possesses high activity towards aflatoxin B% 8,9 - epoxide, the active 
form of the mycotoxin, indicating a putative pathway for protection form 
aflatoxin induced tumours in rats (Stresser et al. 1994).
Whether dietary indole - 3 - carbinol may offer chemoprotective effects 
in humans by elevating in GST activity is as yet unclear. Exposure of rodents to 
diets containing 250ppm indole - 3 - carbinol resulted in only modest induction 
of hepatic GST, and actually decreased the activity in the intestine (Bradfields 
and Bjeldanes 1984). Dietary levels of 125ppm were ineffective at modulating 
GST activity. Bearing in mind that human intake of indole - 3 - carbinol 
approaches 300mg/day (Sones et al. 1984) this dose of 5mg/kg or 150ppm may 
be inadequate for the purposes of inducing GST activity. More promising 
results, however, from dietary intervention studies in humans documented that
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consumption of brussel sprouts (300gms/day) significantly elevated the plasma 
activities of GST class a  in males, whereas the plasma levels of GST class 7C 
remained unchanged (Nijhoff et al. 1995).
The demonstration that such a diversity of chemical compounds can 
induce the Phase II XME and tissue glutathione concentrations has led to the 
proposal of a working hypothesis to suggest a common controlling mechanism. 
Deemed the "Electrophilic Counterattack' (Prestera et al. 1993) the authors 
propose that small doses of electrophilic species to the host tissue or animals 
induces a response through the Electrophilic Responsive Element of the 
genome, largely independent of any effects towards the cytochrome P450 - 
dependent monooxygenases, causing induction of a host of enzymes - 
predominantly the Phase II conjugation enzymes. This hypothesis was given 
credence with the discovery of similar consensus sequences found at the 
upstream regions of various genes, including glutathione - S - transferase and 
quinone reductase.
8.2.4 Cellular Defence against Free Radical Damage and Oxidant Stress
8.2.4.1 The Antioxidant Enzymes
Little evidence exists to suggest that dietary components can modulate 
the activity of the cellular antioxidant enzymes; however it is well established 
that disease states such as diabetes can induce a state of oxidant stress which 
can lead to premature ageing of cellular structures and an increase in the levels 
of oxidative damage to lipids, measured as an increase in the levels of 
malondialdehyde (Mukheijee et al. 1994; Jones and Hothersall 1993).
Chronic calorie restriction has the potential to prevent or reverse many 
of the age - related decreases in glutathione levels, glutathione - S - transferase 
and glutathione peroxidase activities (Laganiere and Yu 1989) as well as the 
activities of catalase and superoxide dismutase (Xia et al. 1995). Dietary 
deficiencies of vitamin E have been shown to decrease glutathione peroxidase
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activity in trout but increase the concentration of glutathione in rat hepatic 
tissue (Williams et al. 1992).
Reddy and Lokesh (1994) have described the ability of turmeric in the 
diet (1% (w/w)) to increase the hepatic activities of catalase, superoxide 
dismutase and glutathione peroxidase. However, basing these figures upon 
human food consumption an intake of up to 20gm/day turmeric is required, 
clearly unrealistic vrith regard to palatability. Studies have also demonstrated 
the potential of dietary indoles, including indole - 3 - carbinol to decrease the 
activities of glutathione peroxidase in hepatic tissue, but these changes were 
modest and may be of little toxicological significance.
Investigation of the chemopreventive potential of green tea fractions 
have revealed that green tea enhanced the activities of glutathione peroxidase 
and catalase in the small intestine, liver and lung (Kahn et al. 1992). These 
findings were contradicted by Bu Abbas et al. (1995) whom noted no changes 
in the activities of catalase, glutathione peroxidase or superoxide dismutase for 
in the liver following administration of aqueous green tea extracts, rather than 
green tea fractions, to rats. It may be of interest to speculate that the 
mutagenicity of tea fractions, in the absence of an activation system, towards 
Salmonella typhmurium strain TA104 reported by Alejandre - Duran et al. 
(1987) may offer some explanation for the potential increase in oxidant defence 
enzymes recorded by Kahn et al. (1992). The presence of a free radical 
challenge , present in the tea, may induce enzymes involved in the removal of 
that challenge. This in vitro mutagenicity was abolished in the presence of 
catalase and was presumably due to the presence of hydrogen peroxide.
S.2.4.2 Dietary Antioxidants
Endogenous antioxidant molecules are principally involved in the 
defence against oxidation by free radicals generated in the course of normal 
metabolism. These antioxidants include vitamin C, vitamin E and glutathione.
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Vitamin E is largely confined to lipid membranes where it protects the 
phospholipids from oxidative damage (Collins et al. 1994). The proportion of 
vitamin E present is very small; possibly only one molecule per 1-2000 
molecules of phospholipid and may be regenerated to the reduced state by 
vitamin C (Leung et al. 1981). This reaction yields the quinone of ascorbic acid 
which can itself be regenerated utilising glutathione.
Much research has been undertaken to evaluate the chemopreventive 
effects of dietary antioxidants, recently reviewed by Weisberger (1991) and 
many such candidates have been proposed as dietary antioxidants. These have 
included the flavanoids (Morel et al. 1993; Shimoi et al. 1994; Robak and 
Gryglewski 1988), the plant polyphenols caffeic acid, chlorogenic acid and 
ferulic acid (Alldrick et al. 1986; Nakayama 1994; Sharma 1976), theaflavins 
and thearubigins found in black tea (Yoshino et al. 1994) and even extracts of 
the herb sage (Cuvelier et al. 1994). Great care must be exercised in 
extrapolating these data to humans. For example, caffeic acid decreased lipid 
peroxidation in vitro by 50% at a concentration of 1.03 ^ M (Sharma 1976) and, 
given that foods such as celery may contain up to 90mg/100g caffeic acid 
(Rapporter 1993), in order to achieve plasma concentrations approaching l.Op 
M only lOgm of celery need be consumed; this does however assume that all 
the caffeic acid was absorbed and that there were no losses fi'om the system. Of 
potential interest was the proposition that an active intestinal uptake 
mechanism may exist for such compounds as caffeic and ferulic acids, which is 
dependent upon sodium ions (Wolfifram et al. 1995). The observation that there 
were remarkably few inhibitors of this uptake may further complement a 
genuine protective effect proposed for such compounds as the cinnamates but 
caffeic acid itself has been implicated in the promotion of chemically - induced 
stomach cancer (Hirose et al. 1992; Hirose et al. 1990) and, in the presence of 
divalent ions, initiated free radical damage of cellular and isolated DNA in vitro 
(Inoue et al. 1992). It may infer that at high concentrations phenolic
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antioxidants may induce a pro - oxidant state. DNA damage was shown to be 
maximal at 50|iM and whilst consumption of 500gm of celery per day is indeed 
unlikely the wide variety of foods containing high levels of caffeic acid 
(Rapporter 1993) may indeed generate some concern.
Similar free radical - mediated damage has been observed in the case of 
quercetin and may be of potential concern if consumed at high concentrations 
(Ahmed et al. 1994). This hypothesis is, however, simplistic since no account is 
made for bacterial metabolism which undoubtedly may govern much of the 
absorption of quercetin from the GI tract, but it does demonstrate that great 
care should be exercised before making sweeping statements regarding 
potential changes to the diet.
Of the remaining dietary antioxidants, vitamin C or ascorbate has 
proved the most extensively studied (Block 1991). In rodent studies, 
supplementation of diets with ascorbate has afforded protection from radiation 
induced chromosomal aberrations (El - Nahas et al. 1993), from spontaneous 
and UV light - induced skin tumours in mice (Pauling 1991) and protection 
against oxidative injury in isolated hepatocyte cultures (Maellano et al. 1994). 
Human dietary intervention studies demonstrated that supplementing vitamin 
C, to increase plasma ascorbate levels protects LDL from oxidative damage, a 
critical step in the induction of atherosclerosis (Rice Evans 1995). Ascorbate 
has also been described as a potent inhibitor of free radical induced damage by 
a whole range of free radicals including superoxide anions, hydrogen peroxide 
and singlet oxygen atoms (Rice Evans 1995).
Tissue concentrations of ascorbate range between 1-1.5mM in guinea 
pigs (Woolley et al. 1987) and supplementation of the dietary intake with -  
200mg/kg effectively doubled the tissue concentrations. Of particular interest 
was the observation that ascorbate, in the presence of divalent ions enhanced 
chromosomal damage (Stich et al. 1979; Norkus and Kuenzig 1985; Norkus et 
al 1983) by Fenton type reaction. This effect was evident at ascorbate
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concentrations above 0.5mM, therefore direct extrapolation would imply that 
ascorbate supplementation may conceivably prove detrimental. Whether such 
reactions represent a realistic hazard in vivo is, as yet, unconfirmed; however, 
human intervention experiments using small doses of ascorbate (-l.Og/day) 
have demonstrated a slight, beneficial decrease in the levels of gastric mucosal 
DNA damage resulting from atrophic gastritis (Dyke et al. 1994). Ascorbate 
also possesses antimutagenic properties towards alkylating agents in vivo but 
the doses employed may well be considered unrealistic for human prophylaxis ( 
-0.5g/kg = 35g/day) (Aidoo et al. 1994).
8.3 Bacterial Microflora of the Digestive Tract
The gut microfiora may offer a further target for blockade by dietary 
anutrients. The realisation that bacteria within the lumen of the gut express 
enzymes capable of metabolising xenobiotics (Mallet and Rowland 1990), and 
the observation that bacterial metabolism may be of primary importance in the 
degradation of polyphenolics (Bravo et al. 1994) may have implications for 
chemical carcinogenesis.
Gut bacteria are known to modify faecal steroids (Kay 1981) and to 
enhance this tumour promoting potential (Cohen and Raicht 1981). The 
presence of intestinal microfiora has also been associated with potentiation of 
chemically induced tumours (Reddy and Ohmori 1981). Furthermore, they have 
a role to play in the formation of DNA- and haemoglobin - carcinogen adducts 
(Scheepers et al. 1994).
The bacterial expression of P glucuronidase was believed to result in the 
cleavage of glucuronide conjugates and release of the active, non - conjugated 
mutagenic species thus facilitating reabsorption.
Thus far, few compounds have been shown to alter the level of faecal p 
- glucuronidase activity but amongst the most successful is dietary fibre (Bauer 
et al. 1981). Thes authors demonstrated that low intakes of differing sources of
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recorded human intake (Bingham 1990), the potential for modulation cannot be 
ruled out.
8.4 Suppressing Agents
Thus far the discussion of this treatise has focussed upon the agents 
within the diet that may block the initiation event of chemical carcinogenesis. 
By definition the instantaneous nature of this protection does indeed generate 
several problems; for blockade to become an effective mechanism against 
chemical carcinogenesis the continuous presence of a variety of blocking agents 
is essential in order to prevent a single event, which is essentially non - 
predictable. However suppressing agents offer the benefit of long duration; by 
definition suppressing agents act by inhibiting tumour promotion and are 
effective for extended periods following initiation (Johnson et al. 1994) 
consequently suppressing agents may offer a more realistic approach to 
chemoprevention allowing for a greater time scale over which to act effectively.
8.4.1 Inhibition of Cell Proliferation
Bearing in mind that a period of cell division may be required to fix 
mutations to the genome (Soit and Farber 1976) and that promotion results 
fi'om a sustained period of proliferation, chemicals that can prevent or hinder 
this proliferation may prove possible candidates for suppressing agents. Indeed, 
many dietary components can inhibit the promotion phase of chemical 
carcinogenesis, including retinyl acetate (Moon et al. 1977), p carotene 
(Temple and Basu 1987), plant polyphenols, green tea (Katiyar et al. 1993a) 
and the licorice derivative glycyrrhetinic acid (Wang et al. 1991); even 
quercetin has the potential to arrest the division of leukaemia cells late in the 
Gj phase of the cell cycle ( Yoshida et al. 1992).
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8.4.2 The influence of Suppressing Agents Upon Ornithine Decarboxylase 
Activity and Polyamine Synthesis
Increases in the activity of ornithine decarboxylase (GDC) have been 
implicated in the proliferation of cells leading to tumorigenesis (Rao et al. 
1993a). A series of organosulphur tumour promoting agents have all increased 
the activity of tissue ornithine decarboxylase (Takada et al. 1994).
Dietary macronutrients may also provide another source of tumour 
promotors. Modulation of the dietary fat intake has also been noted to alter the 
in vivo activity of ornithine decarbxylases. High com oil diets increasing the 
activity of GDC in the liver and colon compared to diets high in olive and fish 
oils (Rao and Reddy 1993).
Early investigations revealed the ability of tannic acid to modulate the 
promotional effects of TP A on ornithine decarboxylase activity. Tannic acid 
significantly reduced the activity of epidermal GDC, the effect being time- 
dependent and required a molar excess of tannic acid of about 2400 times, 
suggesting a direct barrier between TPA and the epidermis (Gali et al. 1991). 
Similar findings have been recorded for epigallocatechin gallate towards 
MNNG - induced changes in GDC activity in the stomach mucosa (Yamane et 
^  1995). These are difficult to rationalise for a compound with such poor 
absorption characteristics (personal communication E. Copeland, University of 
Surrey), unless EGCG behaved as a blocking agent, decreasing the uptake of 
MNNG form the stomach.
In vitro (Liu et al. 1993) and in vivo (Rao et al. 1993b) investigations 
have described the inhibitory effects of the plant polyphenolic curcumin 
towards GDC activity, but very high dietary concentrations were used, 
unrealistic for human consumption.
Further investigations with polyphenols have established the inhibitory 
effect of caffeic acid esters, derived form honey, towards tissue GDC activity in 
vitro (Rao et al. 1993a). The esters methyl caffeate and phenylethyl caffeate, at
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concentrations of 5-600ppm in the diet, suppressed ODC and tyrosine protein 
kinase activities in the liver and colon, and at the equivalent human intake of 
approximately l.Og/day may indeed offer a realistic prospect for 
chemoprevention in humans.
Possibly the most promising inhibitors of cellular proliferation, as a 
consequence of inhibition of ODC activity, may be the carotenoids. At 500ppm 
in a diet, P - carotene decreased the synthesis of polyamines and the labelling 
index of oral mucosal cells following administration of 4 - nitroquinoline - 1 - 
oxide (Tanaka et al. 1994). Furthermore, P - carotene supplementation 
(30mg/day) in human subjects with chronic atrophic gastritis decreased the 
ODC activity in gastric mucosal biopsy samples (Bukin et al. 1993). Whilst 
prophylatic administration of P - carotene at low doses may present no problem 
to humans, a more realistic and simple approach may involve moderate changes 
to the diet, for example 3 Omg of P carotene can be obtained from some 270gm 
of cooked carrots, thereby negating the need for supplement (Brown et al.
1989).
8.4.3 Dietary Antioxidants
As described previously, the antioxidants provide a mechanism for 
defence against free radical induced damage which may be produced in 
response to normal metabolism.
However, it is now recognised that tumour promotors may indeed act 
by inducing a pro - oxidant state within the tissues and there is evidence to 
suggest that tumour promotors may decrease the GSH/GSSG ratio (Perchellet 
et al. 1986), increase the activity of xanthine oxidase (Lin and Shih 1994) and 
decrease gap junctional intercellular comunication (Klaunig 1992) by a 
mechanism which may purportedly involve oxidative damage (Guppy et al. 
1994).
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Dietary anutrients have shown some potential to effect these promotion 
events. For example, P - carotene has prevented neoplastic transformation 
resulting from 3 - methylcholanthrene treatment of murine fibroblast cells 
(Betram et al. 1991; Pung et al. 1988) and has enhanced gap junctional 
communication between murine fibroblast cells (Zhang et al. 1991). Both of 
these effects occurred at very low concentrations, 10"^M and 10"^M P - 
carotene respectively, and therefore may offer real possibilities for 
chemoprevention of tumours; to attain plasma concentration of 10"^M, p - 
carotene would presumably require 2.5mg of P carotene, being present in only 
23g of carrots or 30g of spinach (Micozzi et al. 1990); however tissue 
distribution of P - carotene may vary so that tissues such as liver, adrenal 
glands and intestine achieve the richest deposition of carotenoids (Ribaya 
Mercado et al. 1992) and plasma levels recording the greatest overall increases 
as a result of supplementation. Pharmacokinetic investigations have revealed 
that P - carotene was rapidly absorbed and cleared from the plasma within 20 
hours of a single bolus dose, the majority being stored as retinol (Krinsky et al. 
1990). These observations indicate the need for regular intake of carotenoids to 
produce the maximum beneficial effect.
Similar suppressing effects have been recorded for plant phenolic 
compounds against tumour promotor - induced increases in xanthine oxidase 
activity (Chang et al. 1994; Lin and Shih 1994). Chang et al. (1994) have 
described the apparent inhibitory effects of a variety of structurally diverse 
compounds isolated from plant stems. For compounds such as caffeic acid, 
uptake processes have been described and therefore some meaningful 
interpretations may be postulated. In order to maintain plasma concentrations 
of caffeic acid at IC50 for xanthine oxidase (39pM), human consumption of 
caffeic acid could be estimated at 35mg/day, achievable from -40gm of celery 
(Rapporter 1993). Little is known however about the cellular uptake and
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properties of polyphenols, so that any genuine positive benefits remain, at 
present, only speculation.
Green tea extracts have also exhibited anti - promoting activity in vitro, 
preventing the inhibition of gap junctional communication caused by tumour 
promotors and decreasing the hepatocyte labelling index in hepatic tissue form 
phénobarbital treated rats (Klaunig 1992). It remains difficult to determine how 
such poorly absorbed components as the polyphenols may influence cell 
proliferation.
8.4.4 Immunomodulation
Amongst the most recent interest in the effects of diet, is the inherent 
capacity of the diet to modify immune function, recently reviewed by Chandra 
and Kumani (1994) and Lowell et al. (1990).
Experimental studies of these general considerations, both 
macronutrient and micronutrients effecting humoral and cell mediated 
immunity. For example, dietary lipids suppressed natural killer cell activity 
(Yaqoob et al. 1994) and altered macrophage fimction (Erickson and Hubbard 
1994).
Deficiencies in dietary vitamin D suppressed cell mediated immunity /« 
vivo (Yang et al. 1993) whilst supplementation of the diet with vitamin E 
elevated the activities of alveolar macrophages and natural killer cells 
(Moriguchi et al. 1990). It is tempting to postulate that such increases in the 
activities of natural killer cells may yield improvements in the immune 
surveillance and possibly decrease tumour incidence. Of further interest was the 
observation that xenobiotics such as alcohol may decrease the immune 
response, leading to increased susceptibility to disease (Jayasinghe et al. 1992).
Anutrient components of the diet may also possess the ability to alter 
immune fonctions. Based upon the demonstration that prostaglandins may 
decrease natural killer cell activity (Brunda et al. 1980), modulators of
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prostaglandin metabolism, derived form arachadonic acid, such as the plant 
phenolics (Huang et al. 1988; Rao et al. 1995; Huang et al. 1991), green tea 
polyphenols (Katiyar et al. 1992) and nordihydroguaiaretic acid, a plant lignin 
(Agarwal et al. 1991) may indeed have potential to modify immune function 
but this aspect has received very little attention.
8.4.5 Cellular Homeostasis and Oncogene Expression
Proto - oncogenes are purported to code for a series of proteins that 
control cell proliferation. Many cancers have been attributed to changes in 
oncogene expression and certain dietary procedures such as methyl donor 
deprivation, have been linked to increased expression of certain oncogenes.
Carotenoids depressed the expression of c - myc oncogene products in 
azoxymethane - induced aberrant crypt foci in rats; in contrast, the expression 
of c - fbs, believed to be responsible for the differentiation of cells, was 
increased by retinoic acid (Stopera and Bird 1993). It is tempting to speculate 
that such changes may confer a switch from a proliferative state to an 
environment favouring the differentiation of cells.
Human dietary interventions have shown that retinoic acid can also 
prevent the accumulation of p53 oncogene products in oral premalignant 
lesions (Lippman et al. 1995). At the low doses of consumption used 
(1.5mg/kg/day), approaching 90mg/day, may easily be achievable without 
dietary modification.
In addition, diet may possess the potential to modify the ADP - 
ribosylation of nuclear proteins. This reaction is believed to be a cellular 
response to DNA damage (Kiehlbauch et al. 1993) resulting in the stimulation 
of DNA repair, and has been shown to decrease in response to repeated 
administration of carcinogens. Moreover ADP - ribosylation has been 
implicated in the promotion of hepatocarcinogenesis by phénobarbital 
(Tsujiuchi et al. 1990). Nutritional status may also alter the ADP - ribosylation
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of nuclear proteins; for example, severe niacin deficiency, led to an increase in 
the activity of poly(ADP - ribose)polymerase enzyme (Zhang et al. 1993b). 
These observations support the interpretation that severe niacin deficiency may 
increase the susceptibility of DNA to damage due to the unavailability of 
cofactor NAD.
Of further interest "was the demonstration that the retinoids, known 
inhibitors of tumour promotion, may display the ability to inhibit poly(ADP - 
ribose) polymerase activity (Troll et al. 1990)
8.4.6 Dietary Oestrogens and Effects upon Oestrogen Metabolism
Certain classes of tumour have described to proliferate when presented 
with oestrogens and as a mechanism of promotion may be of great importance 
amongst human subjects. Indeed, treatment of cultures of normal human breast 
cell lines with oestrogens resulted in elevated oncogene expression (Leygue et 
al 1995) and cellular proliferation (Suto et al. 1992).
Supplementation of diets with indole - 3 - carbinol decreased the 
incidence of spontaneous mammary tumours in mice (Bradlow et al. 1991) and 
spontaneous endometrial tumours in rats (Kojima et al. 1994).
As has been previously described indole - 3 - carbinol modulates the 
expression of CYPIA (Jellinck et al. 1991) by direct interaction with the Ah 
receptor (Jellinck et al. 1993), responsible for the induction of CYPlAl and 
CYP1A2 isoforms of cytochromes P450 (Baldwin and Leblanc 1992). This 
induction of the CYPIA subfamily, principally CYP1A2 was proposed as the 
cause for the modulation of oestrogen metabolism (Jellinck et al. 1994) yielding 
increased levels of 2a  hydroxy- oestradiol, believed to be less effective at 
stimulating cell growth compared with 16a hydroxy - oestradiol (Kohn et al.
1993). Increase in the 2a hydroxylation of oestradiol by indole - 3 - carbinol 
associated with increased CYPIA subfamily expression, led to a decrease in the 
proliferative response of oestrogen responsive cell lines (Tiwari et al. 1994).
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However further studies have implied that induction of CYPIA was not a 
prerequisite for the antioestrogenic effects of indole - 3 - carbinol and other 
indole compounds. Liu et al. (1994) reported a decrease in cell proliferation at 
doses of indolo [3,2-b] carbazole below those necessary for induction of 
CYPIA. This antioestrogenic effect was therefore mediated by the Ah receptor 
without causing induction of CYPIA.
Further studies illustrated the antioestrogenic properties of a wide 
variety Ah receptor ligands including aromatic amines (Cikryt et al. 1990), 
polycyclic aromatic hydrocarbons (Chaloupka et al. 1992) and halogenated 
aromatic hydrocarbons (Harper et al. 1994). All the above classes of Ah 
receptor ligands have been associated with the inhibition of 17(3 oestradiol 
induced growth of cultured cells and displayed a competitive response when 
coadministered with oestradiol. All the ligands tested did not possess any 
binding affinity for the oestrogen receptor itself, but may suggest receptor 
'cross talk' between both oestrogen and Ah receptors, possibly by sharing a 
common factor in the signal transduction pathway (Harper et al. 1994).
Human dietary intervention studies using 500mg of indole - 3 - carbinol 
per day have established an increase in the 2-hydroxylation of oestradiol which 
has been attributed to induction of the CYPIA (Michnovicz and Bradlow 
1990). Whether such interventions may offer real probability for decreasing 
hormone - mediated disease remains inconclusive; however, in light of the 
observations that CYPIA induction by indole - 3 - carbinol may be transient 
(Takahashi et al. 1995a) and that dietary intake of up to 500mg/day of indole - 
3 - carbinol may prove unpaletable, it appears unlikely. Induction of the 
cytochromes P450 may represent an unlikely mechanism for protection from 
steroid - mediated tumour promotion. Potentially, competition for signal 
transduction mechanisms may provide a more complete inhibition of tumour 
promotion, yet extrapolation to the human situation may be extremely difficult.
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8.5 Summary
At the outset this treatise aimed to review the current body of literature 
concerned with dietary antimutagens and anticarcinogens in an attempt to 
establish whether or not there is a scientific basis for the belief that diet may 
have preventive effects towards chemically - induced cancers. This research 
becomes all the more relevant when considering the observation that a western 
style diet, high in fat and phosphate and low in calcium and vitamin D, caused 
hyperproliferation and hyperplasia of mammary epithelial tissue (Kahn et al.
1994).
Whilst the vast pool of epidemiological data would attest to the positive 
benefits afforded by dietary antioxidants (Collins et al. 1994; Weisberger 1991) 
and a variety of anutrient materials (Wattenberg 1992) there appeared to be 
little available information regarding the intake and absorption of many of the 
anutrients discussed. For example, the observations drawn from the discussion 
of dietary indoles focus largely upon estimations of intake (Lewis and Fenwick 
1987) derived form chemical analysis of vegetable materials (Heaney and 
Fenwick 1980) and do not make any assessment of what proportion of such 
components is actually absorbed. Therefore realistic assessment of 'dose' is 
difficult.
The contribution to antimutagenesis and anticarcinogenesis afforded by 
the gut microflora has also received little attention. Whilst bacterial metabolism 
of a variety of dietary constituents is without question a lot of effort has been 
devoted to establish whether bacterial metabolism actually increases or 
decreases the uptake of plant polyphenolics and fiavanoids. Available literature 
indicates that little direct absorption of the fiavanoids occurs (Griffiths 1982), 
explaining the observations of Caporaso et al. (1994), whom observed an 
inhibitory role for phenylethyl isothiocyanate towards the CYP2D6 - mediated 
metabolism of debrisoquine in vitro, but in human intervention experiments no 
inhibition of debrisoquine metabolism was noted in vivo.
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Appreciation of the pharmacokinetic distribution of various compounds, 
including the green tea catechins, may well aid interpretation of current in vivo 
experimental evidence. Of particular interest would be investigations using 
human subjects to establish whether or not absorption of these complex dietary 
components does occur.
Further considerations may include the nature of the protocol employed 
in experimental studies. Does the pattern of human exposure contradict or 
complement the pattern chosen for experimental purposes ? In short, how 
realistic are the experimental approaches chosen to assess anticarcinogenesis ? 
Possibly the greatest criticism may rest with the apparent dose of carcinogen 
used. Human exposure to the dietary heterocyclic aromatic amines, potentially 
the greatest source of exposure to carcinogens that non - smoking humans may 
face has been estimated at the nanogram to microgram range, yet rodents are 
persistently dosed with milligram to hundreds of milligram quantities in order 
to establish a positive effect in such small populations. Therefore by choosing 
such carcinogen doses are we not presenting too great a challenge for putative 
anticarcinogens ? How can an antimutagen or anticarcinogen administered at 
doses approaching dietary intake demonstrate a beneficial effect when 
challenged with unrealistic doses of mutagenic compounds ? Such research has 
demonstrated one vital facet, there is no ‘miracle cure' which may be derived 
fi-om the diet - the 'panacea against all ills' may be simply an idealistic aim.
However some dietary agents may indeed offer realistic protection from 
carcinogenesis. The initial point of contact for most carcinogenic species, the 
digestive tract, contains a variety of direct acting blocking agents including 
fibre, chlorophyll, the plant polyphenolics and fiavanoids all of which have 
demonstrated some ability to intercept carcinogenic species and, provided that 
ingestion of the mutagenic species is restricted, this direct inhibition of uptake 
may indeed be sufficient to eliminate the risk from a majority of dietary 
carcinogens (Hartman and Hartman 1993).
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Whether induction of the phase I XME, including CYPIA family of 
cytochromes P450, demonstrates a chemopreventive role is unclear. A wide 
variety of agents including indole - 3 - carbinol have been established as potent 
inducers (Vang et al. 1990). However, since the association of CYPIA rests 
largely with metabolic activation of chemicals such as B[a]P and IQ it appears 
unlikely that this may offer chemoprevention in a real sense. If prevention of 
metabolic activation were the primary aim, then possibly the simplest 
mechanism may involve the prophylactic prescription of a P450 inhibitor such 
as cimetidine, an impractical approach. Induction of the phase II conjugation 
enzymes, enhancing the elimination of potential carcinogenic species may be of 
some benefit.
Possibly the most important source of chemopreventive agents may 
derive from the dietary antioxidants (Weisberger 1991). Oxidant stress has 
been implicated in the pathogenesis of a variety of degenerative diseases, 
including the initiation and promotion of cancers (Collins et al. 1994). 
Therefore minimising the risk of exposure to such oxidants, or increasing the 
intake of dietary antioxidants may offer some protection (Ito and Hirose 1989) 
- indeed the most widely administered supplements include preparations of 
vitamin C and vitamin E.
The focus of mechanistic research to date has centred upon the 
prevention of events leading to initiation of chemical carcinogenesis, which by 
definition, is a single time point event. Based upon the premise that some 10^ 
mutations occur to the genome each day, it appears improbable that all such 
events can be repaired or prevented (Ames and Gold 1991). Dietary influence 
of the promotional phase of chemical carcinogenesis may offer a more practical 
approach to chemoprevention. By definition the long duration of promotion 
would aid treatment, offering many opportunities to influence the process of 
chemical carcinogenesis and also may favour the approach fostered by 
changing the diet to include a few key agents. This may also be of benefit to the
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population as a whole, it would in essence not preclude any individual - on the 
basis of age - from undertaking such steps to limit promotion.
As this treatise documents, little research has been undertaken with 
regard to the control of this promotion and progression step, which may offer 
the greatest rewards. The scope for further investigations may appear endless.
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Chapter 9
GENERAL DISCUSSION
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9.1 Final Discussion
The data presented in this thesis documents that modifications to the 
diet can modulate the expression of xenobiotic - metabolising enzymes (XME) 
in rodents. The implications of such observations may be wide - ranging and 
suggest that they may have profound effects upon the metabolism and 
subsequent elimination of xenobiotics from the body. Extrapolation of these 
findings to man indicates that diet may influence the toxicity and ultimately the 
carcinogenicity of chemicals.
Direct comparison of these observations with human subjects does 
however, presents many problems. The observation that the expression of, for 
example, the cytochromes P450 monooxygenases can be affected by dietary 
components may not represent comparable changes to human XME. Probably 
the single greatest source of such disparity is the inherent complex nature of the 
human diet. For example, rodents consume the diets or the drinking water 
perpetually, whereas the patterns of consumption observed for humans are 
more sporadic in nature, and the diet consumed contains a far greater diversity 
of chemicals. Typically, rodent diets present a monotonous, chemically - 
defined diet. Indeed in many experimental protocols the presentation of test 
chemicals perpetually in the diet or the drinking water has produced profound 
changes to the XME. Examples include the infusions of green tea (Bu Abbas et 
al 1995) and black tea polyphenols (Sohn et al. 1994), and caffeine (Ayalogu 
et al. 1995) in drinking water fed to rodents. Human consumption patterns do 
not mimic those presented to rodents during these experimental procedures. 
Indeed, humans adopt a more sporadic, random consumption of food 
components.
In addition, the level of nutrition used during these experimental 
protocols differs greatly from humans. For example the procedure of ad libitum 
feeding of rodents has been observed to increase the tumour incidence in 
rodents compared to modest calorie restriction (10 - 15%) (Kritchevsky 1990).
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Ovemutrition has been associated with large increases in the incidence of 
chemically - induced tumours (Albanes 1987; Birt 1987), and the practice of 
meal feeding (eating for only short periods during the day), adopted by humans, 
has been reported to profoundly decrease the incidence of azaserine - induced 
pancreatic tumours in rodents (Roebuck et al. 1993) compared to control, ad 
libitum fed rats receiving azaserine.
The inherent complex nature of the diet has also further precluded one 
avenue of research with particular relevence to human nutritional patterns. For 
example. Individual dietary deficiencies were studied in isolation whereas the 
human diet provides a complex mixture of nutritional components, including 
both inducers and inhibitors of drug - metabolising enzymes, and may therefore 
represent the great discrepancy between human nutrition and the protocols 
adopted during rodent bioassays. The opportunity for interaction between 
different dietary components, as exemplified by methionine deficiency and 
benzo[a]pyrene treatments within this thesis, remains largely unexplored. 
Further examples of such manipulations include the investigations of dietary 
macronutrient levels, where increases to the proportion of carbohydrate, fat or 
protein in a diet were balanced by corresponding decreases to the remaining 
macronutrients. Study of individual macronutrient species in isolation is not 
practical.
Clearly interpretation of the experimental observations documented in 
this thesis must be conducted with caution.
9.2 Glucose, Sucrose and Fructose
The replacement of starch calories in the diet with an equal weight of 
glucose, sucrose or fructose had profound effects upon the growth of the 
animals. Thermogenesis was spectulatively proposed as the cause for this poor 
calorie efficiency, however without further experimentation regarding the 
thermogenic activity of Brown Adipose Tissue or oxygen consumption, an
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indicator of metabolic rate, such suggestions remain speculation at present. The 
apparent lack of effects for glucose, sucrose and fructose upon hepatic 
xenobiotic - metabolising enzymes implies that the form in which carbohydrate 
calories are consumed in the diet has no effect upon the initiation of chemical 
carcinogenesis. Indeed the modest decreases in lauric acid hydroxylase and 
cytosolic catalase activities brought about by high sucrose diets may represent 
little toxicological significance. Moreover, the levels of refined carbohydrates 
present in the experimental diets fed to rodents may be comparable to the 
reported daily consumption of sugars by adolescents (Hackett et al. 1984), 
implying little or no toxicological significance for humans.
Possibly of greater significance may be the observation that diets high in 
sucrose are associated with an increase in faecal bile acid concentrations 
(Cademi et al. 1993), established as promotors for intestinal tumours (Cohen 
and Raicht 1981). Coupled with an increased incidence of azoxymethane - 
induced intestinal tumours (Cademi et al. 1994) diets high in refined 
carbohydrates, particularly sucrose, may present greater effects upon the 
promotion stage of carcinogenesis rather than influencing the initiation step. In 
addition, the hypercholesterolaemia and hypertriglycerideaemia associated with 
diets high in sucrose and fiuctose (Swanson et al. 1992; Halfirsch 1990) may 
be of greatest impact upon coronary heart disease, and this may indeed 
represent the greatest significance for the pathogenesis of human disease.
9.3 ’Dieting*
The practise of 'yo - yo' dieting or intermittent calorie restriction has 
received much recent attention as a method of calorie deprivation, leading to 
weight loss. Given the enormous numbers of people whom undertake such 
food restriction patterns, any changes to the XME may have profound 
consequences for human disease.
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Indeed intermittent calorie restriction led to enhanced hepatic CYP1A2 
and CYP2B activities as well as a decrease in hepatic glutathione 
concentrations. Increases in CYP1A2 activity may be viewed with concern as 
CYP1A2 is the principal isoform of cytochrome P450 responsible for the 
metabolic activation of AIA (Overvik and Gustafsson 1990), a series of 
structurally related dietary procarcinogens derived from amino acids, creatinine 
and sugars during the high temperature cooking procedures adopted for meat 
based products (Sugimura 1982). Coupled with the apparent decrease in the 
availability of reduced glutathione, it is conceivable that the rate of elimination 
of the AIA and its metabolites, as glutathione conjugates, may be greatly 
decreased, thus raising the possibility for an increase in the formation of DNA - 
AIA adducts. A logical interpretation of such findings is that dieting may 
conceivably increase the risk of initiation from carcinogenic reactive 
intermediates and hence increase the risk of chemical carcinogenesis.
However, human patterns of dieting suggest that consumption of plant 
fibres and vegetable matter increases as part of the calorie deprivation protocol. 
Therefore given the potential for vegetable fibres (Kada et al. 1984) and plant 
pigments such as chlorophyll (Ong et al. 1986) to protect against the 
carcinogenicity of AIA, the risk of a DNA - damaging event occurring as a 
result of increased CYP1A2 expression may be much reduced. The plant fibres 
may decrease the availability of precarcinogens in the gut by direct binding or 
may reduce the uptake of precarcinogen species by dilution.
Possibly the greatest concern associated with 'yo - yo' dieting may be 
the decrease in hepatic tissue glutathione concentrations, which has been 
associated with a decreased ability to combat oxidative damage to cells in vitro 
(Comporti et al. 1991). The apparent reason for such depletion of tissue 
glutathione remains unresolved but may relate to the small size of the pool of 
sulphur amino acids within the plasma. Indeed restriction of food intake by 
some 50% decreased the methionine intake from the diet by 50% and may
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represent a profound shortfall in the daily methionine requirements of the rat 
(Shin et al. 1994). Whether such requirements for methionine are also present 
in humans remains unclear, however it appears that humans do not possess 
such high dietary requirements for methionine (Stipanuk 1986) and therefore 
such deprivation of methionine may not represent such dramatic consequences 
to humans.
9.4 Chlorophyllin
Previous studies established that inclusion of chlorophyllin in the diets 
decreased the incidence of tumours in trout treated with aflatoxin B% 
(Dashwood et al 1990). During these investigations chlorophyllin was 
confirmed as a potent antimutagen towards a variety of planar mutagenic 
species and was found to be effective towards promutagens as well as the 
reactive intermediates resulting from their metabolic activation.
In addition, oral administration of chlorophyllin showed limited effects 
upon the hepatic XME. Modest increases in the activity of hepatic glutathione - 
S - transferase were documented for one substrate (DCNB) at the lowest dose 
of chlorophyllin administered. The poor absorption of chlorophyllin was 
believed to be principally responsible for the apparent lack of effects and may 
relate, in part, to the inverse relationship between the concentration of the 
porphyrin chlorophyllin present in the gut and the rate of porphyrin uptake 
from the gut. Conrad et al. (1966) describing that increasing the porphyrin 
content of the gastric lumen decreased the uptake of porphyrins from the gut.
Estimation that human consumption of chlorophyll may approach some 
250mg/day and that dietary intake of AIA has been estimated at ~12.5pg/day 
(Felton et al. 1992) suggests that a molar excess of some 20,000 chlorophyllin 
to AIA may exist in the gut. Data presented in this thesis indicated that a molar 
excess of some 5,000 times was needed to decrease the incidence of mutations
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in the Ames test by 50%; consequently chlorophyllin may itself represent a 
significant protective mechanism against dietary AIA.
9.5 Vitamin E Deficiency
Vitamin E deficiency was achieved by maintaining rats on a diet 
deficient in a  - tocopherol for seven weeks. The effects of this vitamin 
deficiency upon hepatic XME appeared largely confined to microsomal 
cytochrome P450 monooxygenases and was characterised by a rise in CYP3A 
activity and by decreases in the activity of CYP2B. Interestingly the increase in 
CYP3A, characterised by the N - déméthylation of erythromycin, was not 
confirmed by Western blot analysis, suggesting changes to the rate of reaction 
rather than to increasing the apoprotein concentration in hepatic microsomes.
Whether such changes to the activities of XME would be of any 
toxicological significance to humans is difficult to assess. The changes 
described for CYP2B and CYP3A, a 40% decrease and 80% increase in 
activity respectively, were modest and may be of little significance given the 
much higher potential for induction offered by xenobiotics including the 
barbiturates and glucocorticoid steroids. Of greatest concern may be the 
protection against lipid peroxidation afforded by vitamin E. Indeed vitamin E 
has established protective effects against the oxidation of LDL in vitro (Dieber 
- Rothendez et al. 1991) and may offer some protection fi"om the initial steps of 
athersclerosis (Rice - Evans 1995) including LDL oxidation. However, 
consideration must be given to the likelihood of producing overt vitamin E 
deficiency in humans. Vitamin E i s a  fat soluble vitamin and is therefore stored 
rather than eliminated as is the case with water soluble vitamins such as vitamin 
C and the B complexes. Vitamin E is present in an enormous variety of fatty 
food products and is also used to fortify some food products. Therefore 
vitamin E deficiency may be a condition that rarely occurs in humans. However 
with the advent of dietary ’fashions', including low fat diets for the prevention
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of heart disease, vitamin E deficiency may become of concern amongst ’healthy 
eaters.'
9.6 Modulation of Dietary Methionine Levels
Supplementation of a nutritionally adequate diet with excess methionine 
produced profound increases in the microsomal hydroxylation of p - 
nitrophenol, considered as a marker for CYP2E1. Increased CYP2E1 
expression has been associated with increased lipid peroxidation in tissue 
homogenates (Montoliu et al. 1994) and a mechanism has been proposed 
involving the futile cycling of NADPH to generate superoxide anions (Ekstrom 
and Ingelman Sundberg 1989). The contribution of dietary methionine to 
increased expression of CYP2E1 in human subjects is however marginal. In the 
present studies a high dose of methionine (Igm/kg body weight) was employed 
equivalent a human consumption of some 60gm of methionine daily, clearly 
unrealistic. However dietary xenobiotic species, including ethanol may be more 
potent inducers of CYP2E1 activity and, therefore, the contribution afforded by 
dietary nutrients appears very limited. Whether such increases in CYP2E1, 
caused by dietary nutrients or anutrients, would provide sufficient contribution 
to increase the levels of lipid peroxidation in human subjects is unclear. It was 
worth noting however, that induction of CYP2E1 has been linked to the 
pathogenesis of alcoholic liver disease (French et al. 1993) and must therefore 
be viewed with some concern.
Methionine deficiency did not significantly modulate hepatic XME in 
rats. The only effects recorded included a drastic decrease in hepatic 
glutathione concentration, coupled with a compensatory increase in glutathione 
reductase activity. In extrahepatic tissues the only significant effect was a 
decrease in the renal microsomal hydroxylation of lauric acid.
When benzo[a]pyrene was administered to methionine - deficient rats, 
the increase in hepatic CYP1A2 was higher compared to animals fed control
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diets, suggesting overexpression of this isoform of cytochrome P450. The 
implications of such increases may be cause for concern given the ability of 
CYP1A2 to activate the dietary precarcinogens, the heterocyclic amines 
(Aryton et al. 1990). However the generation of methionine deficiency in 
humans may be difficult to achieve. Rodents have a high dietary requirement 
for methionine, whereas humans demonstrate much less dependence upon this 
essential amino acid (Stipanuk 1986). Indeed methionine deficiency may prove 
extremely difficult to maintain without continuous consumption of a very 
restricted diet. However such diets do present themselves amongst the human 
population, eg. Vegans and certain oriental faiths abstain from all meat and 
dairy foods, relying upon plant sources to provide all their protein 
requirements. Dietary sources of vegetable protein, including soya and other 
pulses, possess a very low content of sulphur amino acids and therefore it is not 
inconceivable that such dietary regimes may indeed lead to overt deficiencies in 
humans.
Of interest was the observation that such dietary methionine 
deficiencies could elevate the expression of c - myc oncogene products in 
hepatic tissue. Whether these changes were due to increases in the rate of cell 
turnover and were indicative of apoptosis (Wyllie 1993) was unclear but the 
possibility that such changes may in themselves represent the proliferation of 
cells towards a malignant state cannot be ruled out. If such proliferative 
changes occur this may represent a more insidious facet of methionine 
deficiency, which was not evident throughout the experimental period. During 
the period of study the rats appeared healthy and active and grew normally.
9.7 Dietary Antimutagens and Anticarcinogens
Investigation of potential anticarcinogens has revealed that whilst 
certain classes of anutrients hold promise for the prevention of chemical
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carcinogenesis, extrapolation to human subjects is hazardous. As previously 
discussed, the discrepancies between the continuous dosing regimes used for 
rodent carcinogenicity assays and the more sporadic nature of anutrient 
consumption by humans may provide the greatest concern to experimental 
observation. For example, indole - 3 - carbinol (13 C) has been documented to 
decrease tumour incidence in rodents when fed continuously in the diet. 
However, more recent research has outlined that intermittent dosing with 13C, 
more closely resembling human intake patterns, may indeed have a tumour 
promoting effect on aflatoxin B \ induced hepatic tumours (Dashwood et al.
1990).
Further discrepancy may arise from interpretation of these experimental 
observations. Indeed 13C was observed to induce both CYPlAl and CYP1A2 
(Stresser et al. 1994) and this has been initially associated with the 
anticarcinogenic potential of I3C. However both CYPlAl and CYP1A2 have 
also been associated with the metabolic activation of precarcinogen species 
(Borlakoglu et al. 1993; Aryton et al. 1990).
The most likely approach affording benefit to human subjects appeared 
to be the induction of phase II conjugation enzymes, described as the 
'Electrophilic Counterattack' (Prestera et al. 1993) and through effects upon the 
tumour promotion phase of chemical carcinogenesis. It appeared unrealistic to 
suggest that the maximum protection from chemical carcinogenesis may arise 
from inhibitors of initiation events as such inhibitors of bioactivation are 
unlikely to possess the necessary specificity and may also conceivably interact 
with enzymes responsible for the metabolism of endogenous substrates. The 
most practical approach may be to look for agents which modify the promotion 
and progression steps of chemical carcinogenesis, allowing greater scope for 
treatment regimes to be effective. However, at present the molecular 
mechanisms governing promotion and progression are not understood.
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Concluding Remarks
Without doubt, the data presented within this thesis has demonstrated 
that certain aspects of the diet may be altered to modulate the activity of 
hepatic xenobiotic - metabolising enzymes. However, in general, these 
modifications appeared modest in nature and may indeed represent very little 
toxicological significance to the test species. In these studies, the rat was 
chosen as the focus for research but the use of further species may be advisable 
in order to validate these changes. For example, the rat may be resistant to 
XME modulation as a result of dietary modifications and may therefore 
represent a poor surrogate for man.
In addition, it must be considered that many such modifications to the 
diet were investigated in isolation; the complex nature of the diet could imply 
that such investigations represent the exception rather than the norm - the diet 
is a complex mixture of inducers, inhibitors, anutrients and potentially 
mutagenic species and therefore isolation of a single component may 
demonstrate the effects of single dietary components but may represent little 
realistic significance when the diet is assessed as 'a whole’.
Furthermore, with the discovery of genetic polymorphisms in a variety 
of cytochromes P450 including CYPlAl (Nebert et al. 1991), CYP2E1 
(Uematsu et al. 1994) and CYP2B (Grimm et al. 1994) recording several fold 
difference in the activities across a range of polymorphism, the diet may only be 
a minor contributor to the overall expression of XME. The greatest control 
exerted over XME expression may be attributed to xenobiotic components and 
genetic differences. Enormous scope remains for further investigation of the 
impact of diet upon chemical carcinogenesis and the expression of XME, 
however care must be exercised in planning experimental protocols in order to 
generate useful results. It may be prudent to modify dietary protocols to 
encompass dietary intakes similar to those of human subjects and also decrease 
the frequently used massive doses of carcinogen species used to generate
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tumours. Whilst such doses guarantee a high incidence of tumours amongst 
rodents used during experiments, they do not represent the usually low levels 
to which humans are exposed, and conceivably overcome the detoxication 
pathways of the XME. This may present too great a challenge for any dietary 
anticarcinogens to overcome. Without more careful consideration of the 
experimental procedure we run the risk of losing sight of the ultimate goal, a 
better understanding of the interaction between diet and carcinogenesis.
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